<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://media.rss.com/style.xsl"?>
<rss xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:psc="http://podlove.org/simple-chapters" xmlns:atom="http://www.w3.org/2005/Atom" xml:lang="en" version="2.0">
  <channel>
    <title><![CDATA[European Society for Vascular Surgery ]]></title>
    <link>https://esvs.org/</link>
    <atom:link href="https://media.rss.com/esvs/feed.xml" rel="self" type="application/rss+xml"/>
    <atom:link rel="hub" href="https://pubsubhubbub.appspot.com/"/>
    <description><![CDATA[<p>The ESVS offers resources for vascular surgeons, nurses, trainees and more so we may fulfil our mission of improving vascular health for the public benefit.</p><p>ESVS has received sponsorship for the inclusion of some topics to be addressed in some podcasts, but the focus, content and development of all podcasts are fully independent.</p>]]></description>
    <generator>RSS.com 2026.428.112250</generator>
    <lastBuildDate>Thu, 14 May 2026 08:00:47 GMT</lastBuildDate>
    <language>en</language>
    <copyright><![CDATA[European Society for Vascular Surgery 2023]]></copyright>
    <itunes:image href="https://media.rss.com/esvs/20230120_090158_b59ccc32f9f990197a4847a57a603779.jpg"/>
    <podcast:guid>ade91830-d5e9-59bc-baa2-36c7cf9f31e6</podcast:guid>
    <image>
      <url>https://media.rss.com/esvs/20230120_090158_b59ccc32f9f990197a4847a57a603779.jpg</url>
      <title>European Society for Vascular Surgery </title>
      <link>https://esvs.org/</link>
    </image>
    <podcast:locked>yes</podcast:locked>
    <podcast:license>European Society for Vascular Surgery 2023</podcast:license>
    <itunes:author>European Society for Vascular Surgery</itunes:author>
    <itunes:owner>
      <itunes:name>European Society for Vascular Surgery</itunes:name>
    </itunes:owner>
    <itunes:explicit>false</itunes:explicit>
    <itunes:type>episodic</itunes:type>
    <itunes:category text="Health &amp; Fitness">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <podcast:medium>podcast</podcast:medium>
    <podcast:txt purpose="ai-content">false</podcast:txt>
    <item>
      <title><![CDATA[Sac shrinkage after EVAR: a true marker of success or a misleading signal? with K. Mani]]></title>
      <itunes:title><![CDATA[Sac shrinkage after EVAR: a true marker of success or a misleading signal? with K. Mani]]></itunes:title>
      <description><![CDATA[<p>Rosalinda D’Amico interviews Prof. Kevin Mani on one of the key controversies in EVAR follow-up: is aneurysm sac shrinkage truly a marker of success, or can it sometimes provide false reassurance? They discuss the current definition of sac regression, the importance of timing and sac stability and whether sac shrinkage should influence surveillance strategies. The episode also explores the role of CTA versus duplex ultrasound and the future potential of volumetric and AI-based assessment in EVAR surveillance</p><p>References:</p><p>Tinelli G, D'Oria M, Sica S, Mani K, Rancic Z, Resch TA, Beccia F, Azizzadeh A, Da Volta Ferreira MM, Gargiulo M, Lepidi S, Tshomba Y, Oderich GS, Haulon S; SLIM F-U EVAR, Collaborative Study Group. The sac evolution imaging follow-up after endovascular aortic repair: An international expert opinion-based Delphi consensus study. J Vasc Surg. 2024 Sep;80(3):937-945. doi: 10.1016/j.jvs.2024.03.007. Epub 2024 Mar 8. PMID: 38462062.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2816625</link>
      <enclosure url="https://content.rss.com/episodes/9552/2816625/esvs/2026_05_12_11_56_13_0f5d8c40-ad3b-49a1-a9b8-33f8860a0bb8.mp3" length="14729760" type="audio/mpeg"/>
      <guid isPermaLink="false">dc49cf9a-aa30-4ced-9072-bfd1f9ad66f2</guid>
      <itunes:duration>920</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 14 May 2026 08:00:00 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2816625/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[The Invisible Risk Factor for PAD: Air Pollution with A. Settembrini]]></title>
      <itunes:title><![CDATA[The Invisible Risk Factor for PAD: Air Pollution with A. Settembrini]]></itunes:title>
      <description><![CDATA[<p>In this episode of the ESVS Podcast, we explore air pollution as an often-overlooked risk factor for peripheral arterial disease (PAD).</p><p>We are joined by Professor Alberto Maria Settembrini. Professor Settembrini is a vascular surgeon in Milan in MultiMedica and Professor of vascular surgery at Unicamillus University in Rome. He is a co-author of a large Rome-based longitudinal study involving over 1.7 million individuals. The study shows that long-term exposure to PM2.5, NO₂, and black carbon is associated with increased PAD incidence, with stronger effects in males and people aged 55–69.</p><p>Professor Settembrini discusses the links between different pollutants and PAD, how pollution interacts with traditional risk factors (obesity, diabetes, smoking, hypertension), the underlying mechanisms, and practical advice for vascular specialists in daily practice.</p><p>During the episode, we also hear from Porto’s City Councillor for the Mobility and Transportation, Engineer Hugo Beirão, who shares the city’s efforts to improve urban health.</p><p>References:</p><p>1- Ravalli S, Musumeci G, et al. Chelation therapy in patients with cardiovascular disease: a systematic review. <em>Journal of Clinical Medicine</em>. 2022;11(4):1033. doi:10.3390/jcm11041033</p><p>2- Serra R, Abramo A, Ielapi N, Procopio S, Marino P. Environmental pollution and peripheral artery disease. <em>Risk Manag Healthc Policy</em>. 2021;14:2181–2190.</p><p>3- Liao SH, Chiu CS, Jang LH, Hu SY, How CK, Hsieh VCR, et al. Long-term exposures to air pollutants and risk of peripheral arterial occlusive disease: a nationwide cohort study in Taiwan. <em>Front Cardiovasc Med</em>. 2022;9:796423.</p><p>4- Gwon JG, Park JH, Kim JS, Seo HM. Exposure to long-term air pollution and incidence of peripheral arterial disease in the general population: a national population-based retrospective cohort study. <em>[Preprint]</em>. 2021.</p><p>5- Deng Z, Duan L, Wang K. Revisiting the association between air pollution and peripheral artery disease: evidence from Mendelian randomization analysis. <em>Eur J Intern Med</em>. 2025;132:164–166.</p><p>6- Di Blasi C, Nobile F, Settembrini AM, Stafoggia M, Davoli M, Michelozzi P, et al. Association between long-term exposure to air pollution and incidence of peripheral artery disease: evidence from a longitudinal study. <em>Eur J Intern Med</em>. 2025;132:113–117.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2770610</link>
      <enclosure url="https://content.rss.com/episodes/9552/2770610/esvs/2026_04_27_13_16_56_9cf91d0f-ed3b-4b7d-bb9e-2232bc876337.mp3" length="18072760" type="audio/mpeg"/>
      <guid isPermaLink="false">044784c3-91a1-496c-a118-00f0e0c58ee1</guid>
      <itunes:duration>1129</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 07 May 2026 08:00:00 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2770610/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[ESVS 2026 Clinical Practice Guidelines on the Management of Descending Thoracic and Thoraco-Abdominal Aortic Diseases - Part 3]]></title>
      <itunes:title><![CDATA[ESVS 2026 Clinical Practice Guidelines on the Management of Descending Thoracic and Thoraco-Abdominal Aortic Diseases - Part 3]]></itunes:title>
      <description><![CDATA[<p>In this episode, we’ll focus on the final sections of the guideline, which deal with rupture, trauma, and post-operative complications. These are scenarios where decisions are often made under time pressure, evidence is limited, and outcomes can be profoundly affected by organisation of care, experience, and judgement.</p><p><strong>Guests</strong>:</p><p>Prof. Anders Wanhainen</p><p>Dr. Carlota Fernández-Prendes </p><p>Prof. Athanasios Katsargyris</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2748794</link>
      <enclosure url="https://content.rss.com/episodes/9552/2748794/esvs/2026_04_20_08_03_36_074d484b-4b1f-42fe-816c-74817eec6725.mp3" length="18077245" type="audio/mpeg"/>
      <guid isPermaLink="false">040dc621-aa95-4b84-9c4f-7bd610156550</guid>
      <itunes:duration>1129</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 23 Apr 2026 08:00:00 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2748794/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[ESVS 2026 Clinical Practice Guidelines on the Management of Descending Thoracic and Thoraco-Abdominal Aortic Diseases - Part 2]]></title>
      <itunes:title><![CDATA[ESVS 2026 Clinical Practice Guidelines on the Management of Descending Thoracic and Thoraco-Abdominal Aortic Diseases - Part 2]]></itunes:title>
      <description><![CDATA[<p>Welcome back to the ESVS Podcasts. This is Suzanne Stokmans, and you are listening to part 2 of the Q&amp;A series on the ESVS 2026 Clinical Practice Guidelines on the Management of Descending Thoracic and Thoraco-Abdominal Aortic Diseases.</p><p>In this episode, we move from the general principles discussed in part 1 to disease-specific management. We’ll focus on acute thoracic aortic syndromes, chronic type B aortic dissection, and degenerative descending thoracic and thoraco-abdominal aortic aneurysms, conditions that make up a large part of daily aortic practice, where decision-making is often nuanced and time-critical.</p><p></p><p><strong>Full names of guests:</strong></p><p>Prof. Anders Wanhainen</p><p>Dr. Carlota Fernández Prendes </p><p>Prof. Athanasios Katsargyris.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2712597</link>
      <enclosure url="https://content.rss.com/episodes/9552/2712597/esvs/2026_04_09_07_51_03_a953a145-438b-4871-937e-581512628898.mp3" length="27225954" type="audio/mpeg"/>
      <guid isPermaLink="false">4efc7b46-09f4-4fa1-a929-0d661552a087</guid>
      <itunes:duration>1701</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 16 Apr 2026 08:00:00 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2712597/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[ESVS 2026 Clinical Practice Guidelines on the Management of Descending Thoracic and Thoraco-Abdominal Aortic Diseases - Part 1]]></title>
      <itunes:title><![CDATA[ESVS 2026 Clinical Practice Guidelines on the Management of Descending Thoracic and Thoraco-Abdominal Aortic Diseases - Part 1]]></itunes:title>
      <description><![CDATA[<p>In today’s episode, the first of this three-part series, we will discuss the opening section of the guideline: service standards and general considerations. Before moving to specific disease entities or operative strategies, the guideline deliberately starts with the fundamentals — how care should be organised, how patients should be assessed, and which general principles should guide our decision making.</p><p><strong>Full names of guests:</strong></p><p>Prof. Anders Wanhainen</p><p>Dr. Carlota Fernández Prendes </p><p>Prof. Athanasios Katsargyris.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2712595</link>
      <enclosure url="https://content.rss.com/episodes/9552/2712595/esvs/2026_04_09_07_48_19_605a8b47-4668-4308-8a15-fe1e49ba307b.mp3" length="19486186" type="audio/mpeg"/>
      <guid isPermaLink="false">ea115f25-da40-4dd6-b428-31dd712d02bf</guid>
      <itunes:duration>1217</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 09 Apr 2026 08:00:55 GMT</pubDate>
      <podcast:txt purpose="ai-content">false</podcast:txt>
      <podcast:transcript url="https://transcripts.rss.com/9552/2712595/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[Chronic Venous Disease: The Treatment is Clear… But Do Patients Follow It? - with D. Celovska & A. Pathak]]></title>
      <itunes:title><![CDATA[Chronic Venous Disease: The Treatment is Clear… But Do Patients Follow It? - with D. Celovska & A. Pathak]]></itunes:title>
      <description><![CDATA[<p>In this episode of the ESVS Podcast, supported by Servier, we explore the importance of therapy adherence in chronic venous disease (CVD). The episode opens with short patient testimonies, highlighting real-world reasons for non-adherence.</p><p>To explore this further, we are joined by Professor Denisa Celovska and Professor Atul Pathak. Professor Celovska is an Associate Professor of Angiology and Internal Medicine at the University Hospital and Comenius University in Bratislava, Slovakia. She is currently the President of the Slovak Angiology Society. Professor Pathak is the Head of the National Institute of Cardiology, Cardiac Surgery and Interventional Cardiology in Luxembourg.</p><p>In this episode, they share their clinical perspective on why patients frequently disengage from treatment, the most common barriers to adherence in daily practice, and practical strategies to improve long-term treatment persistence.</p><p>The episode also includes insights from a community pharmacist, offering a complementary view on what happens between prescription and real-life use, particularly regarding venoactive drugs. We conclude by emphasising that effective CVD management extends beyond prescribing treatment. Patient education, shared decision-making, follow-up, and human connection are essential to improve adherence and long-term outcomes in CVD.</p><p>References:</p><ol><li>Kim H, Cho S, Lee K, Lee SH, Joh JH. A nationwide study of compliance of venoactive drugs in chronic venous disease patients. Ann Surg Treat Res. 2023 May;104(5):288-295. doi: 10.4174/astr.2023.104.5.288. Epub 2023 Apr 28. PMID: 37179697; PMCID: PMC10172027.</li><li>Burnier M. The role of adherence in patients with chronic diseases. Eur J Intern Med. 2024 Jan;119:1-5. doi: 10.1016/j.ejim.2023.07.008. Epub 2023 Jul 20. PMID: 37479633.</li><li>Mezalek ZT, Feodor T, Chernukha L, Chen Z, Rueda A, Sánchez IE, Ochoa AJG, Chirol J, Blanc-Guillemaud V, Lohier-Durel C, Ulloa JH. VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease. Adv Ther. 2023 Nov;40(11):5016-5036. doi: 10.1007/s12325-023-02643-6. Epub 2023 Sep 20. Erratum in: Adv Ther. 2024 Jan;41(1):464-465. doi: 10.1007/s12325-023-02722-8. Erratum in: Adv Ther. 2024 Jun;41(6):2540-2541. doi: 10.1007/s12325-024-02857-2. PMID: 37728696; PMCID: PMC10567827.</li><li>Bogachev, V., Arribas, J.M.J., Baila, S. et al. Management and evaluation of treatment adherence and effectiveness in chronic venous disorders: results of the international study VEIN Act Program. Drugs Ther Perspect 35, 396–404 (2019). https://doi.org/10.1007/s40267-019-00637-5</li><li>Golna C, Poimenidou C, Giannoukari EE, Saridi M, Liberopoulos E, Souliotis K. Assessing a pharmacist-enabled intervention to improve adherence to medication for hypertension, dyslipidemia, and chronic venous circulation disorders in Greece. <em>Patient Prefer Adherence</em>. 2023;17:3341–3352. doi:10.2147/PPA.S420811</li></ol><p>6. Branisteanu DE, Munteanu AE, Dolofan BM, Popescu EG, Vittos O. Adherence to pharmacological treatment in chronic venous disease: results of a real-world, prospective, observational cohort study. <em>Life (Basel)</em>. 2025;15(3):377. doi:10.3390/life15030377.</p><p>7. Ulloa JH, Guerra D, Cadavid LG, Fajardo D, Villarreal R, Bayona G, Hoyos AS, Garcia G. Nonoperative approach for symptomatic patients with chronic venous disease: results from the VEIN Act program. <em>Phlebolymphology</em>. 2018;25(2):123</p><p><strong><em>Servier </em></strong><em>is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from </em><strong><em>Servier</em></strong><em>. Always consult the Instructions for Use (IFU) prior to using any medical device</em>.</p><p></p>]]></description>
      <link>https://rss.com/podcasts/esvs/2660635</link>
      <enclosure url="https://content.rss.com/episodes/9552/2660635/esvs/2026_03_25_11_32_43_1def4b20-04d8-41b9-9c97-31b1df073749.mp3" length="23494944" type="audio/mpeg"/>
      <guid isPermaLink="false">c30f4b94-f465-41f3-af0e-73044bfa9de9</guid>
      <itunes:duration>1468</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 26 Mar 2026 09:00:00 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2660635/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[Vascular Graft and Endograft Infection – Building a Common Language with T. Wyss and K. Sörelius]]></title>
      <itunes:title><![CDATA[Vascular Graft and Endograft Infection – Building a Common Language with T. Wyss and K. Sörelius]]></itunes:title>
      <description><![CDATA[<p>In this episode of the ESVS Podcast, we tackle one of medicine’s most deceptively simple challenges : agreeing on what we’re actually talking about. Vascular graft and endograft infections (VGEI) are rare, serious, and universally dreaded, but when it comes to defining them, classifying them, and reporting outcomes, it turns out the vascular world hasn’t always been speaking the same language. Safa Riahi is joined by Dr Thomas Wyss and Dr Karl Sörelius to discuss a recent international Delphi consensus that brought together 43 multidisciplinary experts to do something surprisingly difficult: agree on definitions. From the long-standing debate over early versus late infection, to the subtle but clinically important difference between graft-enteric erosion and fistula, to the brave attempt to define what “cure” actually means in a disease that likes to relapse when you least expect it, this episode explores how a shared vocabulary might finally help researchers compare studies, registries make sense, and multidisciplinary teams argue a little more productively. As it turns out, building a common language might be one of the most important steps toward better science; and better care; in VGEI.</p><p>The Delphi consensus discussed in this episode can be accessed here:</p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ejves.com/article/S1078-5884(25)00707-5/">https://www.ejves.com/article/S1078-5884(25)00707-5/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/2619759</link>
      <enclosure url="https://content.rss.com/episodes/9552/2619759/esvs/2026_03_11_14_37_50_681f8d65-f800-4734-8547-5de8571fc8d8.mp3" length="20371953" type="audio/mpeg"/>
      <guid isPermaLink="false">b3e13572-6f2c-4c18-b19b-b1a99af8ec57</guid>
      <itunes:duration>1273</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 Mar 2026 09:00:00 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2619759/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[Aortic Dissections – The Asian Perspective with P. Robless]]></title>
      <itunes:title><![CDATA[Aortic Dissections – The Asian Perspective with P. Robless]]></itunes:title>
      <description><![CDATA[<p>How common are aortic dissections in Asia, and why do some patients appear to present nearly a decade earlier than in Western cohorts? Laurence Bertrand speaks with Dr. Peter Robless, founder of vascular surgery at the national university hospital of Singapore and former President of the Asian Society for Vascular Surgery, about Asian epidemiology, treatment approaches, and evolving endovascular practice.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2619727</link>
      <enclosure url="https://content.rss.com/episodes/9552/2619727/esvs/2026_03_11_14_25_39_33b85356-ace4-434a-8695-8f322eb0b690.mp3" length="21341456" type="audio/mpeg"/>
      <guid isPermaLink="false">27befada-52eb-4f8e-805f-8ae437258623</guid>
      <itunes:duration>1333</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 12 Mar 2026 09:00:00 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2619727/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[The Secret Life Of MRI/MRA]]></title>
      <itunes:title><![CDATA[The Secret Life Of MRI/MRA]]></itunes:title>
      <description><![CDATA[<p>Join us for another episode in our Secret Lives series of podcasts, where we delve into the science behind some of the everyday tools and equipment we use in the field of vascular surgery. In this episode, we will be taking a look at what is probably one of the most fearfully complicated pieces of equipment out there, the Magnetic Resonance Imaging or MRI scanner. A true marvel of applied physics and engineering that combines super-conducting magnets and radio-frequency to produce some of the most detailed medical imaging available. We will also take a look at how MR angiography works and how to interpret those grainy MRA images. No need to get confused with those T1 and T2 imaging sequences anymore; All will be explained! With Justin Woolgar.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2596411</link>
      <enclosure url="https://content.rss.com/episodes/9552/2596411/esvs/2026_03_03_08_30_59_3fd94300-3866-4c1a-8cd4-8c567a2113a7.mp3" length="18809870" type="audio/mpeg"/>
      <guid isPermaLink="false">77fd1efe-0e68-4669-9eb6-8f04bb034357</guid>
      <itunes:duration>1175</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 05 Mar 2026 09:32:26 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2596411/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[ESVS 2025 Mesenteric Ischaemia Guidelines Q&A - Pt 3 - with Guidelines Writing Committee]]></title>
      <itunes:title><![CDATA[ESVS 2025 Mesenteric Ischaemia Guidelines Q&A - Pt 3 - with Guidelines Writing Committee]]></itunes:title>
      <description><![CDATA[<p>Welcome to the final episode of the Q&amp;A series of the 2025 ESVS Clinical Practice Guidelines on the Management of Diseases of the Mesenteric and Renal Arteries and Veins. The final episode completes the Q&amp;A series by addressing several important and often rare vascular conditions covered in the 2025 ESVS guidelines.</p><p>Topics include acute and chronic mesenteric venous thrombosis, anticoagulation strategies and the role of DOACs, and indications for endovascular or surgical intervention. The discussion then turns to renal vascular disease, including renal artery stenosis, fibromuscular dysplasia, and Nutcracker syndrome. The episode concludes with an overview of visceral artery aneurysms and spontaneous isolated dissections of the mesenteric and renal arteries, focusing on diagnosis, risk stratification, and treatment thresholds. This concluding episode offers a comprehensive overview of the remaining guideline chapters and practical insights for clinical decision-making.</p><p><strong>Full names of guests:</strong></p><p>Dr. Mark Koelemay </p><p>Professor Dr. Bob Geelkerken </p><p>Dr. Nicola Leone </p><p>Dr. Jussi Kärkkäinen (Part 2)</p><p><strong>Shownotes:</strong></p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ejves.com/article/S1078-5884(25)00516-7/fulltext">https://www.ejves.com/article/S1078-5884(25)00516-7/fulltext</a></p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://open.spotify.com/episode/45Hk77hIyikYNcWklAyVMA">https://open.spotify.com/episode/45Hk77hIyikYNcWklAyVMA</a></p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://open.spotify.com/episode/58yEYHdIdh7IgVQY13gcmk">https://open.spotify.com/episode/58yEYHdIdh7IgVQY13gcmk</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/2513402</link>
      <enclosure url="https://content.rss.com/episodes/9552/2513402/esvs/2026_02_02_08_30_15_3f59254c-b2d7-4945-88d8-46486411975d.mp3" length="33509552" type="audio/mpeg"/>
      <guid isPermaLink="false">c53447ac-d8a0-488a-b46d-7845de188c0d</guid>
      <itunes:duration>2094</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 Feb 2026 08:55:01 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2513402/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[ESVS 2025 Mesenteric Ischaemia Guidelines Q&A - Pt 2 - with Guidelines Writing Committee]]></title>
      <itunes:title><![CDATA[ESVS 2025 Mesenteric Ischaemia Guidelines Q&A - Pt 2 - with Guidelines Writing Committee]]></itunes:title>
      <description><![CDATA[<p>Welcome to part 2 of the Q&amp;A series of the 2025 ESVS Clinical Practice Guidelines on the Management of Diseases of the Mesenteric and Renal Arteries and Veins. In this podcast, we will highlight the new, complex and most controversial recommendations in this guideline. In episode two, the discussion moves to Median Arcuate Ligament Syndrome (MALS), acute mesenteric ischaemia (AMI), and non-occlusive mesenteric ischaemia (NOMI)—three challenging and clinically relevant conditions.</p><p>The experts explore patient selection and diagnostic criteria for MALS, ongoing controversies in treatment, and current research. The episode also covers the clinical presentation, imaging findings, and updated diagnostic approach to acute mesenteric ischaemia, including why biomarkers such as lactate and D-dimer are no longer recommended for diagnosis. Finally, management strategies for NOMI, including multidisciplinary care and intra-arterial vasodilator therapy, are discussed.</p><p><strong>Guests:</strong></p><p>Dr. Mark Koelemay </p><p>Professor Dr. Bob Geelkerken </p><p>Dr. Nicola Leone </p><p>Dr. Jussi Kärkkäinen (Part 2)</p><p> <strong>Shownotes:</strong></p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ejves.com/article/S1078-5884(25)00516-7/fulltext">https://www.ejves.com/article/S1078-5884(25)00516-7/fulltext</a></p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://open.spotify.com/episode/45Hk77hIyikYNcWklAyVMA">https://open.spotify.com/episode/45Hk77hIyikYNcWklAyVMA</a></p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://open.spotify.com/episode/58yEYHdIdh7IgVQY13gcmk">https://open.spotify.com/episode/58yEYHdIdh7IgVQY13gcmk</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/2513401</link>
      <enclosure url="https://content.rss.com/episodes/9552/2513401/esvs/2026_02_02_08_27_43_f807c663-fc28-47cb-a2a0-c2d6d0ef0f33.mp3" length="39111041" type="audio/mpeg"/>
      <guid isPermaLink="false">0e148150-66c2-4086-9a11-88e6a253daab</guid>
      <itunes:duration>2444</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 12 Feb 2026 09:00:00 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2513401/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[ESVS 2025 Mesenteric Ischaemia Guidelines Q&A - Pt 1 - with Guidelines Writing Committee]]></title>
      <itunes:title><![CDATA[ESVS 2025 Mesenteric Ischaemia Guidelines Q&A - Pt 1 - with Guidelines Writing Committee]]></itunes:title>
      <description><![CDATA[<p>This is part 1 of the Q&amp;A series of the 2025 ESVS Clinical Practice Guidelines on the Management of Diseases of the Mesenteric and Renal Arteries and Veins. In this podcast, we will highlight the new, complex and most controversial recommendations in this guideline. Today, for the first episode of this 3-part series, we will specifically talk about chronic mesenteric ischaemia. </p><p>Topics include the definition and diagnosis of chronic mesenteric ischaemia, the role of duplex ultrasound and CT angiography, indications for treatment in symptomatic and asymptomatic patients, and decision-making around endovascular versus open revascularisation. New evidence on stent choice and surgical strategies is also discussed. This episode provides practical guidance and expert insight into the updated recommendations for managing chronic mesenteric ischaemia in daily clinical practice.</p><p></p><p><strong>Guests:</strong></p><p>Dr. Mark Koelemay </p><p>Professor Dr. Bob Geelkerken </p><p>Dr. Nicola Leone </p><p>Dr. Jussi Kärkkäinen (part 2)</p><p></p><p> <strong>Shownotes:</strong></p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ejves.com/article/S1078-5884(25)00516-7/fulltext">https://www.ejves.com/article/S1078-5884(25)00516-7/fulltext</a></p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://open.spotify.com/episode/45Hk77hIyikYNcWklAyVMA">https://open.spotify.com/episode/45Hk77hIyikYNcWklAyVMA</a></p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://open.spotify.com/episode/58yEYHdIdh7IgVQY13gcmk">https://open.spotify.com/episode/58yEYHdIdh7IgVQY13gcmk</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/2513397</link>
      <enclosure url="https://content.rss.com/episodes/9552/2513397/esvs/2026_02_02_08_23_21_57aa795c-8b17-41f5-a520-2270b8850841.mp3" length="30600138" type="audio/mpeg"/>
      <guid isPermaLink="false">2e90d863-e4fc-401d-bf87-bb9222165a91</guid>
      <itunes:duration>1912</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 05 Feb 2026 10:09:20 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2513397/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[Beyond Numbers, Towards Belonging: A Conversation with J. Gilroy]]></title>
      <itunes:title><![CDATA[Beyond Numbers, Towards Belonging: A Conversation with J. Gilroy]]></itunes:title>
      <description><![CDATA[<p>In this episode of the ESVS Podcast, host Vaiva Dabravolskaite speaks with Judith Gilroy (Ireland), a medical educator and clinician working on training culture, psychological safety, and fairness in career progression. They reflect on everyday discrimination, belonging, allyship, and the hidden curriculum in surgery. Inspired by research on sexual misconduct and microaggressions, this conversation invites honest self-reflection on how culture shapes careers and how we can do better for each other.</p><p>Literature sources to be shared if possible (divided into two groups) : </p><p>1. Key Report &amp; Ongoing Work</p><p>• Breaking the Silence: Addressing Sexual Misconduct Prof Carrie Newlands, Ms Tamzin Cuming, Ms Philippa Jackson University of Surrey / RCSI presentation (2024) <a target="_blank" rel="noopener noreferrer nofollow" href="https://openresearch.surrey.ac.uk/esploro/fulltext/report/BREAKING-THE-SILENCE-Addressing-Sexual-Misconduct/99944566102346">https://openresearch.surrey.ac.uk/esploro/fulltext/report/BREAKING-THE-SILENCE-Addressing-Sexual-Misconduct/99944566102346</a></p><p>• Workplace Sexual Misconduct in Surgery (WPSMS) – updates &amp; research <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.wpsms.org.uk/">https://www.wpsms.org.uk/</a></p><p>2. Reflection &amp; Allyship Videos</p><p>• <em>“That Little Voice”</em> <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=Ll56imVATLk">https://www.youtube.com/watch?v=Ll56imVATLk</a></p><p>• <em>What is Intersectionality?</em> – Peter Hopkins <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=O1islM0ytkE">https://www.youtube.com/watch?v=O1islM0ytkE</a></p><p>• <em>How are Microaggressions Like Mosquitoes?</em> <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=emz49wSnNcs">https://www.youtube.com/watch?v=emz49wSnNcs</a></p><p>• <em>Heartbreaking Moment When Kids Learn About White Privilege</em> <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=1I3wJ7pJUjg">https://www.youtube.com/watch?v=1I3wJ7pJUjg</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/2477058</link>
      <enclosure url="https://content.rss.com/episodes/9552/2477058/esvs/2026_01_22_08_41_44_af11fc5c-1354-47e6-9f0d-f84c5f4a846e.mp3" length="53649729" type="audio/mpeg"/>
      <guid isPermaLink="false">5f325172-ea61-4626-862f-b431dd670223</guid>
      <itunes:duration>3353</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 22 Jan 2026 11:00:00 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2477058/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[A Deep Dive into Aortic Dissections - with N. Tsilimparis]]></title>
      <itunes:title><![CDATA[A Deep Dive into Aortic Dissections - with N. Tsilimparis]]></itunes:title>
      <description><![CDATA[<p>Want to know why Prof. Tsilimparis says <strong>“the dissection membrane is not always your enemy”</strong>? Tune in to this ESVS Podcast for an in-depth discussion on <strong>indications, decision-making, technical tips and tricks</strong>, and what the future may hold for the evolving field of aortic dissection management.</p><p>Recorded live at <strong>LMU University Hospital in Munich</strong>, this episode of the <strong>ESVS Podcast</strong> features host <strong>Laurence Bertrand</strong> in conversation with <strong>Prof. Tsilimparis</strong>, Head of Vascular Surgery and an internationally recognised expert in aortic dissection management.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2460323</link>
      <enclosure url="https://content.rss.com/episodes/9552/2460323/esvs/2026_01_14_15_59_25_20b9bf65-79e2-4785-8674-13dcfb808bf2.mp3" length="37645442" type="audio/mpeg"/>
      <guid isPermaLink="false">2b57f093-817f-442b-99e1-0f595a996501</guid>
      <itunes:duration>2352</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 15 Jan 2026 11:00:00 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2460323/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[Get Moving: How Exercise Impacts Deep Vein Thrombosis- with M. J. van Rijn]]></title>
      <itunes:title><![CDATA[Get Moving: How Exercise Impacts Deep Vein Thrombosis- with M. J. van Rijn]]></itunes:title>
      <description><![CDATA[<p>Can exercise really make a difference after deep vein thrombosis? We talk with Professor Marie José van Rijn from Erasmus University Medical Center about how physical activity can influence recovery, reduce complications like post-thrombotic syndrome, and improve quality of life. From early mobilisation to long-term exercise strategies, discover how “get moving” may change the way we manage DVT.</p><p>Join us for this insightful conversation!</p><p>References:</p><p>1. Martins, A; Junior L; Oliveira, J. (2023). Benefits of early mobilization in patients with deep venous thrombosis: a scope review. Heart, Vessels and Transplantation.</p><p>2. Rook B, van Rijn MJE, Jansma EP, van Montfrans C. Effect of exercise after a deep venous thrombosis: A systematic review. J Eur Acad Dermatol Venereol. </p><p>3. Kahn SR. The post-thrombotic syndrome. Hematology Am Soc Hematol Educ Program. </p><p>4. Liu Z, Tao X, Chen Y, Fan Z, Li Y. Bed rest versus early ambulation with standard anticoagulation in the management of deep vein thrombosis: a meta-analysis. PLoS One. </p><p>5. Anderson CM, Overend TJ, Godwin J, Sealy C, Sunderji A. Ambulation after deep vein thrombosis: a systematic review. Physiother Can. </p><p>6. Kahn SR, Comerota AJ, Cushman M, Evans NS, Ginsberg JS, Goldenberg NA, Gupta DK, Prandoni P, Vedantham S, Walsh ME, Weitz JI; American Heart Association Council on Peripheral Vascular Disease, Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association.</p><p>Circulation. 2014 Oct 28;130(18):1636-61. doi: 10.1161/CIR.0000000000000130. Epub 2014 Sep 22. Erratum in: Circulation. </p><p>7. Kakkos SK, Gohel M, Baekgaard N, Bauersachs R, Bellmunt-Montoya S, Black SA, Ten Cate-Hoek AJ, Elalamy I, Enzmann FK, Geroulakos G, Gottsäter A, Hunt BJ, Mansilha A, Nicolaides AN, Sandset PM, Stansby G, Esvs Guidelines Committee, de Borst GJ, Bastos Gonçalves F, Chakfé N, Hinchliffe R, Kolh P, Koncar I, Lindholt JS, Tulamo R, Twine CP, Vermassen F, Wanhainen A, Document Reviewers, De Maeseneer MG, Comerota AJ, Gloviczki P, Kruip</p><p>MJHA, Monreal M, Prandoni P, Vega de Ceniga M. Editor's Choice – European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg. </p><p>8. Jasionowska S, Turner BRH, Machin M, Onida S, Gwozdz AM, Shalhoub J, Davies AH. Systematic review of exercise therapy in the management of post-thrombotic syndrome. Phlebology. </p><p>9. Steiner D, Nopp S, Pabinger I, Dassler E, Koppensteiner R, Müller M, Weber B, Ay C, Schlager O. Impact of thrombosis location on walking capacity: a cohort study of patients with acute deep vein thrombosis. Res Pract Thromb Haemost. </p><p>10. Wu C, Li X, Zhao H, Ling Y, Ying Y, He Y, Zhang S, Liang S, Wei J, Gan X. Resistance exercise promotes the resolution and recanalization of deep venous thrombosis in a mouse model via SIRT1 upregulation. BMC Cardiovasc Disord. </p><p>11. Mota GR, Simim MAM, Dos Santos IA, Sasaki JE, Marocolo M. Effects of Wearing Compression Stockings on Exercise Performance and Associated Indicators: A Systematic Review. Open Access J Sports Med. </p>]]></description>
      <link>https://rss.com/podcasts/esvs/2430470</link>
      <enclosure url="https://content.rss.com/episodes/9552/2430470/esvs/2026_01_05_10_25_37_fa4559c4-59be-4c7d-8ce8-7b184738266e.mp3" length="14802485" type="audio/mpeg"/>
      <guid isPermaLink="false">f2c62d12-5dee-4002-b800-16486d4ea527</guid>
      <itunes:duration>925</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 08 Jan 2026 11:00:00 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2430470/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[PTFE And The Ghost Of Christmas Past]]></title>
      <itunes:title><![CDATA[PTFE And The Ghost Of Christmas Past]]></itunes:title>
      <description><![CDATA[<p>In our special holiday podcast we take a look at the current controversy surrounding PFAS or Forever chemicals. Were you aware that one of the most commonly used compounds in vascular surgery, PTFE, actually falls into this category of substances? Is there anything to worry about? What should we be telling patients? All of these burning questions will be answered. With Justin Woolgar.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2394288</link>
      <enclosure url="https://content.rss.com/episodes/9552/2394288/esvs/2025_12_16_12_48_26_a0599cb4-31ae-4e95-85cc-985fe0eed8ea.mp3" length="11605507" type="audio/mpeg"/>
      <guid isPermaLink="false">dcde2d7a-98ac-4ee1-9ece-f8fb7d2a6db2</guid>
      <itunes:duration>725</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 24 Dec 2025 09:00:00 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Trainee Perspective in Vascular Surgery Across Europe with M. Golian, C. Chwila, D. van den Hondel, and D. Wippel]]></title>
      <itunes:title><![CDATA[Trainee Perspective in Vascular Surgery Across Europe with M. Golian, C. Chwila, D. van den Hondel, and D. Wippel]]></itunes:title>
      <description><![CDATA[<p>In this episode, we focus on the trainee perspective in vascular surgery across Europe.</p><p>Trainees and young vascular surgeons share what works in training, what doesn’t, and what they would change if they could, touching on structure, mentorship, autonomy, soft skills, and everyday challenges.</p><p>We’re also joined by Dr David Wippel, who presents insights from his research on the training experience of young vascular surgeons, including burnout, fulfilment, and professional development.</p><p>Get involved</p><p>If you’re a trainee or young vascular surgeon and would like to take part in the survey discussed in this episode, you can join here: </p><p><strong>Link to the Trainee Survey: </strong><a target="_blank" rel="noopener noreferrer nofollow" href="https://redcap.link/8ubj206v">https://redcap.link/8ubj206v</a></p><p>If you’re a consultant in vascular surgery with over 5 years of experience and would like to take part in the survey discussed in this episode, you can join here: </p><p><strong>Link to the Trainer Survey: </strong><a target="_blank" rel="noopener noreferrer nofollow" href="https://redcap.link/shp8nthl">https://redcap.link/shp8nthl</a></p><p>Your input helps shape the future of vascular surgery training.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2391420</link>
      <enclosure url="https://content.rss.com/episodes/9552/2391420/esvs/2025_12_15_16_03_46_dcabe3cb-1cc1-45c9-b72a-cc3bf9f27bdc.mp3" length="19902749" type="audio/mpeg"/>
      <guid isPermaLink="false">eee21ff6-7641-4001-ac82-ae4dfbe3a4aa</guid>
      <itunes:duration>1243</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 18 Dec 2025 11:00:00 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2391420/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[Realities of Training Young Vascular Surgeons - E. Iborra & I. Končar ]]></title>
      <itunes:title><![CDATA[Realities of Training Young Vascular Surgeons - E. Iborra & I. Končar ]]></itunes:title>
      <description><![CDATA[<p>In Part 1 of our ESVS training series, we speak with Professor Elena Iborra and Professor Igor Končar about the realities of training young vascular surgeons across Europe. They discuss expectations, mentorship, and how to shape safe, effective learning environments for the next generation.</p><p>A concise, insightful look at what defines good vascular training today.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2383092</link>
      <enclosure url="https://content.rss.com/episodes/9552/2383092/esvs/2025_12_11_08_17_32_c60f72f1-a437-4c29-828d-eb88ac3a211d.mp3" length="21259111" type="audio/mpeg"/>
      <guid isPermaLink="false">903285ae-6a53-4df2-b54a-e84ad39c4173</guid>
      <itunes:duration>1328</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Dec 2025 11:00:17 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2383092/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[TOGETHER Registry - with K.K. Yeung and T. Resch]]></title>
      <itunes:title><![CDATA[TOGETHER Registry - with K.K. Yeung and T. Resch]]></itunes:title>
      <description><![CDATA[<p>How can a global, imaging-rich registry powered by AI reshape surveillance and quality of life after EVAR and TEVAR?</p><p>In this episode of the ESVS Podcast, host Egle Kavaliunaite speaks with Prof. Kak Khee Yeung (Amsterdam UMC, ESVS President 2026–27-elect) and Prof. Timothy Resch (Copenhagen University Hospital) about the <strong>TOGETHER Registry</strong>, a large, prospective, long-term aortic registry capturing real-world data on EVAR, TEVAR and iliac branch devices, including hostile as well as standard anatomy.</p><p>In this conversation, they explore:</p><ul><li>What makes TOGETHER different from previous aortic registries (central imaging, longer follow-up, global scope)</li><li>How advanced imaging and AI-ready data may help predict which patients need intensive surveillance – and who may safely need less</li><li>The clinical meaning of sac regression, endoleaks and durability when viewed through patient quality of life</li><li>The strengths and limitations of a single-brand registry in a multi-device treatment landscape</li><li>How remote monitoring, mobile tools and future biomarkers could transform aortic follow-up</li></ul><p><strong>Listen now</strong>, and subscribe to the ESVS Podcast on Spotify, Apple Podcasts or SoundCloud, and explore more aortic content in the ESVS Library.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2368505</link>
      <enclosure url="https://content.rss.com/episodes/9552/2368505/esvs/2025_12_04_13_27_20_ea8460b8-1183-49e0-bac5-536c44464d33.mp3" length="22650087" type="audio/mpeg"/>
      <guid isPermaLink="false">b8aef8bb-cfee-40ee-9394-1c16ac18ba5f</guid>
      <itunes:duration>1415</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 04 Dec 2025 13:29:18 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2368505/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[Exploring Peripheral Arterial Disease in Women]]></title>
      <itunes:title><![CDATA[Exploring Peripheral Arterial Disease in Women]]></itunes:title>
      <description><![CDATA[<p>We explore the challenges of Peripheral Arterial Disease (PAD) in women, with two renowned experts: Professor Maarit Venermo and Professor Mirjami Laivuori.</p><p>Together, we discuss why PAD continues to be underdiagnosed in women despite equal or even higher prevalence, the limitations of the ankle–brachial index (ABI) in female patients, the intricate interplay between estrogen, menopause, and vascular health, the growing trend toward endovascular-first strategies in women, and the conflicting evidence surrounding revascularisation outcomes.</p><p>An evidence-based and clinically relevant conversation awaits.</p><p>References</p><ul><li><strong>Divakaran S, Krawisz AK, Secemsky EA, Kant S.</strong> <em>Sex and Racial Disparities in Peripheral Artery Disease.</em> <strong>2023</strong></li><li><strong>Jelani QU, Petrov M, Martinez SC, Holmvang L, Al-Shaibi K, Alasnag M.</strong> <em>Peripheral Arterial Disease in Women: an Overview of Risk Factor Profile, Clinical Features, and Outcomes.</em> <strong>2018</strong></li><li><strong>Kozak M, Poredoš P, Blinc A, Kaja Ježovnik M, Poredoš P.</strong> <em>Peripheral arterial disease in women.</em> <strong>2024</strong></li><li><strong>Porras CP, Bots ML, Teraa M, van Doorn S, Vernooij RWM.</strong> <em>Differences in Symptom Presentation in Women and Men with Confirmed Lower Limb Peripheral Artery Disease: A Systematic Review and Meta-Analysis.</em> <strong>2022</strong></li><li><strong>Kavurma MM, Boccanfuso L, Cutmore C, Passam F, Patel S, Hennessy A, Loa J, Figtree GA, Golledge J, Robinson DA, Aitken S.</strong> <em>A hidden problem: peripheral artery disease in women.</em> <strong>2023</strong></li><li><strong>Srivaratharajah K, Abramson BL.</strong> <em>Women and Peripheral Arterial Disease: A Review of Sex Differences in Epidemiology, Clinical Manifestations, and Outcomes.</em> <strong>2018</strong></li><li><strong>Pabon M, Cheng S, Altin SE, Sethi SS, Nelson MD, Moreau KL, Hamburg N, Hess CN.</strong> <em>Sex Differences in Peripheral Artery Disease.</em> <strong>2022</strong></li><li><strong>Twine CP, Kakkos SK, Aboyans V, Baumgartner I, Behrendt CA, Bellmunt-Montoya S, Jilma B, Nordanstig J, Saratzis A, Reekers JA, Zlatanovic P; ESVS Guidelines Committee; Antoniou GA, de Borst GJ, Bastos Gonçalves F, Chakfé N, Coscas R, Dias NV, Hinchliffe RJ, Kolh P, Lindholt JS, Mees BME, Resch TA, Trimarchi S, Tulamo R, Vermassen FEG, Wanhainen A; Document Reviewers; Koncar I, Fitridge R, Matsagkas M, Valgimigli M.</strong> <em>European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases.</em> <strong>2023</strong></li><li><strong>Nordanstig J, Behrendt CA, Baumgartner I, Belch J, Bäck M, Fitridge R, Hinchliffe R, Lejay A, Mills JL, Rother U, Sigvant B, Spanos K, Szeberin Z, van de Water W; ESVS Guidelines Committee; Antoniou GA, Björck M, Gonçalves FB, Coscas R, Dias NV, Van Herzeele I, Lepidi S, Mees BME, Resch TA, Ricco JB, Trimarchi S, Twine CP, Tulamo R, Wanhainen A; Document Reviewers; Boyle JR, Brodmann M, Dardik A, Dick F, Goëffic Y, Holden A, Kakkos SK, Kolh P, McDermott MM.</strong> <em>European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication.</em> <strong>2024</strong></li></ul>]]></description>
      <link>https://rss.com/podcasts/esvs/2351113</link>
      <enclosure url="https://content.rss.com/episodes/9552/2351113/esvs/2025_11_27_08_29_40_b6edd52b-d83a-4679-9ea3-d8cf9ff6cb37.mp3" length="25077594" type="audio/mpeg"/>
      <guid isPermaLink="false">e41f0a98-ef18-4e6a-b71c-8334fa8509a8</guid>
      <itunes:duration>1567</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 27 Nov 2025 10:35:09 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[CO2 Flushing w/T. Kölbel]]></title>
      <itunes:title><![CDATA[CO2 Flushing w/T. Kölbel]]></itunes:title>
      <description><![CDATA[<p>In this episode, with Prof. Tilo Kölbel, we discuss the significant risks associated with air embolism during aortic surgery, the innovative technique of CO2 flushing of aortic endografts, and the practical tips and tricks of implementing this technique in clinical practice. The conversation also touches on current guidelines and the future of CO2 flushing in endovascular protocols, emphasising its potential to improve patient outcomes. Unmissable!</p><p>Also, check out these papers that we mentioned in the podcast:</p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ejves.com/action/showPdf?pii=S1078-5884%2825%2900409-5">https://www.ejves.com/action/showPdf?pii=S1078-5884%2825%2900409-5</a></p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://journals.sagepub.com/doi/10.1177/1526602816633705">https://journals.sagepub.com/doi/10.1177/1526602816633705</a></p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10151986/">https://pmc.ncbi.nlm.nih.gov/articles/PMC10151986/</a></p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ejves.com/action/showPdf?pii=S1078-5884%2818%2930692-0">https://www.ejves.com/action/showPdf?pii=S1078-5884%2818%2930692-0</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/2319305</link>
      <enclosure url="https://content.rss.com/episodes/9552/2319305/esvs/2025_11_10_09_21_56_334cde2b-a8ee-4600-af9a-1d8a2e5a2c36.mp3" length="14554420" type="audio/mpeg"/>
      <guid isPermaLink="false">f66c8a6e-164a-467d-8cd8-06e707628ee9</guid>
      <itunes:duration>909</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 13 Nov 2025 11:01:13 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Gaza: A Vascular Surgeon's Experience]]></title>
      <itunes:title><![CDATA[Gaza: A Vascular Surgeon's Experience]]></itunes:title>
      <description><![CDATA[<p>The war in Gaza has been described as a humanitarian catastrophe. Ever since the war began 2 years ago, following the October 7th attack by Hamas it is estimated that over 68,000 people have been killed, with a further 180,000 injured. Thousands have been displaced, and many have suffered starvation and famine because of the Israeli blockade. The plight of medics trying to treat civilians has also been extremely challenging and dangerous, with health care facilities often targeted by the IDF airstrikes. In this podcast, we talk to Mr Ed Brown, a consultant vascular surgeon from the UK who has recently returned from Gaza and describes his experiences working in a warzone. What does it take to work in such an environment? What are the challenges facing surgeons and other health professionals in Gaza? Ever thought of humanitarian work yourself? These are the questions we hope to answer. With Justin Woolgar.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2307043</link>
      <enclosure url="https://content.rss.com/episodes/9552/2307043/esvs/2025_11_04_08_43_04_79d3044a-cf6b-4532-99fb-139264398f4a.mp3" length="17502494" type="audio/mpeg"/>
      <guid isPermaLink="false">949a416f-4574-4922-894e-6321bc4eeb7f</guid>
      <itunes:duration>1093</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 06 Nov 2025 11:01:12 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2025: Management of Aortic Graft Infections with A. LeJay]]></title>
      <itunes:title><![CDATA[#ESVS2025: Management of Aortic Graft Infections with A. LeJay]]></itunes:title>
      <description><![CDATA[<p>Aortic stent infections remain among the most feared and complex complications in vascular surgery—rare but devastating when they occur. In episode, recorded live in ESVS Istanbul, <strong>Dr. Laurence Bertrand</strong> speaks with <strong>Dr. Anne Le Jay</strong>, about complex aortic reconstruction and graft infection management. Together, they examine how vascular specialists are redefining best practice: from early recognition and imaging to multidisciplinary treatment planning, surgical decision-making, and long-term outcomes. </p>]]></description>
      <link>https://rss.com/podcasts/esvs/2296949</link>
      <enclosure url="https://content.rss.com/episodes/9552/2296949/esvs/2025_10_29_10_02_22_a54127ad-2b9e-4434-bc8c-3fe6c7f6c7c8.mp3" length="14962564" type="audio/mpeg"/>
      <guid isPermaLink="false">73eff2e8-6bf2-4875-89c5-ceef6b802ee0</guid>
      <itunes:duration>935</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 30 Oct 2025 11:01:12 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2296949/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[#ESVS2025 - Oncovascular Surgery with P. Vikatmaa and S. Ancetti]]></title>
      <itunes:title><![CDATA[#ESVS2025 - Oncovascular Surgery with P. Vikatmaa and S. Ancetti]]></itunes:title>
      <description><![CDATA[<p>Recorded live during the ESVS Annual Meeting, this episode brings together two experts shaping the field of <em>oncovascular surgery</em> Dr. Pirkka Vikatmaa and Dr. Stefano Ancetti. We explore how multidisciplinary oncovascular teams are transforming cancer surgery, the expanding role of vascular surgeons in complex tumour resections, and the use of endovascular techniques in oncovascular surgery.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2286841</link>
      <enclosure url="https://content.rss.com/episodes/9552/2286841/esvs/2025_10_23_07_58_54_25e89351-5b26-4f08-96a0-db152cc2d4a5.mp3" length="8014319" type="audio/mpeg"/>
      <guid isPermaLink="false">c173f082-2286-41bb-ba55-334c7b3a8cae</guid>
      <itunes:duration>500</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 23 Oct 2025 10:01:14 GMT</pubDate>
      <podcast:location rel="creator" geo="geo:41.04627045,28.98896488" osm="W267046312" country="tr">Istanbul Congress Center, Darülbedai Caddesi, Taşkışla, Harbiye, Şişli, Istanbul, 34367, Turkey</podcast:location>
    </item>
    <item>
      <title><![CDATA[#ESVS2025 - Basic DFU Biomechanics w/J. Pascual]]></title>
      <itunes:title><![CDATA[#ESVS2025 - Basic DFU Biomechanics w/J. Pascual]]></itunes:title>
      <description><![CDATA[<p>In this episode, recorded live at the 39th ESVS Annual Meeting, we sit down with Prof. Javier Pascual<strong>,</strong> a podiatrist specialised in diabetic foot care and wound biomechanics. Together, we explore the biomechanical principles behind the most common diabetic foot ulcers (DFUs) — why they develop, how abnormal pressure and gait contribute to tissue breakdown, and what clinicians can do to enhance healing and to prevent ulcer recurrence. Dr. Pascual breaks down complex concepts into practical insights, making this a must-listen for vascular specialists, podiatrists, wound-care nurses, and anyone involved in multidisciplinary diabetic foot management.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2268227</link>
      <enclosure url="https://content.rss.com/episodes/9552/2268227/esvs/2025_10_13_09_47_24_57cf76b1-6ef5-49f3-aff0-b21a8666c855.mp3" length="11057394" type="audio/mpeg"/>
      <guid isPermaLink="false">a9cb409c-19e1-4206-a497-b145d844a15b</guid>
      <itunes:duration>691</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 16 Oct 2025 10:01:27 GMT</pubDate>
      <podcast:transcript url="https://transcripts.rss.com/9552/2268227/transcript" type="text/vtt"/>
    </item>
    <item>
      <title><![CDATA[The Secret Life of Stents]]></title>
      <itunes:title><![CDATA[The Secret Life of Stents]]></itunes:title>
      <description><![CDATA[<p>Join us for another episode in our journey into the secret lives of vascular machines and devices. In this episode, we look at the ubiquitous vascular stent. Ever wondered who invented them and when they were first used to treat vascular disease? Ever thought about why they are made of stainless steel or nitinol? In fact, what actually is Nitinol? All your burning questions answered in this podcast that delves into the world of vascular bioengineering. Presented by Justin Woolgar.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2258365</link>
      <enclosure url="https://content.rss.com/episodes/9552/2258365/esvs/2025_10_07_09_28_48_1cf18d96-d32f-45f5-984c-cb2a96dda702.mp3" length="15077077" type="audio/mpeg"/>
      <guid isPermaLink="false">132984db-8ae1-4749-94ae-8fd0bdf33d3e</guid>
      <itunes:duration>942</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 09 Oct 2025 09:28:20 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Patient adherence to treatment with K. Hafidh ]]></title>
      <itunes:title><![CDATA[Patient adherence to treatment with K. Hafidh ]]></itunes:title>
      <description><![CDATA[<p>Only about 50% of patients with chronic diseases adhere to treatment recommendations, and the consequences can be devastating. In this thought-provoking episode of the ESVS Podcasts, we delve into this important and under-discussed issue. Together with Professor Khadija Hafidh, we analyse some factors that help explain why so many patients struggle with adherence, as well as some strategies that have proved effective in improving patient compliance. Spoiler: empathy, communication, shared decision making, and simplifying the treatment regime are key elements. Join us in this episode that can really help your clinical practice.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2250977</link>
      <enclosure url="https://content.rss.com/episodes/9552/2250977/esvs/2025_10_03_07_12_40_9f02f093-06e3-44e0-aac3-46b37850f7c8.mp3" length="26241415" type="audio/mpeg"/>
      <guid isPermaLink="false">030e7b83-e66c-4ed1-8f0d-0475116999d0</guid>
      <itunes:duration>1640</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Fri, 03 Oct 2025 10:01:12 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[The Secret Life of The Hand-Held Doppler Machine]]></title>
      <itunes:title><![CDATA[The Secret Life of The Hand-Held Doppler Machine]]></itunes:title>
      <description><![CDATA[<p>As vascular surgeons, we all use various pieces of equipment and technology in our day jobs. Everything from the hand-held Doppler to complex ultrasound machines, CT and MRI scanners. Every time we treat vascular disease we use some form of technology, be it an angioplasty balloon, stent or a vascular graft. We are surrounded by technology and use it all the time, but how many of us actually have any clue as to how it works? In this series of podcasts, we will take a slightly light-hearted look at the biomedical engineering involved in some of the pieces of kit that most of us take for granted. Nothing too overwhelming, but enough to explain the science behind the machine.</p><p>In the first episode, we will take a look at the humble hand-held Doppler machine and explain how this frequently used machine does what it does. We will explain how the Doppler and piezoelectric effects combine to make an essential tool for clinicians and allied healthcare professionals in the field of vascular surgery.</p><p>Presented by Justin Woolgar.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2219197</link>
      <enclosure url="https://content.rss.com/episodes/9552/2219197/esvs/2025_09_17_07_31_24_ac11a48c-9dd5-40c8-a07a-a0c812f606f8.mp3" length="15576538" type="audio/mpeg"/>
      <guid isPermaLink="false">359d7e2c-724b-4224-9972-9d20eae833ef</guid>
      <itunes:duration>973</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 18 Sep 2025 08:44:10 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ERAS in Abdominal Aortic Aneurysm Repair – International Perspectives (Pt 2) w/A. Settembrini & A. K Vavra]]></title>
      <itunes:title><![CDATA[ERAS in Abdominal Aortic Aneurysm Repair – International Perspectives (Pt 2) w/A. Settembrini & A. K Vavra]]></itunes:title>
      <description><![CDATA[<p>In this episode, we’re joined by Prof. Alberto Settembrini and Associate Professor Ashley K. Vavra to discuss the application of Enhanced Recovery After Surgery (ERAS) protocols in the treatment of abdominal aortic aneurysms.</p><p>We explore how ERAS principles are adapted for both open and endovascular AAA repair, covering key elements such as preoperative risk assessment, anaesthetic management, early mobilisation, and discharge planning.</p><p>The conversation underscores the importance of bridging the gap between evidence and clinical practice, as well as the central role of the entire multidisciplinary team, comprising surgeons, anesthesiologists, nurses, physiotherapists, and dietitians.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2210403</link>
      <enclosure url="https://content.rss.com/episodes/9552/2210403/esvs/2025_09_11_08_00_56_c1862b2a-0d67-4c3c-a89a-460b0f1589ab.mp3" length="9833608" type="audio/mpeg"/>
      <guid isPermaLink="false">6dd74954-c3ca-4a85-8594-119cdbbb56fc</guid>
      <itunes:duration>614</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Sep 2025 10:01:15 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ERAS in Vascular Surgery - Setting Patients Up for Success (Pt 1) - w/K.McGinigle]]></title>
      <itunes:title><![CDATA[ERAS in Vascular Surgery - Setting Patients Up for Success (Pt 1) - w/K.McGinigle]]></itunes:title>
      <description><![CDATA[<p>In this episode, we’re joined by Prof. Kate McGinigle – vascular surgeon, researcher, and expert in Enhanced Recovery After Surgery (ERAS).</p><p>We explore the role of ERAS protocols in optimising outcomes for vascular surgery patients, with a focus on preoperative risk assessment, nutritional support, and structured prehabilitation.</p><p>Drawing on clinical data and implementation experience, Prof. McGinigle outlines practical strategies that surgical teams can adopt to reduce complications, support recovery, and personalise care pathways.</p><p>This is Part 1 of a two-part series on perioperative optimisation in vascular surgery.</p><p>Recommended for surgeons, anesthesiologists, dietitians, physiotherapists, and all healthcare professionals involved in perioperative care.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2195010</link>
      <enclosure url="https://content.rss.com/episodes/9552/2195010/esvs/2025_09_02_10_32_01_1b48cf07-e17a-4dc8-979d-a07cd072d790.mp3" length="18473644" type="audio/mpeg"/>
      <guid isPermaLink="false">dc94f2ac-a4e6-4acb-86dc-961167959362</guid>
      <itunes:duration>1154</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 04 Sep 2025 10:01:27 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Chronic Wound Treatment Part 2 - Dr. Magdalena Antoszewska and Kamila Mazuryk]]></title>
      <itunes:title><![CDATA[Chronic Wound Treatment Part 2 - Dr. Magdalena Antoszewska and Kamila Mazuryk]]></itunes:title>
      <description><![CDATA[<p>In Part 2 of our wound care series, we shift focus to what happens on the wound bed itself. From negative pressure therapy to advanced dressings and skin grafts – this episode is all about local treatment strategies.</p><p>Our expert guests, dermatologist Dr. Magdalena Antoszewska and wound care nurse Kamila Mazuryk, walk us through practical solutions, clinical tips, and the logic behind what works (and what doesn’t) in complex wound care, especially when perfusion is compromised.</p><p> This episode covers:</p><ul><li>Skin grafts: when, how, and why they succeed or fail</li><li>The do’s and don’ts of NPWT in ischemic and grafted wounds</li><li>How to approach wound bed preparation with limited vascular supply</li><li>Dressing selection: infection control, moisture balance, and biofilm management</li><li>When to avoid debridement – and what to do instead</li><li>Incorporating patient quality of life and mental health into long-term wound plans</li><li>Advanced materials and smart bandage technology</li></ul><p>If you’re dealing with diabetic feet, graft failures, or wounds that just won’t close, this episode brings frontline advice from the people who live in the wound world every day.</p><p>Whether you're in theatre, clinic, or at the bedside, this is the practical wound wisdom you need.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2125659</link>
      <enclosure url="https://content.rss.com/episodes/9552/2125659/esvs/2025_07_22_09_51_07_5056e48b-05d6-4b71-98ed-731a836e2d76.mp3" length="28130778" type="audio/mpeg"/>
      <guid isPermaLink="false">0b08c769-fd88-4ea5-a2a1-b976ffa70d06</guid>
      <itunes:duration>1758</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 24 Jul 2025 11:01:35 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Thoracic branch devices - Giovanni Pratesi]]></title>
      <itunes:title><![CDATA[Thoracic branch devices - Giovanni Pratesi]]></itunes:title>
      <description><![CDATA[<p>In a short series of podcasts, we are going to explore the evolving field of complex thoracic aortic repair, with a particular focus on complex endovascular devices implanted in the aortic arch or even the ascending aorta, that is, zones 0 to 2. In today’s episode, we are going to dig into proximal landing zone 2, that is, the need to place the TEVAR device between the left carotid and the left subclavian arteries, so over the origin of the LSA, and strategies to preserve left subclavian artery perfusion.</p><p> </p>]]></description>
      <link>https://rss.com/podcasts/esvs/2118440</link>
      <enclosure url="https://content.rss.com/episodes/9552/2118440/esvs/2025_07_17_10_44_09_421d6a30-0b2e-469f-85a9-0d37e84f16e2.mp3" length="25746664" type="audio/mpeg"/>
      <guid isPermaLink="false">ac251ce4-9bfd-4a41-bb63-d13e5a969b04</guid>
      <itunes:duration>1601</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 17 Jul 2025 10:44:19 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Are Women Left Behind in Carotid Stenosis Treatment? - Barbara Rantner and Claudia Schrimpf]]></title>
      <itunes:title><![CDATA[Are Women Left Behind in Carotid Stenosis Treatment? - Barbara Rantner and Claudia Schrimpf]]></itunes:title>
      <description><![CDATA[<p>In this thought-provoking episode of the ESVS Podcast we delve into an important and under-discussed issue in vascular surgery: Are women left behind in carotid stenosis treatment?</p><p>Carotid stenosis is a contributor to ischemic strokes, and some papers show women may experience delays or suboptimal care in comparison to men. In this episode, we will listen to Professor Barbara Rantner, a senior consultant vascular surgeon from Munich, Germany, and Dr Claudia Schrimpf, a leading expert from Zurich, Switzerland. Together, they explore sex-related differences in carotid disease treatment and share their insights on the latest research and clinical experiences.</p><p>Join us in this episode!</p><p>References:</p><p>Naylor R, Rantner B, Ancetti S, de Borst GJ, De Carlo M, Halliday A, Kakkos SK, Markus HS, McCabe DJH, Sillesen H, van den Berg JC, Vega de Ceniga M, Venermo MA, Vermassen FEG. European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease. <em>Eur J Vasc Endovasc Surg</em>. 2023;65(1):7–111. doi:10.1016/j.ejvs.2022.04.011</p><p>van Dam-Nolen DHK, van Egmond NCM, Koudstaal PJ, van der Lugt A, Bos D. Sex differences in carotid atherosclerosis: a systematic review and meta-analysis. <em>Stroke</em>. 2023;54(2):315–326. doi:10.1161/STROKEAHA.122.041046</p><p>Skowronska M, Piorkowska A, Czlonkowska A. Differences in carotid artery atherosclerosis between men and women in the early phase after ischemic event. <em>Neurol Neurochir Pol</em>. 2018;52(1):35–40. doi:10.1016/j.pjnns.2017.09.002</p><p>Schmid S, Tsantilas P, Knappich C, Kallmayer M, König T, Breitkreuz T, Zimmermann A, Kuehnl A, Eckstein H-H. Risk of in-hospital stroke or death is associated with age but not sex in patients treated with carotid endarterectomy for asymptomatic or symptomatic stenosis in routine practice: secondary data analysis of the nationwide German statutory quality assurance database from 2009 to 2014. <em>J Am Heart Assoc</em>. 2017;6(10):e004764. doi:10.1161/JAHA.116.004764</p><p>Behrendt CA, Ten Bosch JA, Cronenwett JL, Dick F, Guekht A, Halliday A, et al. Sex-related differences in indication and procedural outcomes of carotid interventions in VASCUNET. <em>Eur J Vasc Endovasc Surg</em>. 2023;66(1):7–14. doi:10.1016/j.ejvs.2023.04.022</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2108841</link>
      <enclosure url="https://content.rss.com/episodes/9552/2108841/esvs/2025_07_10_13_13_11_dce010a1-db6a-4026-b06a-63c51e0c843a.mp3" length="21777231" type="audio/mpeg"/>
      <guid isPermaLink="false">c6022fbf-f488-4b29-85eb-973c48652a04</guid>
      <itunes:duration>1361</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 10 Jul 2025 13:16:41 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Chronic Wound Treatment - w/K. Isoherranen ]]></title>
      <itunes:title><![CDATA[Chronic Wound Treatment - w/K. Isoherranen ]]></itunes:title>
      <description><![CDATA[<p>What role will AI, smart bandages, and regenerative therapies play in the future of wound care? </p><p>Dr. Kirsi Isoherranen (Immediate Past President of the European Wound Management Association) joins us to explore how advanced technology is reshaping diagnostics, wound bed preparation, and chronic wound treatment, especially for diabetic and ischaemic ulcers. This conversation covers both frontline clinical insights and forward-looking perspectives from one of Europe’s leading wound healing centres.</p><p>Dr. Isoherranen shares with us how collaboration between vascular surgeons and wound care specialists improves outcomes in managing ischemic and diabetic wounds. They discuss diagnostic delays, treatment planning, and how a multidisciplinary approach, including dermatologists, podiatrists, and nutritionists, can make or break complex wound care cases.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2099819</link>
      <enclosure url="https://content.rss.com/episodes/9552/2099819/esvs/2025_07_03_10_04_58_f301965c-e471-43b9-99ae-728ce51a09c3.mp3" length="21554352" type="audio/mpeg"/>
      <guid isPermaLink="false">24593892-2322-4b36-a8fc-3457710947a3</guid>
      <itunes:duration>1347</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 03 Jul 2025 10:05:06 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Mind the Gap: Women and Aortic Aneurysms w/ C. Fernandez-Prendes & A.-L. Pouncey]]></title>
      <itunes:title><![CDATA[Mind the Gap: Women and Aortic Aneurysms w/ C. Fernandez-Prendes & A.-L. Pouncey]]></itunes:title>
      <description><![CDATA[<p>Join us for a compelling episode of the ESVS Podcast as we explore the sex disparities in aortic disease with two experts in aortic surgery in women — Dr. Carlota Fernandez-Prendes and Dr. Anna-Louise Pouncey.</p><p>In this episode, we discuss why women remain under-represented in clinical trials, which subgroups may benefit most from targeted screening, and why women face higher complication rates after both open and endovascular aneurysm repair in the immediate perioperative period. </p><p>We also examine the underlying causes of these differences and how vascular surgeons can optimise outcomes for their female patients.</p><p>This episode underscores the importance of heightened clinical awareness and tailored research. Stay tuned until the end for key insights on aortic aneurysm in women.</p><p>Referenced articles:</p><p>Talvitie M, Åldstedt-Nyrønning L, Stenman M, Roy J, Cohnert T, Hultgren R. Women with large intact abdominal aortic aneurysms remain untreated. <em>J Vasc Surg</em>. 2023;78(3):657–667. doi:10.1016/j.jvs.2023.05.025.</p><p>O’Donnell TFX, Patel PB, Marcaccio CL, Dansey KD, Swerdlow NJ, Rastogi V, Patel VI, Beck AW, Zettervall SL, Schermerhorn ML. Outcomes of complex endovascular treatment of post-dissection aneurysms. <em>Eur J Vasc Endovasc Surg</em>. 2023;66(1):58–66. doi:10.1016/j.ejvs.2023.04.013.</p><p>Gorgatti F, Nana P, Panuccio G, Rohlffs F, Torrealba JI, Kölbel T. Post-dissection thoraco-abdominal aortic aneurysm managed by fenestrated or branched endovascular aortic repair. <em>Eur J Vasc Endovasc Surg</em>. 2024;68(3):325–334. doi:10.1016/j.ejvs.2024.04.041.</p><p>Huckaby LV, Sultan I, Trimarchi S, Leshnower B, Chen EP, Brinster DR, et al. Sex-based aortic dissection outcomes from the International Registry of Acute Aortic Dissection. <em>Ann Thorac Surg</em>. 2022;113(2):498–505. doi:10.1016/j.athoracsur.2021.03.100.</p><p>Tenorio ER, Oderich GS, Farber MA, Schneider DB, Timaran CH, Schanzer A, et al. Outcomes of endovascular repair of chronic postdissection compared with degenerative thoracoabdominal aortic aneurysms using fenestrated-branched stent grafts. <em>J Vasc Surg</em>. 2020;72(3):822–836. doi:10.1016/j.jvs.2019.10.091.</p><p>Lo RC, Bensley RP, Hamdan AD, Wyers M, Adams JE, Schermerhorn ML; Vascular Study Group of New England. Gender differences in abdominal aortic aneurysm presentation, repair, and mortality in the Vascular Study Group of New England. <em>J Vasc Surg</em>. 2013;57(5):1261–1268.e5. doi:10.1016/j.jvs.2012.11.039.</p><p>Lancaster EM, Gologorsky R, Hull MM, Okuhn S, Solomon MD, Avins AL, et al. The natural history of large abdominal aortic aneurysms in patients without timely repair. <em>J Vasc Surg</em>. 2022;75(1):109–117. doi:10.1016/j.jvs.2021.07.125.</p><p>Bulder RMA, Tedjawirja VN, Hamming JF, Koelemay MJ, Balm R, Lindeman JHN; on behalf of the study group collaborators. Hypothesis of the high mortality of female patients following elective open abdominal aortic aneurysm repair. <em>Eur J Vasc Endovasc Surg</em>. 2022;63(5):773–774. doi:10.1016/j.ejvs.2022.01.018.</p><p>Pouncey AL, David M, Morris RI, Ulug P, Martin G, Bicknell C, Powell JT. Systematic review and meta-analysis of sex-specific differences in adverse events after open and endovascular intact abdominal aortic aneurysm repair: consistently worse outcomes for women. <em>Eur J Vasc Endovasc Surg</em>. 2021;62(3):367–378. doi:10.1016/j.ejvs.2021.05.029.</p><p>O’Donnell TFX, Verhagen HJ, Pratesi G, Pratesi C, Teijink JAW, Vermassen FEG, et al. Female sex is associated with comparable 5-year outcomes after contemporary endovascular aneurysm repair despite more challenging anatomy. <em>J Vasc Surg</em>. 2019;70(6):1782–1792.e2. doi:10.1016/j.jvs.2019.05.065.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2089953</link>
      <enclosure url="https://content.rss.com/episodes/9552/2089953/esvs/2025_06_26_07_05_51_2b23e793-f20d-43a5-b019-ab06741a97ea.mp3" length="39645980" type="audio/mpeg"/>
      <guid isPermaLink="false">48415da2-15fc-46da-9733-1305aedc0111</guid>
      <itunes:duration>2477</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 26 Jun 2025 10:00:47 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[EJVES:  Mesenteric Artery Stenosis is a Risk Factor for Anastomotic Leakage in Colorectal Surgery by Harmankaya et al]]></title>
      <itunes:title><![CDATA[EJVES:  Mesenteric Artery Stenosis is a Risk Factor for Anastomotic Leakage in Colorectal Surgery by Harmankaya et al]]></itunes:title>
      <description><![CDATA[<p>With today's guests, Koen Vree Egberts and Desiree van Noord, we dive into this open-access paper. The study revealed that a stenosis exceeding 50% in the superior mesenteric (SMA) or inferior mesenteric artery on pre-operative computed tomography (CT) scan correlates with an elevated risk of anastomotic leakage (AL) after colorectal surgery. These findings suggest the potential for more personalised risk assessment regarding AL in patients undergoing a colorectal resection by pre-operative screening for mesenteric artery stenosis by duplex ultrasound or CT scan. For cases of SMA stenosis, alternative surgical approaches such as primary stoma creation or (endovascular) revascularisation of the stenosis before colorectal resection could be considered, as well as close post-operative surveillance of patients at risk.</p><p></p>]]></description>
      <link>https://rss.com/podcasts/esvs/2080868</link>
      <enclosure url="https://content.rss.com/episodes/9552/2080868/esvs/2025_06_19_12_22_19_31eb843c-ff7d-4af2-a138-5510d0ea7635.mp3" length="16673038" type="audio/mpeg"/>
      <guid isPermaLink="false">c5c64e70-aa11-4bff-ba51-64f01471dc9d</guid>
      <itunes:duration>1037</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 Jun 2025 12:22:28 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Vascular Fundamentals - Haemodynamics of Venous Disorders - Part 4]]></title>
      <itunes:title><![CDATA[Vascular Fundamentals - Haemodynamics of Venous Disorders - Part 4]]></itunes:title>
      <description><![CDATA[<p>Welcome to the final episode of our ESVS Vascular Fundamentals podcasts. In the last episode, we looked at some basic venous physiology. In this podcast, we will be looking at the haemodynamics of specific venous disorders such as acute venous thrombosis, primary varicose veins and chronic venous insufficiency. Ever wondered why exactly a DVT causes limb swelling? What happens to the venous physiology in phlegmasia? Why do people get varicose veins? What are the haemodynamic consequences of chronic venous insufficiency? Lots more burning questions that we will answer! Stay tuned!</p><p>With Justin Woolgar and Joanna Halman.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2038959</link>
      <enclosure url="https://content.rss.com/episodes/9552/2038959/esvs/2025_05_21_15_03_17_2277fc47-4c09-4679-8999-8189fc0e6c25.mp3" length="26466465" type="audio/mpeg"/>
      <guid isPermaLink="false">cc4c6f6b-abe4-4c86-ad98-1aa7f9b9d96b</guid>
      <itunes:duration>1654</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 29 May 2025 10:01:22 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Vascular Fundementals Part 3 - Venous Haemodynamics]]></title>
      <itunes:title><![CDATA[Vascular Fundementals Part 3 - Venous Haemodynamics]]></itunes:title>
      <description><![CDATA[<p>Welcome to Part 3 of our ESVS Vascular Fundamentals series of podcasts. In the last two podcasts we concentrated on arterial haemodynamics; now it's the turn of the venous system.</p><p>In this episode we look at what constitutes venous pressure and flow. How does blood flow in this low pressure system with what are effectively collapsible tubes. We explain what happens to venous pressure on standing and during exercise. What is ambulatory venous pressure? How does the cardiac cycle affect venous pressure? We will also explain how important the calf muscle pump is in reducing venous pressure and returning blood to the heart. What role do venous valves play? All basic principles in understanding venous patho-physiology.</p><p>With Justin Woolgar and Joanna Halman.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2038956</link>
      <enclosure url="https://content.rss.com/episodes/9552/2038956/esvs/2025_05_21_15_01_23_0312d749-f085-4367-80e6-aa382cf655d2.mp3" length="17240852" type="audio/mpeg"/>
      <guid isPermaLink="false">b12500b0-a36f-4be6-8678-b607e7825fed</guid>
      <itunes:duration>1077</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 22 May 2025 10:01:07 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Vascular Fundamentals: Arterial Haemodynamics - Part 2]]></title>
      <itunes:title><![CDATA[Vascular Fundamentals: Arterial Haemodynamics - Part 2]]></itunes:title>
      <description><![CDATA[<p>Welcome to the second episode of our  ESVS Vascular Fundamentals podcast series. In the last episode, we looked at the relationship of pressure, flow and resistance and how they interact in the circulation. In part 2, we will be examining how these parameters are affected during exercise, intermittent claudication and limb ischaemia. We will also examine the haemodynamics of vascular grafts and aortic aneurysms. Some of the questions we will explore include why exercise is recommended for claudication, flow dynamics at the graft-arterial anastomosis and why aneurysms rupture. With Justin Woolgar and Joanna Halman.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2027977</link>
      <enclosure url="https://content.rss.com/episodes/9552/2027977/esvs/2025_05_14_08_04_03_898af704-30da-4c9e-b18e-9885318160a7.mp3" length="21401636" type="audio/mpeg"/>
      <guid isPermaLink="false">d4f25802-c263-4097-9cbf-c2ea24a30f06</guid>
      <itunes:duration>1337</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 15 May 2025 10:01:24 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Vascular Fundamentals: Arterial Haemodynamics - Part 1]]></title>
      <itunes:title><![CDATA[Vascular Fundamentals: Arterial Haemodynamics - Part 1]]></itunes:title>
      <description><![CDATA[<p>Join us for the first of our series of Vascular Fundamentals podcasts. In our first episode, we will be breaking down the basics of arterial haemodynamics looking at the physiology of the circulation and how an understanding of it aids our decision making as vascular surgeons.  We will attempt to explain the relationship between pressure, flow and peripheral resistance and how they are affected in vascular disease. What role does blood viscosity and Poiseuille's Law play in affecting blood flow? What actually is peripheral resistance? At what point does a stenosis become a significant stenosis and why? Some of the important questions we will explain. With Justin Woolgar and Joanna Halman.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/2016762</link>
      <enclosure url="https://content.rss.com/episodes/9552/2016762/esvs/2025_05_06_12_01_56_6d2ee9b9-e352-4841-9366-70d751664ffd.mp3" length="15552715" type="audio/mpeg"/>
      <guid isPermaLink="false">8ccc700a-0e2b-454d-ba62-70588b4ca930</guid>
      <itunes:duration>971</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 08 May 2025 10:00:46 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[BASIL-3 RCT with M. Popplewell, lead investigator]]></title>
      <itunes:title><![CDATA[BASIL-3 RCT with M. Popplewell, lead investigator]]></itunes:title>
      <description><![CDATA[<p>In this podcast, Prof. Matthew Popplewell, lead investigator, discusses the BASIL-3 RCT, diving into the trial's design, the recruitment challenges, the statistical power, and the relevance of its findings to current clinical practice. The discussion also touches on the demographics of the patient population involved in the trial, the underrepresentation of women in vascular trials, the mortality toll of these patients, the recurrent nature of chronic limb-threatening ischemia and the implications for generalizability of the results. Unmissable!</p><p>Read the full text- article open access through this link:</p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bmj.com/content/bmj/388/bmj-2024-080881.full.pdf">https://www.bmj.com/content/bmj/388/bmj-2024-080881.full.pdf</a></p><p> </p><p>And check out the companion BASIL Prospective Cohort Study mentioned in the podcast:</p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ejves.com/action/showPdf?pii=S1078-5884%2823%2900804-3">https://www.ejves.com/action/showPdf?pii=S1078-5884%2823%2900804-3</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/2004860</link>
      <enclosure url="https://content.rss.com/episodes/9552/2004860/esvs/2025_04_28_11_18_51_62a069a7-3ce3-4ccf-a789-463daa663a4e.mp3" length="36925694" type="audio/mpeg"/>
      <guid isPermaLink="false">1b1fc9d3-7dcb-4743-b793-572314ac651c</guid>
      <itunes:duration>2307</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 30 Apr 2025 10:01:39 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Editor’s Choice: Radiation Protection and Pregnancy in Vascular Surgery and Interventional Radiology in the Netherlands by Jongen et al]]></title>
      <itunes:title><![CDATA[Editor’s Choice: Radiation Protection and Pregnancy in Vascular Surgery and Interventional Radiology in the Netherlands by Jongen et al]]></itunes:title>
      <description><![CDATA[<p>Nationally and internationally, there is a growing awareness of radiation exposure, safety, and protection. In 2023, the ESVS issued a new guideline on radiation safety. In addition, there is growing attention to pregnant healthcare workers. This paper openly discusses the intersection of radiation safety and pregnancy. It was published as an Editor’s Choice paper in EJVES December 2024. </p><p>Find the original article here:</p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ejves.com/article/S1078-5884(24)00802-5/abstract">https://www.ejves.com/article/S1078-5884(24)00802-5/abstract</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1985795</link>
      <enclosure url="https://content.rss.com/episodes/9552/1985795/esvs/2025_04_14_08_53_21_6acd934d-cce3-45f1-94f1-8cf39c56bb5e.mp3" length="12459705" type="audio/mpeg"/>
      <guid isPermaLink="false">4b96d940-4d60-440b-9cfc-216e3613ab17</guid>
      <itunes:duration>776</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 24 Apr 2025 10:01:18 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[The New 2025 ESVS Vascular Trauma Guidelines: A South African Perspective - with B. Pillay & D. Clarke]]></title>
      <itunes:title><![CDATA[The New 2025 ESVS Vascular Trauma Guidelines: A South African Perspective - with B. Pillay & D. Clarke]]></itunes:title>
      <description><![CDATA[<p>In this episode of our series of podcasts looking at the new ESVS Vascular Trauma Guidelines, Laurence Bertrand and Justin Woolgar interview Professor Bala Pillay, Head of the Durban Metropolitan Vascular Service and Professor Damian Clarke, Head of the Pietermaritzburg Trauma Service, to find out what the guidelines mean and the challenges faced by vascular and trauma surgeons in developing countries such as South Africa. Enjoy!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1979346</link>
      <enclosure url="https://content.rss.com/episodes/9552/1979346/esvs/2025_04_09_08_05_52_6aa9163e-bcf2-4e47-9ea3-06ac28837d0b.mp3" length="22746631" type="audio/mpeg"/>
      <guid isPermaLink="false">3a87e379-84ef-482e-8f80-28d5ee1ebf7e</guid>
      <itunes:duration>1420</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 10 Apr 2025 10:01:34 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Q&A ESVS Guidelines on Vascular Trauma: Pt 4 w/C. Wahlgren & L. Davidovic - Focus Paediatric Vascular Trauma and more]]></title>
      <itunes:title><![CDATA[Q&A ESVS Guidelines on Vascular Trauma: Pt 4 w/C. Wahlgren & L. Davidovic - Focus Paediatric Vascular Trauma and more]]></itunes:title>
      <description><![CDATA[<p>Join us for another interview with Prof. Dr. Carl M. Wahlgren and Prof. Dr. Lazar B. Davidovic, two of the writers of the Vascular Trauma Guidelines Committee. This episode focuses on the paediatric vascular trauma, but also overall gaps in the knowledge and the patient perspective. </p><p>This is Part 4 of our Vascular Trauma Guideline Series, Enjoy!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1969775</link>
      <enclosure url="https://content.rss.com/episodes/9552/1969775/esvs/2025_04_02_12_41_51_55e1e7da-e67b-46bc-84af-cd70fe684d12.mp3" length="30019126" type="audio/mpeg"/>
      <guid isPermaLink="false">d6623c3f-f335-47f8-93fe-89d9ff20923f</guid>
      <itunes:duration>1876</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 03 Apr 2025 10:01:36 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Q&A ESVS Guidelines on Vascular Trauma: Pt 3 with V. Jongkind and M.A. Ruffino]]></title>
      <itunes:title><![CDATA[Q&A ESVS Guidelines on Vascular Trauma: Pt 3 with V. Jongkind and M.A. Ruffino]]></itunes:title>
      <description><![CDATA[<p>Join us for an interview with two of the writers of the vascular trauma guideline committee, focusing on the extremity and abdominal sections. This is Part 3 of our Vascular Trauma Guideline Series. Enjoy!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1960299</link>
      <enclosure url="https://content.rss.com/episodes/9552/1960299/esvs/2025_03_27_09_02_26_71159ba4-aed3-4056-8f29-f433af2528de.mp3" length="27612260" type="audio/mpeg"/>
      <guid isPermaLink="false">291e6516-88da-4c87-83aa-8507c98df571</guid>
      <itunes:duration>1725</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 27 Mar 2025 11:01:39 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Q&A ESVS Vascular Trauma Guidelines: Pt 2 with P. Vikatmaa and J.-B. Ricco - Neck and Thorax ]]></title>
      <itunes:title><![CDATA[Q&A ESVS Vascular Trauma Guidelines: Pt 2 with P. Vikatmaa and J.-B. Ricco - Neck and Thorax ]]></itunes:title>
      <description><![CDATA[<p>Join us for an interview with the minds behind the new vascular trauma guidelines: Professors Pirkka Vikatmaa and Jean-Baptise Ricco share the thought processes behind the Neck and Thorax sections.  This is Part 2 of our Vascular Trauma Guideline Series, Enjoy!</p><p></p><p></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1949501</link>
      <enclosure url="https://content.rss.com/episodes/9552/1949501/esvs/2025_03_20_08_46_51_7b50475f-fdf6-4058-92a7-1e80ef3ed4ec.mp3" length="30017454" type="audio/mpeg"/>
      <guid isPermaLink="false">209cd542-320d-40f9-a226-d1d57f9bd18a</guid>
      <itunes:duration>1876</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 20 Mar 2025 11:01:26 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Q&A on the New ESVS Vascular Trauma Guidelines: Part 1]]></title>
      <itunes:title><![CDATA[Q&A on the New ESVS Vascular Trauma Guidelines: Part 1]]></itunes:title>
      <description><![CDATA[<p>Here is Part 1 in our podcast series focussing on the recently published ESVS Vascular Trauma Guidelines, the first of its kind. Join us today for a personal Q&amp;A session with the chairs of the writing committee, Professors Carl Wahlgren and Karim Brohi, themselves for an in depth look at section 2 of the guidelines: General considerations in vascular trauma.  We discuss who should perform vascular trauma, what is the role of endovascular trauma, and how does the new ESVS vascular trauma classification system work, and much more.</p><p>Enjoy!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1938454</link>
      <enclosure url="https://content.rss.com/episodes/9552/1938454/esvs/2025_03_13_07_27_08_922031c1-b167-4405-b5f5-3cdb8cedd3f3.mp3" length="28124252" type="audio/mpeg"/>
      <guid isPermaLink="false">5dae0e17-5412-4e35-953f-c54807291b8d</guid>
      <itunes:duration>1757</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 13 Mar 2025 11:01:27 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Editor's Choice - Can Machine Learning Models help Predict the Edoleak Typ Ia]]></title>
      <itunes:title><![CDATA[Editor's Choice - Can Machine Learning Models help Predict the Edoleak Typ Ia]]></itunes:title>
      <description><![CDATA[<p>Join us for this week’s Editor’s Choice Article about ‘Machine Learning Based Prediction of Post-operative Infrarenal Endograft Apposition for Abdominal Aortic Aneurysms' (Nov 2024 EJVES).  We are honoured to have the first author Dr. van Veldhuizen join us for an in depth discussion of the paper, explaining the intricacies of the model and what this research could mean for future automated preoperative aortic planning.</p><p> </p><p>Link to full article:</p><p>Machine Learning-Based Prediction of Post-operative Infrarenal Endograft Apposition for Abdominal Aortic Aneurysms</p><p>Willemina van Veldhuizen, Jean-Paul P.M. de Vries, Annemarii Tuinstra, Jelmer M. Wolterink, Richte. C.L. Schuurmann, Virtual Stenting Study Group. European Journal of Vascular and Endovascular Surgery. November 2024. 68(5):577-578.</p><ol><li>Unlocking Endoleak Risk: Machine Learning and Aortic Geometry in Endovascular Aneurysm Repair Failure Prediction Ryan Gouveia E Melo, Graeme K Ambler European Journal of Vascular and Endovascular Surgery November 2024. Volume 68, Issue 5, P577-578.Link to full article: <a target="_blank" rel="noopener noreferrer nofollow" href="https://linkinghub.elsevier.com/retrieve/pii/S1078-5884(24)00685-3">https://linkinghub.elsevier.com/retrieve/pii/S1078-5884(24)00685-3</a></li><li>Shortest Apposition Length at the First Postoperative Computed Tomography Angiography Identifies Patients at Risk for Developing a Late Type la Endoleak, After Endovascular Aneurysm Repair. Anna C.M. Geraedts, MD, Roy Zuidema, MD. ODYSSEUS-TIEL Study Group. Volume 31, Issue 2. Journal of Endovascular Therapy. Volume 31, Issue 2, April 2024. Pages 274-281.Link to full article: <a target="_blank" rel="noopener noreferrer nofollow" href="https://doi.org/10.1177/15266028221120514">https://doi.org/10.1177/15266028221120514</a></li><li>Use of Artificial Intelligence With Deep Learning Approaches for the Follow-up of Infrarenal Endovascular Aortic Repair. Quentin Coatsaliou, Fabien Largyre, Caroline Caradu, et al. Journal of Endovascular Therapy. 2024 May 9.<a target="_blank" rel="noopener noreferrer nofollow" href="https://doi.org/10.1177/15266028241252097">https://doi.org/10.1177/15266028241252097</a></li></ol><p></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1927297</link>
      <enclosure url="https://content.rss.com/episodes/9552/1927297/esvs/2025_03_05_13_44_36_3e4fa611-280f-4b60-9188-8011a52d7db1.mp3" length="23485047" type="audio/mpeg"/>
      <guid isPermaLink="false">f4e0dbb0-7ee0-4dc8-9436-957cbadf2275</guid>
      <itunes:duration>1467</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 06 Mar 2025 11:00:56 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Editor's Choice: Challenges of Predicting Arteriovenous Access Survival Prior to Conversion from Catheter by Hofmann et al.]]></title>
      <itunes:title><![CDATA[Editor's Choice: Challenges of Predicting Arteriovenous Access Survival Prior to Conversion from Catheter by Hofmann et al.]]></itunes:title>
      <description><![CDATA[<p>This paper explores whether machine learning techniques can improve the prediction of arteriovenous access survival and avoid failures in patients transitioning from central venous catheters to arteriovenous fistulas or grafts. It was published as an Editor’s choice paper in EJVES November 2024.</p><p></p><p>Shownotes:</p><p>Editor's Choice – Challenges of Predicting Arteriovenous Access Survival Prior to Conversion from Catheter</p><p>Hofmann, Amun G et al. </p><p>European Journal of Vascular and Endovascular Surgery, Volume 68, Issue 5, 654 - 662, November 2024</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1906749</link>
      <enclosure url="https://content.rss.com/episodes/9552/1906749/esvs/2025_02_20_12_56_18_47cbaaaf-6866-44ff-9556-c78cd6a4b5c9.mp3" length="9717939" type="audio/mpeg"/>
      <guid isPermaLink="false">530cfcb1-20fc-4de2-8931-7bf3ecbca62d</guid>
      <itunes:duration>604</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 20 Feb 2025 12:56:22 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2024 - Vascular Access w/ F. Gentile & R. Brambilla]]></title>
      <itunes:title><![CDATA[#ESVS2024 - Vascular Access w/ F. Gentile & R. Brambilla]]></itunes:title>
      <description><![CDATA[<p>During the ESVS Annual Meeting in Kraków, we had the lovely opportunity to exchange with Flavia Gentile and Roberta Brambilla, respectively the former and current ESVS Academy Pathway Leads for Dialysis.</p><p>Together, we dig deeper into the gaps of evidence in vascular access obstruction. In this second part of this discussion.</p><p>More on the ESVS Dialysis Pathway: <a target="_blank" rel="noopener noreferrer nofollow" href="https://esvs.org/esvs-academy/esvs-academy-pathways/vascular-access-path/">https://esvs.org/esvs-academy/esvs-academy-pathways/vascular-access-path/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1889566</link>
      <enclosure url="https://content.rss.com/episodes/9552/1889566/esvs/2025_02_10_10_51_34_77d15c65-e29b-48d4-8558-419f0ed9d68c.mp3" length="20243897" type="audio/mpeg"/>
      <guid isPermaLink="false">208128ec-1828-470d-b435-9e14653d2b2d</guid>
      <itunes:duration>1265</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 13 Feb 2025 11:01:40 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2024 - Vascular Access Pre-Op Planning & Patient Selectiong w/ F. Gentile & R. Brambilla]]></title>
      <itunes:title><![CDATA[#ESVS2024 - Vascular Access Pre-Op Planning & Patient Selectiong w/ F. Gentile & R. Brambilla]]></itunes:title>
      <description><![CDATA[<p>During the ESVS Annual Meeting in Kraków, we had the lovely opportunity to exchange with Flavia Gentile and Roberta Brambilla, respectively the former and current ESVS Academy Pathway Leads for Dialysis.</p><p>Together, we dig deeper into the gaps of evidence in vascular access obstruction. In this first part of this discussion, we discuss pre-operative planning, and patient selection and assessment. </p><p>More on the ESVS Dialysis Pathway: <a target="_blank" rel="noopener noreferrer nofollow" href="https://esvs.org/esvs-academy/esvs-academy-pathways/vascular-access-path/">https://esvs.org/esvs-academy/esvs-academy-pathways/vascular-access-path/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1882335</link>
      <enclosure url="https://content.rss.com/episodes/9552/1882335/esvs/2025_02_05_10_30_25_f9a5f6a7-f63e-4b0a-8cb3-fbe0dcbcc48f.mp3" length="14060608" type="audio/mpeg"/>
      <guid isPermaLink="false">9631b867-47d0-451c-abc7-e7fcf43cfd32</guid>
      <itunes:duration>878</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 06 Feb 2025 11:01:22 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Editor's Choice: Impact of Infrapopliteal Revascularisation Establishing In Line Flow to the Wound in Patients with Chronic Limb Threatening Ischaemia by Iida et al]]></title>
      <itunes:title><![CDATA[Editor's Choice: Impact of Infrapopliteal Revascularisation Establishing In Line Flow to the Wound in Patients with Chronic Limb Threatening Ischaemia by Iida et al]]></itunes:title>
      <description><![CDATA[<p>In today's podcast, Laurence Bertrand and Suzanne Stokmans dissect this multicentre observational study from Japan recently published in the EJVES looking at infra popliteal revascularisation in CLTI.  This study focuses on choosing the appropriate target lesion to achieve infrapopliteal revascularisation.  They compare targeting in line flow to the wound based on personalised angiograms as opposed to in line flow to the foot based on the traditional angiosome concept.  </p><p> </p><p>Link to the full article (Open Access): <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ejves.com/article/S1078-5884(24)00634-8/fulltext">https://www.ejves.com/article/S1078-5884(24)00634-8/fulltext</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1859949</link>
      <enclosure url="https://content.rss.com/episodes/9552/1859949/esvs/2025_01_22_14_26_46_6148b80d-5da1-4a16-bbb0-3c2447c31d4b.mp3" length="9504337" type="audio/mpeg"/>
      <guid isPermaLink="false">1933982f-9aa5-494e-85bc-09a93c2d7240</guid>
      <itunes:duration>593</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 23 Jan 2025 11:01:36 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Editorial: Reporting Standards w/M. Björck & J. Boyle]]></title>
      <itunes:title><![CDATA[Editorial: Reporting Standards w/M. Björck & J. Boyle]]></itunes:title>
      <description><![CDATA[<p>Editor-in-chief of the European Journal of Vascular and Endovascular Surgery (EJVES), Prof. Martin Björck, and Senior Editor, Assistant Prof. Jon Boyle joins Egle Kavaliunaite in today's podcast.</p><p>Together, they discuss the latest EJVES Editorial on Reporting Standards, "Why Should You Submit Your Best Papers to the <em>European Journal of Vascular and Endovascular Surgery</em>?", published in the January 2025 issue. </p><p>Read the editorial here: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ejves.com/article/S1078-5884(24)00905-5/fulltext">https://www.ejves.com/article/S1078-5884(24)00905-5/fulltext</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1849656</link>
      <enclosure url="https://content.rss.com/episodes/9552/1849656/esvs/2025_01_16_08_59_50_45da1ffc-c3c1-4ecd-8f8f-18382922a9a3.mp3" length="25851390" type="audio/mpeg"/>
      <guid isPermaLink="false">053050c6-cdbc-4a47-bcdc-ee1afe80ac76</guid>
      <itunes:duration>1615</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 16 Jan 2025 11:01:36 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Editor’s Choice: Association of Pedal Acceleration Time With Healing and Amputation Free Survival in Patients With Ulceration and Gangrene by O. Hart et al ]]></title>
      <itunes:title><![CDATA[Editor’s Choice: Association of Pedal Acceleration Time With Healing and Amputation Free Survival in Patients With Ulceration and Gangrene by O. Hart et al ]]></itunes:title>
      <description><![CDATA[<p>Today we are going to discuss another Editor’s Choice article from the European Journal for Vascular and Endovascular Surgery (EJVES). The title is: Association of Pedal Acceleration Time With Healing and Amputation Free Survival in Patients With Ulceration and Gangrene by Odette Hart et al from The University of Auckland and Waikato Hospital in Hamilton, New Zealand. The article was published as an Editor’s choice in the European Journal of Vascular and Endovascular surgery in October 2024. </p><p><strong>Shownotes</strong>:</p><p>Editor's Choice – Association of Pedal Acceleration Time With Healing and Amputation Free Survival in Patients With Ulceration and Gangrene</p><p>Hart, Odette et al.</p><p>European Journal of Vascular and Endovascular Surgery, Volume 68, Issue 4, 490 - 497</p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ejves.com/article/S1078-5884(24)00471-4/fulltext">https://www.ejves.com/article/S1078-5884(24)00471-4/fulltext</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1837443</link>
      <enclosure url="https://content.rss.com/episodes/9552/1837443/esvs/2025_01_08_11_37_22_6d24a367-1ce4-4d2b-adbf-ec3436f202db.mp3" length="11592255" type="audio/mpeg"/>
      <guid isPermaLink="false">c2421762-a43b-43c1-8ad3-ce1e63d3c306</guid>
      <itunes:duration>723</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 09 Jan 2025 11:01:41 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Teaser - ESVS Podcasts in 2025]]></title>
      <itunes:title><![CDATA[Teaser - ESVS Podcasts in 2025]]></itunes:title>
      <description><![CDATA[<p>Here is a teaser of some of what you can expect from ESVS this year... Happy 2025! </p>]]></description>
      <link>https://rss.com/podcasts/esvs/1837452</link>
      <enclosure url="https://content.rss.com/episodes/9552/1837452/esvs/2025_01_08_11_41_30_cd5539e4-3101-4305-9027-608741721010.mp3" length="5014010" type="audio/mpeg"/>
      <guid isPermaLink="false">30901974-5669-46d2-b813-9d4133109a33</guid>
      <itunes:duration>313</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 09 Jan 2025 10:01:18 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2024 - CVD and CV risk with J. Ferreira]]></title>
      <itunes:title><![CDATA[#ESVS2024 - CVD and CV risk with J. Ferreira]]></itunes:title>
      <description><![CDATA[<p>Chronic venous disease, which affects almost 70% of the population, has recently been proved to be associated with increased prevalence of cardiovascular risk factors and all-cause death. We explore the evidence sustaining this statement, potential pathophysiological pathways underlying the association, and implications for everyday clinical practice with Dr. Joana Ferreira. You'll be surprised, and inspired, by this paradigm shift!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1805532</link>
      <enclosure url="https://content.rss.com/episodes/9552/1805532/esvs/2024_12_17_13_31_15_fdcef18d-0231-4b5a-b3f0-85ad238cfe1c.mp3" length="16024708" type="audio/mpeg"/>
      <guid isPermaLink="false">2b90dfb5-697b-4fd7-b7bd-889708eeaf6a</guid>
      <itunes:duration>1001</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 Dec 2024 11:01:45 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Introducing the EVeR Registry with R. Hinchliffe & S. Black]]></title>
      <itunes:title><![CDATA[Introducing the EVeR Registry with R. Hinchliffe & S. Black]]></itunes:title>
      <description><![CDATA[<p>This podcast with Prof. Robert Hinchliffe and Prof. Stephen Black gives some extra information on the EVeR registry, an initiative aimed at advancing our understanding and treatment of venous diseases. This registry is a collaborative effort between leading vascular specialists, researchers, and healthcare institutions across Europe. The registry was developed in collaboration with the European Vascular Research Collaborative (EVRC).</p><p>Deep venous diseases affect millions of people worldwide. Despite their prevalence, many aspects of these conditions remain poorly understood. EVeR will play a crucial role in addressing this knowledge gap by:</p><p>- Collecting comprehensive data: Gathering detailed information on patients with venous diseases, including their symptoms, medical history, treatments, and outcomes.</p><p>- Evaluating treatment effectiveness: Assessing the efficacy of different treatment options for venous diseases.</p><p>- Improving patient care: Ultimately, EVeR will help to improve the treatment and management of venous diseases</p><p>If you are a healthcare professional treating patients with venous diseases, we encourage you to join EVeR. By contributing data to the registry, you can help to improve the lives of patients with these conditions.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1794922</link>
      <enclosure url="https://content.rss.com/episodes/9552/1794922/esvs/2024_12_10_13_31_19_af60c7cc-0525-4476-ba74-a5f0c03eb5e8.mp3" length="14607390" type="audio/mpeg"/>
      <guid isPermaLink="false">4ddabeb3-c9ca-4794-8d35-9bc76b5ca3d6</guid>
      <itunes:duration>911</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 12 Dec 2024 11:01:48 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Treatment Strategy for High Grade SFA Lesions: Are P1 level Bypasses going Extinct? with W. Van de Water & M. Bosiers]]></title>
      <itunes:title><![CDATA[Treatment Strategy for High Grade SFA Lesions: Are P1 level Bypasses going Extinct? with W. Van de Water & M. Bosiers]]></itunes:title>
      <description><![CDATA[<p>Join us in this expert interview of 2024 PAD guideline Co-Author Dr. Van de Water (Maastricht) and 2023 ZILVERPASS Author Dr. Bosiers (Bern) in this timely debate.</p><p><strong>References:</strong></p><p>- Bosiers M, De Donato G, Torsello G, et al. ZILVERPASS study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal lesions. J Cardiovasc Surg. 2023. https://doi.org/10.23736/S0021- 9509.23.12607</p><p>- RJ Vossen, TM Fokkema, AC Vahl, and R Balm. Systematic review and meta-analysis comparing the autogenous vein bypass versus a prosthetic graft for above-the-knee femoropopliteal bypass surgery in patients with intermittent claudication. Vascular. Sept 6 2022. Vol 32 issue 1. </p><p>- Maxime Dubosq-Lebaz , Audrey Fels , Gilles Chatellier , Yann Gouëffic Systematic Review and Meta-analysis of Clinical Outcomes After Endovascular Treatment in Patients With Femoropopliteal Lesions Greater Than 150 mm. J Endovasc Ther. 2023 Sep 30:15266028231202709.</p><p>- Alik Farber et al. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia (BEST-CLI). N Engl J Med. 2022 Dec 22;387(25):2305-2316.</p><p>- Andrew W Bradbury et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet. 2023 May 27;401(10390):1798-1809.</p><p>- Nordanstig et al. European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication. Eur J Vasc Endovasc Surg (2024) 67, 9e96)<strong>References:</strong></p><p>- Bosiers M, De Donato G, Torsello G, et al. ZILVERPASS study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal lesions. J Cardiovasc Surg. 2023. https://doi.org/10.23736/S0021- 9509.23.12607</p><p>- RJ Vossen, TM Fokkema, AC Vahl, and R Balm. Systematic review and meta-analysis comparing the autogenous vein bypass versus a prosthetic graft for above-the-knee femoropopliteal bypass surgery in patients with intermittent claudication. Vascular. Sept 6 2022. Vol 32 issue 1. </p><p>- Maxime Dubosq-Lebaz , Audrey Fels , Gilles Chatellier , Yann Gouëffic Systematic Review and Meta-analysis of Clinical Outcomes After Endovascular Treatment in Patients With Femoropopliteal Lesions Greater Than 150 mm. J Endovasc Ther. 2023 Sep 30:15266028231202709.</p><p>- Alik Farber et al. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia (BEST-CLI). N Engl J Med. 2022 Dec 22;387(25):2305-2316.</p><p>- Andrew W Bradbury et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet. 2023 May 27;401(10390):1798-1809.</p><p>- Nordanstig et al. European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication. Eur J Vasc Endovasc Surg (2024) 67, 9e96)</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1787077</link>
      <enclosure url="https://content.rss.com/episodes/9552/1787077/esvs/2024_12_05_13_14_52_0ec448e9-d86d-41af-9e0b-3713e1de69a0.mp3" length="30468042" type="audio/mpeg"/>
      <guid isPermaLink="false">8040b9c7-42fe-499a-9932-e66d254a7e32</guid>
      <itunes:duration>1904</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 05 Dec 2024 14:36:15 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2024 - Aortopathies with G.Teixido Tura]]></title>
      <itunes:title><![CDATA[#ESVS2024 - Aortopathies with G.Teixido Tura]]></itunes:title>
      <description><![CDATA[<p>In this week's episode, together with a cardiologist Dr. Gisela Teixido Tura, we will try to unwrap a complex topic of aortopathies, placing a lot of focus on the success of the treatment in diagnostics of those conditions and a multidisciplinary management. Take a listen! </p>]]></description>
      <link>https://rss.com/podcasts/esvs/1759407</link>
      <enclosure url="https://content.rss.com/episodes/9552/1759407/esvs/2024_11_18_12_44_28_2f32a9b9-00f1-409e-9e47-f27d224135cb.mp3" length="27856026" type="audio/mpeg"/>
      <guid isPermaLink="false">af6efe26-f2b2-40d6-b5ca-d46533400eb1</guid>
      <itunes:duration>1737</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 21 Nov 2024 11:01:18 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2024 - Non-Technical Skills with R. Darwood & A. Garnham]]></title>
      <itunes:title><![CDATA[#ESVS2024 - Non-Technical Skills with R. Darwood & A. Garnham]]></itunes:title>
      <description><![CDATA[<p>Non-technical skills have a big influence on surgical patient outcomes. For the first time, during the ESVS Annual Meeting, a specific Academy workshop was focused on this topic. In this podcast, Drs. Andrew Garnham and Rosie Darwood guide us through the concept, teaching and practice of these skills for vascular surgeons. Listen on!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1753794</link>
      <enclosure url="https://content.rss.com/episodes/9552/1753794/esvs/2024_11_14_09_53_05_b7964f7a-5a04-4155-afa4-752eed7e9988.mp3" length="14305198" type="audio/mpeg"/>
      <guid isPermaLink="false">07305e0a-28b1-42be-82c7-d51d77d52789</guid>
      <itunes:duration>894</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 14 Nov 2024 11:01:34 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2024 - Vascular Access with F. Gentile and R. Brambilla]]></title>
      <itunes:title><![CDATA[#ESVS2024 - Vascular Access with F. Gentile and R. Brambilla]]></itunes:title>
      <description><![CDATA[<p>In this podcast, the Academy leads for Vascular Access Pathway, Dr. Flavia Gentile and Dr. Roberta Brambilla. </p><p>Discover the pathway: <a target="_blank" rel="noopener noreferrer nofollow" href="https://esvs.org/esvs-academy/esvs-academy-pathways/vascular-access-path/">https://esvs.org/esvs-academy/esvs-academy-pathways/vascular-access-path/</a>.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1741207</link>
      <enclosure url="https://content.rss.com/episodes/9552/1741207/esvs/2024_11_07_09_23_26_0579f3b3-0f88-4aa9-8eb3-efc43e0fd964.mp3" length="8990764" type="audio/mpeg"/>
      <guid isPermaLink="false">870d03a8-a175-4875-a98f-b195971e2525</guid>
      <itunes:duration>561</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 07 Nov 2024 10:30:11 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2024 - Venous Embolisation with E. Avgerinos]]></title>
      <itunes:title><![CDATA[#ESVS2024 - Venous Embolisation with E. Avgerinos]]></itunes:title>
      <description><![CDATA[<p>Today’s episode is a throwback to ESVS Annual meeting in Krakow. Prof. E.Avgerinos has shared his knowledge about pelvic venous disease, while also taking opportunity to raise awarness on this condition. We focus on an overview of the disease with detailed information on pelvic embolisation- take a listen, you won’t regret it. </p>]]></description>
      <link>https://rss.com/podcasts/esvs/1712751</link>
      <enclosure url="https://content.rss.com/episodes/9552/1712751/esvs/2024_10_21_10_16_52_f22006fb-dd0f-4f13-9450-afe9f20e03e8.mp3" length="24437699" type="audio/mpeg"/>
      <guid isPermaLink="false">a5d5ff1a-7641-48ce-b629-dc3e162a3fcb</guid>
      <itunes:duration>1527</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 24 Oct 2024 10:02:01 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2024 - EJVES Vascular Forum with M. Vega de Ceniga & A. Chaudhuri]]></title>
      <itunes:title><![CDATA[#ESVS2024 - EJVES Vascular Forum with M. Vega de Ceniga & A. Chaudhuri]]></itunes:title>
      <description><![CDATA[<p>In this podcast, we talk with Drs. Melina Vega de Ceniga and Arindam Chaudhuri, former and current Editors in chief of the ESVS journal Vascular Forum, about the revamp and development of the journal, about the achievement of the impact factor, about team work, and much more!</p><p>EJVES Vascular Forum is aimed primarily at vascular surgeons dealing with patients who have arterial, venous and lymphatic diseases. The focus of the journal is to provide an inclusive multimedia platform for education, dissemination of scientific content, interactive discussion and opinion formation. It publishes case reports and case series, technical notes, original research in a medium length format, literary reviews with educational value and other commissioned educational pieces, like evidence based clinical scenarios.</p><p>Head to the European Journal of Vascular and Endovascular Surgery Vascular Forum at ejvesreports.com</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1705895</link>
      <enclosure url="https://content.rss.com/episodes/9552/1705895/esvs/2024_10_16_09_56_20_9d3d26e5-2660-4c79-b3b1-55ab514e95b1.mp3" length="18049706" type="audio/mpeg"/>
      <guid isPermaLink="false">9a5566f9-b6fd-43ef-be7b-0f9195363dfa</guid>
      <itunes:duration>1128</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 17 Oct 2024 10:30:19 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2024: Vascular Nomads with C. Fernandez Prendes & V. Dabravolskaité]]></title>
      <itunes:title><![CDATA[#ESVS2024: Vascular Nomads with C. Fernandez Prendes & V. Dabravolskaité]]></itunes:title>
      <description><![CDATA[<p>Have you moved to a different country to do your training or to work as a consultant, or are you thinking of doing it and are wondering about the pros and cons? Well, this is exactly the topic of today’s podcast: vascular nomads. Recording from the 2024 ESVS Annual Meeting in Krakow we are grateful for the open and honest stories of Carlota Fernandez Prendes and Vaiva Dabravolskaité, living and working successfully as Vascular Nomads.</p><p>Enjoy!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1695560</link>
      <enclosure url="https://content.rss.com/episodes/9552/1695560/esvs/2024_10_10_07_26_25_ccaf210f-41a6-4c02-89b0-7257cc94cbfe.mp3" length="28454287" type="audio/mpeg"/>
      <guid isPermaLink="false">159ea4ab-911c-4284-8789-44c62b5dd510</guid>
      <itunes:duration>1778</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 10 Oct 2024 11:48:09 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Editor's Choice: The COSTLY-TLR with K.Stavroulakis and A. Saratzis]]></title>
      <itunes:title><![CDATA[Editor's Choice: The COSTLY-TLR with K.Stavroulakis and A. Saratzis]]></itunes:title>
      <description><![CDATA[<p>Editor's Choice Episode: the COSTLY-TLR study evaluates the cost of revascularising PAD patients with restenosed or reoccluded stents. Laurence Bertrand interviews authors Dr. Konstantinos Stavroulakis and Prof. Dr. Athanasios Saratzis to discuss their findings and the potential consequences for clinical practice.</p><p>Enjoy!</p><p>Link to the original article: </p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ejves.com/article/S1078-5884(24)00160-6/fulltext">https://www.ejves.com/article/S1078-5884(24)00160-6/fulltext</a></p><p>Link to references article in discussion:</p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://academic.oup.com/bjsopen/article/7/6/zrad112/7343202">https://academic.oup.com/bjsopen/article/7/6/zrad112/7343202</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1682250</link>
      <enclosure url="https://content.rss.com/episodes/9552/1682250/esvs/2024_10_02_09_28_34_d0aa6153-1d5e-4a20-9f16-2ba2e12edf55.mp3" length="27600988" type="audio/mpeg"/>
      <guid isPermaLink="false">58cd688d-b746-40f3-9a86-85d85d6be25b</guid>
      <itunes:duration>1725</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 03 Oct 2024 10:30:22 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ESVS AAA Guidelines with the Writing Committee - Part 3]]></title>
      <itunes:title><![CDATA[ESVS AAA Guidelines with the Writing Committee - Part 3]]></itunes:title>
      <description><![CDATA[<p>Welcome to the final episode of the Q&amp;A series of the 2024 ESVS clinical practice guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. In this series of podcasts, we are highlighting the new, complex and most controversial recommendations in these guideline. On today’s episode we will talk about the postoperative management of AAA patients. </p>]]></description>
      <link>https://rss.com/podcasts/esvs/1642084</link>
      <enclosure url="https://content.rss.com/episodes/9552/1642084/esvs/2024_09_04_14_59_42_c9b93675-e820-4148-8e84-6ae54c18b12e.mp3" length="27087301" type="audio/mpeg"/>
      <guid isPermaLink="false">7986aa46-edef-4266-ac04-421de54d7edd</guid>
      <itunes:duration>1684</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 Sep 2024 10:30:16 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ESVS AAA Guidelines with the Writing Committee - Part 2]]></title>
      <itunes:title><![CDATA[ESVS AAA Guidelines with the Writing Committee - Part 2]]></itunes:title>
      <description><![CDATA[<p>Welcome to  part 2 of the Q&amp;A series of the 2024 ESVS clinical practice guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. In this podcast, we will highlight the new, complex and most controversial recommendations in this guideline. On today’s episode we will dive deeper into the peroperative management of AAA patients. </p>]]></description>
      <link>https://rss.com/podcasts/esvs/1642078</link>
      <enclosure url="https://content.rss.com/episodes/9552/1642078/esvs/2024_09_04_14_57_58_63331172-d8cb-4382-a7c3-70a6da0cadcf.mp3" length="32546708" type="audio/mpeg"/>
      <guid isPermaLink="false">fde6891b-9b95-49d4-b92e-c9758e3ba687</guid>
      <itunes:duration>2030</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 12 Sep 2024 10:30:27 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ESVS AAA Guidelines with the Writing Committee - Part 1]]></title>
      <itunes:title><![CDATA[ESVS AAA Guidelines with the Writing Committee - Part 1]]></itunes:title>
      <description><![CDATA[<p>Here is the first of a 3 part Q&amp;A serie on the 2024 ESVS clinical practice guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. In this podcast, we will highlight the new, complex and most controversial recommendations in this guideline. Today for the first episode of this 3-part series, we will specifically talk about the preoperative process. The rest of the guideline will be covered in the next two episodes. We are proud to welcome 4 of the 17 members of the guideline writing committee as our guests in all three episodes; Prof. dr. Isabelle Van Herzeele, Prof. Dr. Anders Wanhainen, Dr. Frederico Bastos Gonçalves and Dr. Carlota Fernandez Prendes. </p>]]></description>
      <link>https://rss.com/podcasts/esvs/1642075</link>
      <enclosure url="https://content.rss.com/episodes/9552/1642075/esvs/2024_09_04_14_56_08_e0b73a76-5016-4490-b796-3326f5757455.mp3" length="17585739" type="audio/mpeg"/>
      <guid isPermaLink="false">74a12ecd-e83a-454d-ab02-75125e70ffeb</guid>
      <itunes:duration>1098</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 05 Sep 2024 10:30:26 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Translational Meeting in Stockholm Part 3: Q&A with Dr. Rachael Forsythe]]></title>
      <itunes:title><![CDATA[Translational Meeting in Stockholm Part 3: Q&A with Dr. Rachael Forsythe]]></itunes:title>
      <description><![CDATA[<p>This week, we release the last of three podcasts recorded live during the Translational Spring Meeting in June in Stockholm.  Dr. Rachael Forsythe gives us an invaluable insider's look into the emerging science of biomarkers in Aortic imaging.  Where do they come from, how did we find them and what are they for?  All of this and more in this weeks episode.</p><p>Here-below the referenced sources in the episode.</p><p>Enjoy!</p><p> </p><p>Links:</p><p>UK vascular charities:</p><p>Circulation Foundation: <a target="_blank" rel="noopener noreferrer nofollow" href="http://www.circulationfoundation.org.uk">www.circulationfoundation.org.uk</a></p><p>British Heart Foundation: <a target="_blank" rel="noopener noreferrer nofollow" href="http://www.bhf.org.uk">www.bhf.org.uk</a></p><p>Relevant papers:</p><p>The SoFIA3 Study:</p><p><a target="_blank" rel="noopener noreferrer nofollow" href="https://doi.org/10.1016/j.jacc.2017.11.053">https://doi.org/10.1016/j.jacc.2017.11.053</a></p><p>The MA3RS Study: <a target="_blank" rel="noopener noreferrer nofollow" href="https://doi.org/10.1161/circulationaha.117.028433">10.1161/CIRCULATIONAHA.117.028433</a></p><p>18F NaF following EVAR: <a target="_blank" rel="noopener noreferrer nofollow" href="http://DOI.org">DOI.org</a> <a target="_blank" rel="noopener noreferrer nofollow" href="https://doi.org/10.1136/heartjnl-2023-322514">https://doi.org/10.1136/heartjnl-2023-322514</a></p><p>Dr Marc Bailey / Dr Michael Bell (Leeds) pre-clinical 18F NaF imaging: DOI: 10.1055/s-0042-1750913</p><p> </p><p>Other links:</p><p>UK Metformin Aneurysm Trial: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/uk-mat/#:~:text=The%20Metformin%20Aneurysm%20Trial%20(MAT,repair%20and%20AAA%20mortality%20(due">https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/uk-mat/#:~:text=The%20Metformin%20Aneurysm%20Trial%20(MAT,repair%20and%20AAA%20mortality%20(due</a></p><p> </p><p>Profiles:</p><p>Dr Rachael Forsythe, Edinburgh: @ROForsythe  <a target="_blank" rel="noopener noreferrer nofollow" href="https://surgery.ed.ac.uk/staff/profiles/rachael-forsythe">https://surgery.ed.ac.uk/staff/profiles/rachael-forsythe</a></p><p>Professor David Newby, Edinburgh: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ed.ac.uk/profile/david-newby">https://www.ed.ac.uk/profile/david-newby</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1583492</link>
      <enclosure url="https://content.rss.com/episodes/9552/1583492/esvs/2024_07_26_06_17_43_68cefeae-2911-4db2-9283-32730fbb6025.mp3" length="30078476" type="audio/mpeg"/>
      <guid isPermaLink="false">33d33c80-507b-4216-ac6e-9f152b653514</guid>
      <itunes:duration>1879</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Fri, 26 Jul 2024 07:44:22 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Translational Meeting in Stockholm. Together with Dr. Regent Lee ]]></title>
      <itunes:title><![CDATA[Translational Meeting in Stockholm. Together with Dr. Regent Lee ]]></itunes:title>
      <description><![CDATA[<p>Hello there; in this week’s episode, as promised, we are coming back with a second podcast recorded during the Translational Meeting in Stockholm. Together with Dr. Regent Lee we will talk about  improving aneurysm growth prediction using different biomarkers. Enjoy the listen, and stay tuned!   </p>]]></description>
      <link>https://rss.com/podcasts/esvs/1572763</link>
      <enclosure url="https://content.rss.com/episodes/9552/1572763/esvs/2024_07_18_07_54_28_4f102e29-b9d6-4dd6-8520-1b2f64c08153.mp3" length="18799012" type="audio/mpeg"/>
      <guid isPermaLink="false">d2b1d4ac-39ff-431d-af1c-73fa55f92054</guid>
      <itunes:duration>1174</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 18 Jul 2024 07:55:31 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Translational Spring Meeting Q&A Part 1 with K. McGinigle & J. Raffort-Lareyre]]></title>
      <itunes:title><![CDATA[Translational Spring Meeting Q&A Part 1 with K. McGinigle & J. Raffort-Lareyre]]></itunes:title>
      <description><![CDATA[<p>This week, we release first of three podcasts recorded live during the Translational Spring Meeting in June in Stockholm. Vaiva Dabravolskaite had a please talking with two extraordinary physicians and scientists: Prof. Katherine McGinigle and Dr. Juliette Raffort-Lareyre. Together we will introduce concepts of machine learning, artificial intelligence and etc and will dive in deeper into different ways it can assist us in predicting risk models for patients with CLTI. Enjoy!</p><ul><li>Arteria L’avenir de vos artères (Nice, France): <a target="_blank" rel="noopener noreferrer nofollow" href="https://arter-ia.com/en/">https://arter-ia.com/en/</a></li></ul>]]></description>
      <link>https://rss.com/podcasts/esvs/1564314</link>
      <enclosure url="https://content.rss.com/episodes/9552/1564314/esvs/2024_07_11_10_22_57_8d8ed656-b34e-47cc-b8fb-50195c444212.mp3" length="30957444" type="audio/mpeg"/>
      <guid isPermaLink="false">5a506c2f-3156-48f6-bff4-ee0adb778e5a</guid>
      <itunes:duration>1934</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jul 2024 11:43:31 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Virtual Vascular - Abdominal Compartment Syndrome with M. Björck]]></title>
      <itunes:title><![CDATA[Virtual Vascular - Abdominal Compartment Syndrome with M. Björck]]></itunes:title>
      <description><![CDATA[<p>In this week's podcast, Prof. Martin Björck joins us to tell us all we should know about Abdominal Compartment Syndrome, a life-threatening condition characterised by increased pressure in the abdomen, leading to compromised blood flow to vital organs.</p><p>Read the Virtual Vascular chapter "Abdominal Compartment Syndrome" written by Prof. Björck on the ESVS Library.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1556040</link>
      <enclosure url="https://content.rss.com/episodes/9552/1556040/esvs/2024_07_04_13_49_43_55f49919-933e-4314-bd69-e2e8cf37a246.mp3" length="21857244" type="audio/mpeg"/>
      <guid isPermaLink="false">22c7c20e-21aa-4338-93d2-cdd5d0e32b8b</guid>
      <itunes:duration>1366</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 04 Jul 2024 13:56:05 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ESVS Guidelines on Asymptomatic Lower Limb PAD and Intermittent Claudication Q&A w/J. Nordanstig - Part 3]]></title>
      <itunes:title><![CDATA[ESVS Guidelines on Asymptomatic Lower Limb PAD and Intermittent Claudication Q&A w/J. Nordanstig - Part 3]]></itunes:title>
      <description><![CDATA[<p>This last part of the Q&amp;A series on the ESVS 2024 PAD Guidelines, we will be discussing with the guidelines writing committee chair, Dr. Joakim Nordanstig, about invasive interventions for claudication.</p><p>The ESVS 2024 Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication is available in Open Access <a target="_blank" rel="noopener noreferrer nofollow" href="https://esvs.org/guidelines/">https://esvs.org/guidelines/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1532349</link>
      <enclosure url="https://content.rss.com/episodes/9552/1532349/esvs/2024_06_20_08_13_30_53dbcd8f-1553-4976-8acf-b2929daf4752.mp3" length="25055443" type="audio/mpeg"/>
      <guid isPermaLink="false">b1ce331c-b621-4198-865e-c66c4fb3029f</guid>
      <itunes:duration>1565</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 20 Jun 2024 10:30:26 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ESVS Guidelines on Asymptomatic Lower Limb PAD and Intermittent Claudication Q&A w/J. Nordanstig - Part 2]]></title>
      <itunes:title><![CDATA[ESVS Guidelines on Asymptomatic Lower Limb PAD and Intermittent Claudication Q&A w/J. Nordanstig - Part 2]]></itunes:title>
      <description><![CDATA[<p>This second part of the Q&amp;A series on the ESVS 2024 PAD Guidelines, we will be asking the guidelines writing committee chair, Dr. Joakim Nordanstig, about the treatment recommendations for claudication, the role of supervised exercise therapy, and more!</p><p>The ESVS 2024 Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication is available in Open Access <a target="_blank" rel="noopener noreferrer nofollow" href="https://esvs.org/guidelines/">https://esvs.org/guidelines/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1523765</link>
      <enclosure url="https://content.rss.com/episodes/9552/1523765/esvs/2024_06_13_07_42_37_66710c17-c00f-433e-b6f3-bf310fc247ce.mp3" length="11823691" type="audio/mpeg"/>
      <guid isPermaLink="false">a424e32b-2242-4fbe-a765-ac6d1046f1de</guid>
      <itunes:duration>738</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 13 Jun 2024 10:17:43 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ESVS Guidelines on Asymptomatic Lower Limb PAD and Intermittent Claudication Q&A  w/J. Nordanstig - Part 1]]></title>
      <itunes:title><![CDATA[ESVS Guidelines on Asymptomatic Lower Limb PAD and Intermittent Claudication Q&A  w/J. Nordanstig - Part 1]]></itunes:title>
      <description><![CDATA[<p>This first part of the Q&amp;A series on the ESVS 2024 PAD Guidelines will focus on asymptomatic patients in screening for PAD.</p><p>The guidelines writing committee chair, Dr. Joakim Nordanstig, shares the process and challenges of creating the guidelines. We also zoom in on some of the recommendations in screening approaches and the reasoning behind them.</p><p>The ESVS Guidelines is available in Open Access <a target="_blank" rel="noopener noreferrer nofollow" href="https://esvs.org/guidelines/">https://esvs.org/guidelines/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1513192</link>
      <enclosure url="https://content.rss.com/episodes/9552/1513192/esvs/2024_06_06_07_57_00_28e3f045-831d-4b57-860c-ded2b902823a.mp3" length="10193650" type="audio/mpeg"/>
      <guid isPermaLink="false">c55744e7-b730-432f-b5be-d212918c8011</guid>
      <itunes:duration>637</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 06 Jun 2024 10:01:48 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Editor's Choice Article: Management of Paget-Schroetter-Syndrome; A Systematic Review  ]]></title>
      <itunes:title><![CDATA[Editor's Choice Article: Management of Paget-Schroetter-Syndrome; A Systematic Review  ]]></itunes:title>
      <description><![CDATA[<p>In today's podcast Laurence Bertrand and Suzanne Stokmans dissect the study of Frank Hoexum et al. that was recently published in the EJVES on the Treatment of Paget-Schroetter-Syndrome, a dangerous condition affecting young patients with acute, effort induced thrombosis of the subclavian vein due to a preexisting state of venous thoracic outlet syndrome. More than 30 years of evidence is compiled in this systematic review with comparative analysis of treatment modalities including anticoagulation, catheter directed thrombolysis and first rib removal surgery.</p><p>Link to the full article: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ejves.com/article/S1078-5884(23)00730-X/fulltext">https://www.ejves.com/article/S1078-5884(23)00730-X/fulltext</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1499030</link>
      <enclosure url="https://content.rss.com/episodes/9552/1499030/esvs/2024_05_29_14_24_11_19a71b36-0ea4-43ef-8169-1c676406f35a.mp3" length="12168263" type="audio/mpeg"/>
      <guid isPermaLink="false">a3e244d6-455a-490a-b879-1448071995de</guid>
      <itunes:duration>760</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 30 May 2024 11:30:18 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ESVS Aortic Fellowship with I. Koncar]]></title>
      <itunes:title><![CDATA[ESVS Aortic Fellowship with I. Koncar]]></itunes:title>
      <description><![CDATA[<p>The ESVS is launching it’s first aortic fellowship! In this 2-year program starting in September 2024 surgical trainees or vascular surgeons will have access to face-to-face and online workshops covering the full range of aortic surgery, topped by a two-week placement in a high-volume aortic centre. There is a beginner and an advanced module. ESVS members can apply for a Fellowship grant to cover the costs. Applications are open until July 1st. In this podcast, Dr. Igor Koncar explains the fellowship in more detail. Please find more information about the fellowship on the ESVS website (<a target="_blank" rel="noopener noreferrer nofollow" href="https://esvs.org/esvs-academy/aortic-fellowship/">https://esvs.org/esvs-academy/aortic-fellowship/</a>). </p><p>Dr Igor Koncar, clinic for Vascular and Endovascular Surgery in Belgrade, Serbia and ESVS Academy Committee Chair.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1489115</link>
      <enclosure url="https://content.rss.com/episodes/9552/1489115/esvs/2024_05_22_13_05_28_04a01be5-4942-417f-ae6e-ad2d1f206f21.mp3" length="11978810" type="audio/mpeg"/>
      <guid isPermaLink="false">ccdf17fc-8df4-4d28-820d-51b6a476edbf</guid>
      <itunes:duration>747</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 23 May 2024 10:30:26 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Social Deprivation with Dr. T. Mastracci and Dr. O. Alabi - In Collaboration with Audible Bleeding]]></title>
      <itunes:title><![CDATA[Social Deprivation with Dr. T. Mastracci and Dr. O. Alabi - In Collaboration with Audible Bleeding]]></itunes:title>
      <description><![CDATA[<p>In this episode Abena A and Leana Dogbe (<a target="_blank" rel="noopener noreferrer nofollow" href="https://twitter.com/ldogbe4">@leanadogbe</a>) partner with Vaiva Dabravolskaite (<a target="_blank" rel="noopener noreferrer nofollow" href="mailto:vaivadabravolskaite@gmail.com">vaivadabravolskaite@gmail.com</a>) from ESVS to host an episode discussing social deprivation in vascular surgery. Dr. Tara Mastracci and Dr. Olamide Alabi join us to offer insights into how social deprivation drives disparities in outcomes and steps on how we can shift practice paradigms to better address our patient needs.</p><p></p><p>Dr. Tara Mastracci (@aorticsurgeon) is a vascular surgeon with over 15 years of experience treating and managing complex aortic pathologies. She is currently working at St. Bartholomew’s Hospital in London, UK, on the Cardiothoracic Team doing complex aortic surgery. On top of her clinical duties, Dr. Mastracci is dedicated to studying the social and non-clinical factors influencing vascular outcomes.</p><p></p><p>Dr. Olamide Alabi (<a target="_blank" rel="noopener noreferrer nofollow" href="https://twitter.com/OAlabiMD">@OAlabiMD</a>) is an Associate Professor of Surgery in the Department of Surgery at Emory University School of Medicine. Her clinical effort focuses on the full scope of vascular disease for patients at Emory University Hospital and the Atlanta VA HealthCare System, however, her academic portfolio and funded research is focused primarily on the intersection of peripheral artery disease, quality, and health equity.</p><p></p><p>References:</p><p>● Social Deprivation and the Association With Survival Following Fenestrated Endovascular Aneurysm Repair/2021 <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.annalsofvascularsurgery.com/article/S0890-5096(21)00872-4/fulltext">https://www.annalsofvascularsurgery.com/article/S0890-5096(21)00872-4/fulltext</a></p><p>● Is social deprivation an independent predictor of outcomes following cardiac surgery? An analysis of 240,221 patients from a national registry. BMJ/2015 <a target="_blank" rel="noopener noreferrer nofollow" href="https://bmjopen.bmj.com/content/5/6/e008287.long">https://bmjopen.bmj.com/content/5/6/e008287.long</a></p><p>● Survival Disparity Following Abdominal Aortic Aneurysm Repair Highlights Inequality in Ethnic and Socio-economic Status/ <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ejves.com/article/S1078-5884(17)30521-X/fulltext">https://www.ejves.com/article/S1078-5884(17)30521-X/fulltext</a></p><p>● Nash, D., McClure, G., Mastracci, T. M., &amp; Anand, S. S. (2022). Social deprivation and peripheral artery disease. <em>Canadian Journal of Cardiology</em>, <em>38</em>(5), 612-622.</p><p>● Vart, P., Coresh, J., Kwak, L., Ballew, S. H., Heiss, G., &amp; Matsushita, K. (2017). Socioeconomic status and incidence of hospitalization with lower‐extremity peripheral artery disease: atherosclerosis risk in communities study. <em>Journal of the American Heart Association</em>, <em>6</em>(8), e004995.</p><p>● Henry, A. J., Hevelone, N. D., Belkin, M., &amp; Nguyen, L. L. (2011). Socioeconomic and hospital-related predictors of amputation for critical limb ischemia. <em>Journal of vascular surgery</em>, <em>53</em>(2), 330-339.</p><p>● Demsas, F., Joiner, M. M., Telma, K., Flores, A. M., Teklu, S., &amp; Ross, E. G. (2022, June). Disparities in peripheral artery disease care: A review and call for action. In <em>Seminars in vascular surgery</em> (Vol. 35, No. 2, pp. 141-154). WB Saunders.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1452198</link>
      <enclosure url="https://content.rss.com/episodes/9552/1452198/esvs/2024_04_25_12_09_52_3551ded9-567a-4ae2-8af2-e13e897d9341.mp3" length="64171055" type="audio/mpeg"/>
      <guid isPermaLink="false">0d8d63df-615b-4338-bc13-2dea90e07f6e</guid>
      <itunes:duration>4010</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 25 Apr 2024 13:30:15 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VV Chapter - Mycotic Aneurysm with A. Wanhainen, H. Gavali and I. Heinola]]></title>
      <itunes:title><![CDATA[VV Chapter - Mycotic Aneurysm with A. Wanhainen, H. Gavali and I. Heinola]]></itunes:title>
      <description><![CDATA[<p>The authors of the Virtual Vascular chapter on "Aortic graft infection and mycotic (infected) aortic aneurysms", Anders Wanhainen, Hamid Gavali, and Ivika Heinola, join us on this week's podcast to talk about mycotic aneurysms.</p><p>Virtual Vascular is an online living textbook, with chapters on various topics in vascular surgery, written by experts around the globe. It is accessible via the ESVS Library, open to all ESVS Members.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1432895</link>
      <enclosure url="https://content.rss.com/episodes/9552/1432895/esvs/2024_04_11_12_54_30_f36d0bb0-475f-48ec-945c-d90dc7274992.mp3" length="39635974" type="audio/mpeg"/>
      <guid isPermaLink="false">17e67578-1aa5-4273-8061-c95ef9ca2f34</guid>
      <itunes:duration>2477</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Apr 2024 12:59:58 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Academic Pathway with David Lewis]]></title>
      <itunes:title><![CDATA[Academic Pathway with David Lewis]]></itunes:title>
      <description><![CDATA[<p>In this podcast we talk with Dr. David Lewis, head of the ESVS Academy’s Professional Development and Academic pathway, about the importance of non-technical skills for surgeons, aspects of vascular surgical training that are often overlooked on training programs, what workshops this pathway includes, and who they are addressed to, among other details. You will definitely find it interesting and useful.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1421977</link>
      <enclosure url="https://content.rss.com/episodes/9552/1421977/esvs/2024_04_04_08_42_15_57f8f6db-e8cd-45ca-adf9-4c77408fa35d.mp3" length="14913279" type="audio/mpeg"/>
      <guid isPermaLink="false">c9f78855-1ccf-4a65-b9b8-f9b75842abb9</guid>
      <itunes:duration>932</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 04 Apr 2024 08:52:10 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ESVS Antithrombotic Guidelines Q&A with C. Twine and S. Kakkos - Part 3 ]]></title>
      <itunes:title><![CDATA[ESVS Antithrombotic Guidelines Q&A with C. Twine and S. Kakkos - Part 3 ]]></itunes:title>
      <description><![CDATA[<p>This is the third and last podcast of the Q&A series on the ESVS 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases. In this last edition, we talk with Prof. Chris Twine and Stavros Kakkos about some recommendations and their underlying evidence regarding antithrombotic treatment in venous thromboembolic disease and vascular access for haemodialysis. It has been a pleasure learning from these world experts. More Q&A series on new ESVS clinical practice guidelines coming up soon. Keep tuned!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1397185</link>
      <enclosure url="https://content.rss.com/episodes/9552/1397185/esvs/2024_03_19_12_46_21_1ccc56ab-b017-40a9-9268-2e508da8065c.mp3" length="14953821" type="audio/mpeg"/>
      <guid isPermaLink="false">a3a46eeb-4e7e-4e2b-96c2-74af6af4427f</guid>
      <itunes:duration>934</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 21 Mar 2024 11:01:27 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ESVS Antithrombotic Guidelines Q&A with C. Twine - Part 2]]></title>
      <itunes:title><![CDATA[ESVS Antithrombotic Guidelines Q&A with C. Twine - Part 2]]></itunes:title>
      <description><![CDATA[<p>Here comes the second podcast of the Q&amp;A series&nbsp;on the ESVS 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases. This time we address, with Prof. Chris Twine, evidence and recommendations for antithrombotic treatment in lower limb ischemic disease. A must!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1387682</link>
      <enclosure url="https://content.rss.com/episodes/9552/1387682/esvs/2024_03_13_15_19_36_aee00dbd-1850-4e24-ad1d-20b29fd9fbf9.mp3" length="20850355" type="audio/mpeg"/>
      <guid isPermaLink="false">8dfecc75-2282-4936-bdeb-d241796a3801</guid>
      <itunes:duration>1303</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 14 Mar 2024 11:02:10 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ESVS Antithrombotic Guidelines Q&A with C. Twine - Part 1]]></title>
      <itunes:title><![CDATA[ESVS Antithrombotic Guidelines Q&A with C. Twine - Part 1]]></itunes:title>
      <description><![CDATA[<p>Here is the first of a series of Q&amp;A podcasts on ESVS clinical practice guidelines. We start with the ESVS 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases, and, in this first release, Prof. Chris Twine clarifies the evidence underlying some recommendations on antithrombotic therapy in carotid artery disease. Key for our everyday clinical practice, don't miss it!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1376104</link>
      <enclosure url="https://content.rss.com/episodes/9552/1376104/esvs/2024_03_06_11_19_38_922bb061-01b5-4ea4-a832-0c9c7eabee4c.mp3" length="13508902" type="audio/mpeg"/>
      <guid isPermaLink="false">8cde41cc-2df3-49c2-a362-cb140a0dc3ca</guid>
      <itunes:duration>844</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 07 Mar 2024 11:01:23 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Transatlantic Series - 2023 Intersocietal Guidelines on PAD in Patients with Diabetes and Foot Ulcers by IWGDF, the ESVS, and the SVS]]></title>
      <itunes:title><![CDATA[Transatlantic Series - 2023 Intersocietal Guidelines on PAD in Patients with Diabetes and Foot Ulcers by IWGDF, the ESVS, and the SVS]]></itunes:title>
      <description><![CDATA[<p>Welcome to the Transatlantic Series, a co-production of Audible Bleeding (a publication of the SVS) and the ESVS podcast.&nbsp;In today’s episode, we explore the intersocietal guidelines on peripheral arterial disease in patients with diabetes and foot ulcers authored by the International Working Group on the Diabetic Foot, the European Society for Vascular Surgery, and the Society for Vascular Surgery.</p><p>Dr. Robert Fitridge is a Professor of Vascular Surgery at University of Adelaide in Australia. He is a member of the IWGDF and a member of the steering committee for the Global Vascular Guideline on the management of Chronic Limb-threatening Ischaemia.&nbsp;</p><p>Dr. Vivienne Chuter is a Professor in the Department of Podiatry at Western Sydney University and Honarary Professor in the School of Health SCiences at The University of NewCastle. She is a member of the IWGDF. She has published extensively on diabetic foot disease and leads a clinically based research program focusing on prevention and management of diabetes-related foot disease for Aboriginal and Torres Strait Islander people and for non-Indigenous Australians.</p><p>Dr. Nicolaas Schaper is emeritus professor of Endocrinology at Maastricht University Hospital in the Netherlands. Dr. Schaper was coordinator of the European diabetic foot research consortium, Eurodiale. He is Chair of the 2023 Diabetic Foot Symposium and is Chair of the IWGDF.</p><p>Dr. Joseph L. Mills is a Professor of Vascular Surgery at Baylor in Houston, Texas. He is a member of the IWGDF. Dr. Mills is a leader in the vascular surgery global community, has served as president of the Peripheral Vascular Surgery Society and is currently a member of the Surgery Residency Review Committee of the ACGME.</p><p>Further reading:</p><ul><li>The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer.</li><li>Global vascular guidelines for CLTI</li><li>Best-CLI</li><li>Engaging patients and caregivers to establish priorities for the management of diabetic foot ulcers</li><li>A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers</li><li>A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial</li><li>Release of the National Scheme's Aboriginal and Torres Strait Islander Health and Cultural Safety Strategy 2020-2025; the impacts for podiatry in Australia: a commentary</li><li>ESVS 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases</li><li>Results of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events</li><li>Low-Dose Aspirin for the Primary Prevention of Cardiovascular Disease in Diabetic Individuals: A Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis*</li><li>Diabetes, Lower-Extremity Amputation, and Death</li></ul><p>Hosts:&nbsp;</p><p>Dr. Naveed A. Rahman is chief surgery resident at SUNY Upstate in Syracuse, NY. He will be pursuing vascular surgery fellowship at University of Maryland starting in 2024. His Doximity profile is www.doximity.com/pub/naveed-rahman-md. X: @naveedrahmanmd</p><p>Dr. Suzanne Stokmans is a 5th year vascular surgery resident in the Isala hospital in Zwolle, the Netherlands.</p><p>Dr. Ezra Schwartz is a medical graduate from McGill University currently completing a Masters of Medical Science in Medical Eduation at Harvard Medical School. He is an aspiring vascular surgeon and surgical education researcher. X: @ezraschwartz10</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1356953</link>
      <enclosure url="https://content.rss.com/episodes/9552/1356953/esvs/2024_02_22_09_31_39_94f579ec-4055-4ecf-a833-f37dbb0d0f2e.mp3" length="66804442" type="audio/mpeg"/>
      <guid isPermaLink="false">00d9655e-f3d9-491b-89e3-5df2515e1209</guid>
      <itunes:duration>4175</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 22 Feb 2024 11:30:25 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Translational Spring Meeting 2024 w/U. Hedin & M. Linderquist Liljeqvist]]></title>
      <itunes:title><![CDATA[Translational Spring Meeting 2024 w/U. Hedin & M. Linderquist Liljeqvist]]></itunes:title>
      <description><![CDATA[<p>The 2024 ESVS Translational Spring Meeting will take place in Stockholm on the 3rd&nbsp;and 4th&nbsp;of June. The head of the organizing committee, Prof. Ulf Hedin, and one of the local vascular residents, Moritz Lindquist Liljeqvist, talk to us about the importance of translational science, the program highlights, the spirit of the meeting and much more. Don't miss it!</p><p></p><p><a href="https://esvs.org/events/translational-meeting-2024/">https://esvs.org/events/translational-meeting-2024/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1346896</link>
      <enclosure url="https://content.rss.com/episodes/9552/1346896/esvs/2024_02_15_09_36_19_c47c93b1-19fc-45ce-81f6-cc409e552c92.mp3" length="17825201" type="audio/mpeg"/>
      <guid isPermaLink="false">59319f56-a8f2-4324-b749-b9cc7a167fde</guid>
      <itunes:duration>1114</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 15 Feb 2024 11:40:20 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[FEBVS Exam Prep, Part 4 - Overall Vivas w/M. Gargiulo]]></title>
      <itunes:title><![CDATA[FEBVS Exam Prep, Part 4 - Overall Vivas w/M. Gargiulo]]></itunes:title>
      <description><![CDATA[<p>This week, we are completing the podcast series on FEBVS exam preparations, just in time for our listeners who are taking the exam in a month. Together with Prof. Mauro Gargiulo, we will walk you through the Overall Vivas, once again, with clinical scenarios from previous exams. Enjoy, and good luck to all the future fellows!</p><p>&nbsp;</p><p>&nbsp;</p><p>Shownotes:</p><p>Take a look at those ESVS podcasts to assist you with theoretical information from cases discussed in the podcast:</p><p>ESVS Podcast on Popliteal Artery Aneurysms</p><p>ESVS Podcast on guidelines of Carotid diseases</p><p>ESVS Podcast on Mesenteric ischemia and many more</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1337054</link>
      <enclosure url="https://content.rss.com/episodes/9552/1337054/esvs/2024_02_08_08_57_51_b89b2299-9b2e-4142-89f2-01a1dba10c47.mp3" length="29431475" type="audio/mpeg"/>
      <guid isPermaLink="false">f70e010c-57f3-4f78-aeca-c97e3de07707</guid>
      <itunes:duration>1839</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 08 Feb 2024 11:30:28 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[FEBVS Exam Prep, Part 3 – How Does One Appraise an Academic Paper Successfully? w/M. Gargiulo]]></title>
      <itunes:title><![CDATA[FEBVS Exam Prep, Part 3 – How Does One Appraise an Academic Paper Successfully? w/M. Gargiulo]]></itunes:title>
      <description><![CDATA[<p>In this week's podcast, we are covering FEBVS exam preparation part 3, to be more specific, the most demanding part for most – academic paper appraisal. Together with Prof. M. Gargiulo, we will illustrate how to appraise a paper using an article from previous exams.</p><p>&nbsp;</p><p>Shownotes:</p><p>Official UEMS page for more information: <a href="https://uemsvascular.com/wpsite/wp-content/uploads/2017/12/FEBVS_Academic-Paper.pdf">https://uemsvascular.com/wpsite/wp-content/uploads/2017/12/FEBVS_Academic-Paper.pdf</a></p><p></p><p>Useful links for paper appraisal:</p><p><a href="https://www.cebm.net">https://www.cebm.net</a></p><p><a href="https://www.crd.york.ac.uk/PROSPERO">https://www.crd.york.ac.uk/PROSPERO</a></p><p><a href="http://www.consort-statement.org/consort-statement/flow-diagram"><strong>http://www.consort-statement.org/consort-statement/flow-diagram</strong></a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1322834</link>
      <enclosure url="https://content.rss.com/episodes/9552/1322834/esvs/2024_01_30_08_56_47_10ac137e-b42c-4595-93cc-3b7012132b43.mp3" length="20063338" type="audio/mpeg"/>
      <guid isPermaLink="false">a4f61824-b8b0-40a2-81f3-69945f141d42</guid>
      <itunes:duration>1253</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 01 Feb 2024 11:01:08 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[FEBVS Exam Prep, Part 2 - Clinical Cases w/Prof. M. Gargiulo]]></title>
      <itunes:title><![CDATA[FEBVS Exam Prep, Part 2 - Clinical Cases w/Prof. M. Gargiulo]]></itunes:title>
      <description><![CDATA[<p>In this week’s podcast together with Prof. M. Gargiulo, we will cover the FEBVS exam prep part 2. We will go through clinical cases, illustrating them with real cases from previous FEBVS exams. Below, you will find some helpful links for more information.</p><p>Feel free to reach out if you have any questions or suggestions.</p><p> </p><p>Links:</p><p>Link to the official page: <a href="https://uemsvascular.com/febvs-examination/">https://uemsvascular.com/febvs-examination/</a></p><p>Frequently asked questions: <a href="https://uemsvascular.com/wpsite/wp-content/uploads/2017/12/FAQs_FEBVS-Examination.pdf">https://uemsvascular.com/wpsite/wp-content/uploads/2017/12/FAQs_FEBVS-Examination.pdf</a></p><p>Application forms for the Examiners: <a href="https://uemsvascular.com/febvs-examination/">https://uemsvascular.com/febvs-examination/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1312809</link>
      <enclosure url="https://content.rss.com/episodes/9552/1312809/esvs/2024_01_23_15_39_26_63ad9543-c76a-4fbb-b70f-7a19663d1ff7.mp3" length="31763688" type="audio/mpeg"/>
      <guid isPermaLink="false">dc01099e-468c-4951-883c-d0bf17ec8d5f</guid>
      <itunes:duration>1985</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 24 Jan 2024 11:30:33 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[FEBVS exam prep, Part 1 – structure of the exam with Prof. A. Mansilha]]></title>
      <itunes:title><![CDATA[FEBVS exam prep, Part 1 – structure of the exam with Prof. A. Mansilha]]></itunes:title>
      <description><![CDATA[<p>This week together with prof. A.Mansilha we will talk about the FEBVS exam. This is the first of four-podcast series on the preparation for FEBVS exam. In this podcast we will cover the general concerns regarding the exam and it’s structure. In the following podcast we will walk future fellows through the exam, illustrating it with real cases from the previous exams.</p><p>Feel free to reach out if you have any questions or suggestions.</p><p> </p><p>Links:</p><p>Link to the official page: <a href="https://uemsvascular.com/febvs-examination/">https://uemsvascular.com/febvs-examination/</a></p><p>Frequently asked questions: <a href="https://uemsvascular.com/wpsite/wp-content/uploads/2017/12/FAQs_FEBVS-Examination.pdf">https://uemsvascular.com/wpsite/wp-content/uploads/2017/12/FAQs_FEBVS-Examination.pdf</a></p><p>Application forms for the Examiners: <a href="https://uemsvascular.com/febvs-examination/">https://uemsvascular.com/febvs-examination/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1305108</link>
      <enclosure url="https://content.rss.com/episodes/9552/1305108/esvs/2024_01_17_15_35_59_60baa31a-5727-4f90-838d-d7aa8e27939e.mp3" length="22287717" type="audio/mpeg"/>
      <guid isPermaLink="false">620d91fe-923b-4d9a-a30d-2e206ef4ec27</guid>
      <itunes:duration>1392</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 18 Jan 2024 11:30:19 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Robot-Assisted Aortic Surgery - with Dr. J. Possoz and Dr. C. Swaelens]]></title>
      <itunes:title><![CDATA[Robot-Assisted Aortic Surgery - with Dr. J. Possoz and Dr. C. Swaelens]]></itunes:title>
      <description><![CDATA[<p>The podcast team wishes you all a Happy New Year! In this first episode of 2024, we are talking with Dr. Julien Possoz and Dr. Charles Swaelens, both vascular surgeons from the Grand Hôpital de Charleroi in Belgium about their experience in robot-assisted aortic surgery, mainly for aortic occlusive disease. They have performed about 100 procedures in the past years and tell us all about their experience in launching the robotic program and their tips &amp; tricks.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1287827</link>
      <enclosure url="https://content.rss.com/episodes/9552/1287827/esvs/2024_01_04_08_40_22_191fbf23-d443-4e28-94a2-f67fe90347a4.mp3" length="21031988" type="audio/mpeg"/>
      <guid isPermaLink="false">5935f8d2-9233-409b-9ab9-4e000518d83c</guid>
      <itunes:duration>1313</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 04 Jan 2024 11:30:19 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2023 - 2023 Clinical Practice Guidelines on Radiation Safety with Prof. B. Modarai]]></title>
      <itunes:title><![CDATA[#ESVS2023 - 2023 Clinical Practice Guidelines on Radiation Safety with Prof. B. Modarai]]></itunes:title>
      <description><![CDATA[<p>In today’s episode, we talk with Prof. Bijan Modarai, the chair of the writing committee of the 2023 Clinical Practice Guidelines on Radiation Safety.  This is the last podcast episode that was recorded during the Annual Meeting in Belfast. </p>]]></description>
      <link>https://rss.com/podcasts/esvs/1272764</link>
      <enclosure url="https://content.rss.com/episodes/9552/1272764/esvs/2023_12_20_14_28_16_284d654a-a39c-4cd3-ab9c-077893a9b3e4.mp3" length="16676189" type="audio/mpeg"/>
      <guid isPermaLink="false">bb291cc8-97d0-4c4e-9c49-0d3fe004f912</guid>
      <itunes:duration>1041</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 21 Dec 2023 11:30:23 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2023 - Virtual Vascular Interview with J.Earnshaw and S.Wipper]]></title>
      <itunes:title><![CDATA[#ESVS2023 - Virtual Vascular Interview with J.Earnshaw and S.Wipper]]></itunes:title>
      <description><![CDATA[<p>During #ESVS2023, we held a session on Digital Education is Here to Stay where we discussed the creation of the ESVS's Virtual Vascular textbook and where it's heading.</p><p>Currently, Virtual Vascular chapters are released regularly online, on the ESVS Library, but we also discuss the future of digital education. This interview with Jonothan Earnshaw and Sabine Wipper was recorded live during the session!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1265575</link>
      <enclosure url="https://content.rss.com/episodes/9552/1265575/esvs/2023_12_14_10_54_46_ad1678e2-4838-4dfd-9714-a62f91cf69e7.mp3" length="8077134" type="audio/mpeg"/>
      <guid isPermaLink="false">3dee902a-964b-4b6c-a08a-0d14dbc05d78</guid>
      <itunes:duration>504</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 14 Dec 2023 10:55:45 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[BEST CLI Trial Q&A - Part 3]]></title>
      <itunes:title><![CDATA[BEST CLI Trial Q&A - Part 3]]></itunes:title>
      <description><![CDATA[<p>This is the third and last podcast of our BEST CLI Trial Q&amp;A series, which we recorded live during the 2023 ESVS Annual Meeting in Belfast with PIs Alik Farber and Matt Menard. In this podcast we focus on outcome variables and the different endpoints chosen in the BEST CLI and BASIL 2 trials, and on the next steps to prioritize in CLTI research. Unmissable.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1250636</link>
      <enclosure url="https://content.rss.com/episodes/9552/1250636/esvs/2023_12_04_15_19_23_2205dc2d-ff9a-468c-bff5-43d7eca4616d.mp3" length="10662662" type="audio/mpeg"/>
      <guid isPermaLink="false">184df3ef-8724-4513-aeda-0a553a2040b0</guid>
      <itunes:duration>666</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 07 Dec 2023 11:30:16 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[BEST CLI Trial Q&A - Part 2]]></title>
      <itunes:title><![CDATA[BEST CLI Trial Q&A - Part 2]]></itunes:title>
      <description><![CDATA[<p>Here is the second podcast of our BEST CLI Trial Q&amp;A series, which we recorded live during the 2023 ESVS Annual Meeting in Belfast with PIs Alik Farber and Matt Menard. In this podcast, we dig deeper into the technical failure rate of endovascular treatment and anatomical disease patterns within the trial and how they impact the interpretation of the results and our everyday clinical practice. Enjoy, and more to come soon.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1244334</link>
      <enclosure url="https://content.rss.com/episodes/9552/1244334/esvs/2023_11_29_15_27_47_13ea70c2-4478-420c-92ee-e4075a8782e5.mp3" length="5776301" type="audio/mpeg"/>
      <guid isPermaLink="false">97a71e06-ad43-4984-a90a-4a54ec850039</guid>
      <itunes:duration>360</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 30 Nov 2023 11:30:21 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[BEST CLI Trial Q&A - Part 1]]></title>
      <itunes:title><![CDATA[BEST CLI Trial Q&A - Part 1]]></itunes:title>
      <description><![CDATA[<p>During the 2023 ESVS Annual Meeting in Belfast we sat down with PIs of the BEST CLI trial, Drs. Alik Farber and Matt Menard, to dig deeper into the interpretation of the results of this landmark trial. That conversation has become a series of 3 Q&amp;A podcasts, of which this is the first. Find out in what patients the trial results are applicable and so we should look out for in our everyday clinical practice.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1234125</link>
      <enclosure url="https://content.rss.com/episodes/9552/1234125/esvs/2023_11_21_14_42_30_d85e99ad-69b0-43fb-b87b-6c62d902b7e0.mp3" length="8574564" type="audio/mpeg"/>
      <guid isPermaLink="false">88c0ba45-178f-4638-ba87-c6a8e7290853</guid>
      <itunes:duration>535</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 23 Nov 2023 11:30:18 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2023 - Women in Vascular Surgery w/Dr. T. Mastracci, Prof. A. Halliday, & Prof. P. Shaw]]></title>
      <itunes:title><![CDATA[#ESVS2023 - Women in Vascular Surgery w/Dr. T. Mastracci, Prof. A. Halliday, & Prof. P. Shaw]]></itunes:title>
      <description><![CDATA[<p>One of our last live recorded podcasts from #ESVS2023 Annual Meeting in Belfast has been very special to our team – we had the pleasure to talk with three amazing female vascular role models: Dr. Tara Mastracci, Prof. Alison Halliday, and Prof. Palma Shaw. We focused on equality, inclusivity, and many other challenges in vascular surgery, especially for female physicians. We welcome you to share your thoughts after the podcast, join the European Female Vascular Surgeons group, and stay engaged with ESVS activities because, in the upcoming year, ESVS will present some new projects that will focus on the issues mentioned above and try to increase diversity in the ESVS.</p><p>Shownotes:</p><ul><li>If you want to join the European Female Vascular Surgeons WhatsApp group, contact our team or Dr. Tara Mastracci directly.</li></ul><ul><li>Sisterhood in Surgery page&amp;podcast: <a href="https://www.isevs.org/sisterhood">https://www.isevs.org/sisterhood</a></li></ul><ul><li>Upcoming event - The International Society for Women Surgeons 6th Annual Meeting being held in person on May 3rd, and 4th, 2024 <a href="https://womensvascular.org">https://womensvascular.org</a></li></ul>]]></description>
      <link>https://rss.com/podcasts/esvs/1223477</link>
      <enclosure url="https://content.rss.com/episodes/9552/1223477/esvs/2023_11_15_17_01_33_c37ef684-00b9-459c-8938-5f015c93239e.mp3" length="23936291" type="audio/mpeg"/>
      <guid isPermaLink="false">57a178c8-52d4-4e17-8365-f17232c4a905</guid>
      <itunes:duration>1494</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 16 Nov 2023 11:30:22 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2023 - SUNDAY Trial w/J. Budtz-Lilly]]></title>
      <itunes:title><![CDATA[#ESVS2023 - SUNDAY Trial w/J. Budtz-Lilly]]></itunes:title>
      <description><![CDATA[<p>We continue with another live recording from ESVS AM 2023. This time Egle Kavaliunaite interviews Jacob Budtz-Lilly on the SUNDAY trial - Scandinavian Trial of Uncomplicated Aortic Dissection Therapy. Listen and find out for yourself what we can expect from this international randomised trial!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1211432</link>
      <enclosure url="https://content.rss.com/episodes/9552/1211432/esvs/2023_11_09_10_34_17_2caff901-3691-4fb1-b824-da483a1734b6.mp3" length="9823756" type="audio/mpeg"/>
      <guid isPermaLink="false">b7613b89-a1a1-406a-8bf7-b0912f1cf66f</guid>
      <itunes:duration>613</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 09 Nov 2023 12:40:21 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS 2023 - European Vascular Research Collaborative w/A. Gratl, F. Enzmann, and L. Kukulski]]></title>
      <itunes:title><![CDATA[#ESVS 2023 - European Vascular Research Collaborative w/A. Gratl, F. Enzmann, and L. Kukulski]]></itunes:title>
      <description><![CDATA[<p>In this week’s podcast, we aim to invite vascular surgeons to join a great team of young researchers- the European Vascular Research Collaborative (EVRC), who managed to unite many European Centers together to produce high-quality research. Together with Dr. Alexandra Gratl, Dr. Florian Enzmann, and Dr. Leszek Kukulski, we briefly discuss current activities as well as past, present, and future projects. Regardless of your previous research experience, we encourage you all to reach out to the EVRC team, share your ideas, and join the forces.</p><p>Link for more information below, enjoy the listen!</p><p><a href="https://eurovascresearch.com">https://eurovascresearch.com</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1206320</link>
      <enclosure url="https://content.rss.com/episodes/9552/1206320/esvs/2023_11_06_15_47_04_a38241ff-a269-4505-88d9-b77b8c4fb39c.mp3" length="8302803" type="audio/mpeg"/>
      <guid isPermaLink="false">7b611030-5fa0-4041-8ab5-41efda871d6e</guid>
      <itunes:duration>518</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 09 Nov 2023 11:30:18 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[What is the ESVS KOL Forum? with K. Yeung and F. Gentile]]></title>
      <itunes:title><![CDATA[What is the ESVS KOL Forum? with K. Yeung and F. Gentile]]></itunes:title>
      <description><![CDATA[In this podcast, we will tell you what the new ESVS KOL forum is, who it is for, who the hostesses and key opinion leaders are in the first two editions (of a long series!) and we will even let you listen to some snippets of the first forum, which took place online on the 26th June. The next edition will happen on the 28th of November 2023, focused on vascular access. Register now, send in your case and don't miss it!]]></description>
      <link>https://rss.com/podcasts/esvs/1196596</link>
      <enclosure url="https://content.rss.com/episodes/9552/1196596/esvs/2023_10_31_10_40_30_c108fc98-c6e5-4029-a641-36d940735fd8.mp3" length="20288675" type="audio/mpeg"/>
      <guid isPermaLink="false">feadde65-31af-4cf6-be12-dcb64b24b30d</guid>
      <itunes:duration>1268</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 02 Nov 2023 11:30:17 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2023 with EVST Secretary Petar Zlatanovic]]></title>
      <itunes:title><![CDATA[#ESVS2023 with EVST Secretary Petar Zlatanovic]]></itunes:title>
      <description><![CDATA[In this episode, we are greeting you from the ESVS Annual Meeting with EVST Secretary Petar Zlatanovic. With this podcast, we would like to invite all vascular trainees not only to join educational activities, but also to join the EVST team with your ideas.<a href="https://esvs.org/european-vascular-surgeons-in-training/">https://esvs.org/european-vascular-surgeons-in-training/</a>]]></description>
      <link>https://rss.com/podcasts/esvs/1190106</link>
      <enclosure url="https://content.rss.com/episodes/9552/1190106/esvs/2023_10_26_09_51_16_953605b8-19b8-45a0-8bed-1b06a8fc727e.mp3" length="7166372" type="audio/mpeg"/>
      <guid isPermaLink="false">e149cddb-9217-48b6-bb01-ca2ede3d1c37</guid>
      <itunes:duration>447</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 26 Oct 2023 09:52:27 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2023 with Prize Session Presenters]]></title>
      <itunes:title><![CDATA[#ESVS2023 with Prize Session Presenters]]></itunes:title>
      <description><![CDATA[Here is another ESVS podcast recorded live at Podcast Corner during the ESVS Annual Meeting held in Belfast in September 2023. This time we briefly interviewed some of the presenters of the Prize Session. They explained the main findings of their studies and what it meant to them to be runners-up for this year's prize for best oral presentation. The best of the best!PS. Megan Power Foley won 2nd prize. Congratulations! ]]></description>
      <link>https://rss.com/podcasts/esvs/1190036</link>
      <enclosure url="https://content.rss.com/episodes/9552/1190036/esvs/2023_10_26_08_44_31_14820537-026e-4474-8e5d-7e93bc3e2581.mp3" length="8180434" type="audio/mpeg"/>
      <guid isPermaLink="false">4ba06d0d-9048-4656-976c-db67674ebbe5</guid>
      <itunes:duration>511</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 26 Oct 2023 08:44:54 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2023 with the Academy Chair, Assoc. Prof. I. Koncar]]></title>
      <itunes:title><![CDATA[#ESVS2023 with the Academy Chair, Assoc. Prof. I. Koncar]]></itunes:title>
      <description><![CDATA[As already presented last week, we are happy to share podcasts from the ESVS Annual meeting, this one is with Academy Chair Assoc. Prof. Igor Koncar. We covered activities during the Annual Meeting and academy activities for all of you for the upcoming year. <a href="https://esvs.org/esvs-academy/">https://esvs.org/esvs-academy/</a>]]></description>
      <link>https://rss.com/podcasts/esvs/1179462</link>
      <enclosure url="https://content.rss.com/episodes/9552/1179462/esvs/2023_10_19_13_20_06_2fec317c-59e2-4f7c-890c-dca4ac6cb137.mp3" length="10873670" type="audio/mpeg"/>
      <guid isPermaLink="false">716d5f2c-889b-4b60-83e2-8d3557123b2d</guid>
      <itunes:duration>679</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 Oct 2023 13:39:05 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2023 with ESVS Presidents Prof. P. Kolh & Prof. I. Loftus]]></title>
      <itunes:title><![CDATA[#ESVS2023 with ESVS Presidents Prof. P. Kolh & Prof. I. Loftus]]></itunes:title>
      <description><![CDATA[<p>Show notes: Live from the ESVS Annual Meeting held in Belfast in September 2023. This time at the Podcast Corner we have the current ESVS president prof. P.Kolh and President-elect prof. I. Loftus. You’ll be hearing about the ongoing and future projects in ESVS. Don’t miss out!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1179451</link>
      <enclosure url="https://content.rss.com/episodes/9552/1179451/esvs/2023_10_19_13_11_58_d69f9057-9091-4390-bc2e-403e6c4afa7f.mp3" length="17584422" type="audio/mpeg"/>
      <guid isPermaLink="false">b3d3fda2-5c65-4cfd-91b2-ff0e9179cd7c</guid>
      <itunes:duration>1098</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 Oct 2023 13:13:24 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[#ESVS2023 - Statistics for Surgeons Workshop w/Dr. F. Álvarez Marcos & Dr. Sergi Bellmunt]]></title>
      <itunes:title><![CDATA[#ESVS2023 - Statistics for Surgeons Workshop w/Dr. F. Álvarez Marcos & Dr. Sergi Bellmunt]]></itunes:title>
      <description><![CDATA[Here is another ESVS podcast recorded live at Podcast Corner during the ESVS Annual Meeting held in Belfast in September 2023. This time we briefly interviewed the convenors of the Academy workshop Stats for surgeons, Drs. Francisco Álvarez Marcos and Sergi Bellmunt. They explained the main contents and dynamics of the workshop, the importance of statistical knowledge in clinical practice and upcoming plans for new editions of the workshop. Enjoy and more to come soon! ]]></description>
      <link>https://rss.com/podcasts/esvs/1179446</link>
      <enclosure url="https://content.rss.com/episodes/9552/1179446/esvs/2023_10_19_13_07_34_8b46c3c6-e00b-4d2e-8f7c-7546cf83b7cf.mp3" length="6428784" type="audio/mpeg"/>
      <guid isPermaLink="false">93489274-b61f-457a-84b4-ea14ee480830</guid>
      <itunes:duration>401</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 19 Oct 2023 13:08:34 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ESVS Annual Meeting 2023 with the Programme Directors]]></title>
      <itunes:title><![CDATA[ESVS Annual Meeting 2023 with the Programme Directors]]></itunes:title>
      <description><![CDATA[For the first time, the ESVS Annual Meeting, held in Belfast this September 2023, included a Podcast Corner, where we recorded some podcasts live with invited speakers onsite.The current and upcoming ESVS Programme Chairs Sebastian Debus and Hence Verhagen talk to us about how a conference programme is set up, the highlights of this year’s Annual Meeting and new ideas for the future. Enjoy! ]]></description>
      <link>https://rss.com/podcasts/esvs/1168790</link>
      <enclosure url="https://content.rss.com/episodes/9552/1168790/esvs/2023_10_12_08_36_42_22cc1df7-0ad7-4efd-a463-62d27e1fda3d.mp3" length="9661697" type="audio/mpeg"/>
      <guid isPermaLink="false">c81c857a-2460-4536-be7e-09306332a2bf</guid>
      <itunes:duration>603</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 12 Oct 2023 13:29:04 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Radiation reduction using advanced imaging technologies: IVUS & FORS w/ Dr. J. Teßarek & Prof. T. Kölbel  ]]></title>
      <itunes:title><![CDATA[Radiation reduction using advanced imaging technologies: IVUS & FORS w/ Dr. J. Teßarek & Prof. T. Kölbel  ]]></itunes:title>
      <description><![CDATA[<p>For the past decade, there has been a significant increase in endovascular procedures. Therefore, certain actions have been taken to raise awareness and promote radiation safety. In today’s podcast, our guests are Dr. Jörg Teßarek and Professor Tilo Kölbel. We are going to talk about FORS and IVUS imaging modalities that may facilitate daily practice in vascular medicine by increasing the quality of vascular imaging while significantly reducing radiation exposure in both patients and physicians. Philips sponsored this podcast.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1157825</link>
      <enclosure url="https://content.rss.com/episodes/9552/1157825/esvs/2023_10_06_13_56_28_d488a8b4-3a07-41d3-a0ed-5946873370eb.mp3" length="34400314" type="audio/mpeg"/>
      <guid isPermaLink="false">7353a87c-ea2b-4b4d-88d8-dbfffc17ca77</guid>
      <itunes:duration>2149</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Fri, 06 Oct 2023 13:59:52 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[How to Write and Review a Paper with M. Vega de Ceniga]]></title>
      <itunes:title><![CDATA[How to Write and Review a Paper with M. Vega de Ceniga]]></itunes:title>
      <description><![CDATA[<p>We are so glad to invite you all not only to join our Podcast Corner during the ESVS Annual Meeting in Belfast shortly, but to get some inside information on one of the highly attended Academy Workshops – ‘How to write and review scientific paper?’. Moreover, this podcast was extra special for me – I got to record it with an inventor and mentor of ESVS Podcast - Dr. Melina Vega De Ceniga. Enjoy the listen and come say hi to our podcast booth.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1126951</link>
      <enclosure url="https://content.rss.com/episodes/9552/1126951/esvs/2023_09_18_07_48_04_506fbbf0-6f6d-42bb-9033-8a66a4cf4979.mp3" length="8485607" type="audio/mpeg"/>
      <guid isPermaLink="false">11111c16-3ec2-4a51-8248-4cde903c4d02</guid>
      <itunes:duration>530</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 18 Sep 2023 07:48:54 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Intravascular lithotripsy (IVL) or Shockwave therapy with L. Patrone & M. Bosiers]]></title>
      <itunes:title><![CDATA[Intravascular lithotripsy (IVL) or Shockwave therapy with L. Patrone & M. Bosiers]]></itunes:title>
      <description><![CDATA[After a short summer break, ESVS podcast welcomes you with the new release.  As a new school year marks, a new beginning we continue exploring topics on innovation by inviting you to get yourself more familiar with Intravascular lithotripsy (IVL) or Shockwave therapy. Enjoy the listen! Principles of Intravascular Lithotripsy for Calcific Plaque Modification. Dean J. Kereiakes et al. <a href="https://www.sciencedirect.com/science/article/pii/S193687982100501X?via%3Dihub">https://www.sciencedirect.com/science/article/pii/S193687982100501X?via%3Dihub</a> Intravascular Lithotripsy for Peripheral Artery Calcification: Mid-term Outcomes From the Randomized Disrupt PAD III Trial. Gunnar Tepe et al. <a href="https://www.jscai.org/article/S2772-9303(22)00325-8/fulltext">https://www.jscai.org/article/S2772-9303(22)00325-8/fulltext</a>Human Cadaveric Model for Vessel Preparation Device Testing in Calcified Tibial Arteries. Trisha L. Roy et al. <a href="https://pubmed.ncbi.nlm.nih.gov/36103037/">https://pubmed.ncbi.nlm.nih.gov/36103037/</a>To Cross or Not to Cross: Using MRI-Histology to Characterize Dense Collagenous Plaque in Critical Limb Ischemia. Trisha L. Roy et al. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818044/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818044/</a>]]></description>
      <link>https://rss.com/podcasts/esvs/1105225</link>
      <enclosure url="https://content.rss.com/episodes/9552/1105225/esvs/2023_09_07_13_33_27_d9eee9f6-d15e-40a4-8dfb-09be17087f1a.mp3" length="32264821" type="audio/mpeg"/>
      <guid isPermaLink="false">57611138-378c-4412-9dba-79271cb5993d</guid>
      <itunes:duration>2016</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 07 Sep 2023 13:35:15 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Transatlantic Series: Carotid Guidelines with Dr. B. Rantner & Dr. A. AbuRahma]]></title>
      <itunes:title><![CDATA[Transatlantic Series: Carotid Guidelines with Dr. B. Rantner & Dr. A. AbuRahma]]></itunes:title>
      <description><![CDATA[<p>Modern-day evidence-based medicine mandates a strong understanding of current local and international guidelines. We surgeons often rely heavily on these reports, but what to do when they differ? To explore this topic, Audible Bleeding (a publication of the SVS) and the ESVS podcast have partnered to create the Transatlantic Series. In this inaugural episode, we compare and contrast the SVS carotid artery disease guidelines published in 2022 with the recently updated ESVS guidelines published in 2023.Representing the American perspective, we are excited to speak with Dr. Ali AbuRahma. Dr. AbuRahma is the former president of the Society of Vascular Surgery, the Chief of Vascular and Endovascular Surgery at the Charleston Area Medical Centre at West Virginia University, and the corresponding author of the latest <a href="https://www.google.com/url?q=https://www.google.com/url?q%3Dhttps://www.jvascsurg.org/article/S0741-5214(21)00893-4/fulltext%26amp;sa%3DD%26amp;source%3Deditors%26amp;ust%3D1689764466268582%26amp;usg%3DAOvVaw05NNOE6pbHNTkS1Ocz6mpK&amp;sa=D&amp;source=docs&amp;ust=1689764466282338&amp;usg=AOvVaw3hv9xbclkSHKCH2f5W4kHG">SVS guidelines on extracranial cerebrovascular disease</a>.Representing the European perspective, we are delighted to speak with Dr. Barbara Rantner. Dr. Rantner is the co-chair of the <a href="https://www.google.com/url?q=https://www.google.com/url?q%3Dhttps://esvs.org/wp-content/uploads/2022/10/2023-CPG-on-the-Management-of-Atherosclerotic-Carotid-and-Vertebral-Artery-Disease.pdf%26amp;sa%3DD%26amp;source%3Deditors%26amp;ust%3D1689764466269255%26amp;usg%3DAOvVaw1qRXsvDJ8tyKjPHD22IdTc&amp;sa=D&amp;source=docs&amp;ust=1689764466282662&amp;usg=AOvVaw0wqZxkiSb-nnjjPbDazzTC">2023 European Society of Vascular Surgery Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease</a> and a leading physician at the Ludwig-Maximillian University Hospital in Munich, Germany.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/1051197</link>
      <enclosure url="https://content.rss.com/episodes/9552/1051197/esvs/2023_07_25_07_44_23_2dd9da5c-8c58-4811-9f31-82247d443bc8.mp3" length="56864493" type="audio/mpeg"/>
      <guid isPermaLink="false">c28cd5a0-ffbd-4335-b89c-4d80cd3862d9</guid>
      <itunes:duration>3553</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 26 Jul 2023 12:00:52 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Editor's Choice - The EVAR Surveillance Paradox Summary]]></title>
      <itunes:title><![CDATA[Editor's Choice - The EVAR Surveillance Paradox Summary]]></itunes:title>
      <description><![CDATA[<p>Follow-up after EVAR is a topic of discussion worldwide.</p><p>In this episode, Laurence Bertrand and Suzanne Stokmans summarise an Editor's Choice article from the European Journal of Vascular and Endovascular Surgery (EJVES) on this topic: Meta-Analysis of Compliance with Endovascular Aneurysm Repair Surveillance: The EVAR Surveillance Paradox by Antoniou and colleagues.</p><p>This systematic review compared survival in EVAR surveillance-compliant patients with non-compliant patients. Non-compliance was defined as failure to attend at least one post-EVAR follow-up.</p><p>The findings in this article question the value of intense surveillance in all patients post-EVAR. We are curious about your opinion on EVAR surveillance, so please feel free to let us know via email or by commenting!</p><p>Shownotes:</p><p>Antoniou et al; Meta-Analysis of Compliance with Endovascular Aneurysm Repair Surveillance: The EVAR Surveillance Paradox. Eur J Vasc Endovasc Surg (2023) 65, 244e254 <a href="https://doi.org/10.1016/j.ejvs.2022.10.033">https://doi.org/10.1016/j.ejvs.2022.10.033</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/1025593</link>
      <enclosure url="https://content.rss.com/episodes/9552/1025593/esvs/2023_07_05_16_00_35_5727c98d-1d13-4ec8-b829-75ddb93d7965.mp3" length="12842792" type="audio/mpeg"/>
      <guid isPermaLink="false">08e294d8-a514-49ed-8904-ea95f6929d49</guid>
      <itunes:duration>802</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 05 Jul 2023 16:00:45 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Simulation & Vascular Training with I. Van Herzeele and C. Bicknell Part 2]]></title>
      <itunes:title><![CDATA[Simulation & Vascular Training with I. Van Herzeele and C. Bicknell Part 2]]></itunes:title>
      <description><![CDATA[This is the second part of a Vascular Forum interview with Isabelle Van Herzeele and Colin Bicknell. Carlota Fernández Prendes discusses with them the topic of training programmes, skills development, and recognising failures for vascular residents.]]></description>
      <link>https://rss.com/podcasts/esvs/998768</link>
      <enclosure url="https://content.rss.com/episodes/9552/998768/esvs/2023_06_15_10_30_21_61102204-8cf1-4942-ac33-215641c7f5f1.mp3" length="24113072" type="audio/mpeg"/>
      <guid isPermaLink="false">0983f850-777b-44be-9764-31708c305d0e</guid>
      <itunes:duration>1507</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 15 Jun 2023 11:34:53 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Simulation & Vascular Training with I. Van Herzeele & C. Bicknell Part 1 [Repost]]]></title>
      <itunes:title><![CDATA[Simulation & Vascular Training with I. Van Herzeele & C. Bicknell Part 1 [Repost]]]></itunes:title>
      <description><![CDATA[<p>This is the first part of a Vascular Forum interview with Isabelle Van Herzeele and Colin Bicknell. </p><p>Carlota Fernández Prendes discusses with them the topic of training programmes, skills development, and recognising failures for vascular residents.</p>]]></description>
      <link>https://rss.com/podcasts/esvs/998761</link>
      <enclosure url="https://content.rss.com/episodes/9552/998761/esvs/2023_06_15_10_26_06_8fe81571-1c90-44e1-8c40-683b0a69312f.mp3" length="23315215" type="audio/mpeg"/>
      <guid isPermaLink="false">d6d94020-61e4-4812-8693-578335cf5a19</guid>
      <itunes:duration>1457</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 15 Jun 2023 10:29:50 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Virtual Vascular Chapter: Late complications & Surveillance after EVAR with Dr. F. Bastos Gonçalves & Prof. Dr. H. Verhagen]]></title>
      <itunes:title><![CDATA[Virtual Vascular Chapter: Late complications & Surveillance after EVAR with Dr. F. Bastos Gonçalves & Prof. Dr. H. Verhagen]]></itunes:title>
      <description><![CDATA[At this week’s podcast, we dive deeper into the Virtual Vascular Chapter on Late complications and Surveillance after EVAR. We talk – among other things - about the different types of endoleaks and how some of them are ‘wolf in sheep's clothing’. We also discuss extensively about follow up and what we can learn from medical oncologists on this matter. Please tune in, and make sure to also read the accompanying chapter in VV that you can find in the E-library at <a href="http://ESVS.org">ESVS.org</a>!<strong>Shownotes:</strong>You can find this chapter and all the other the Virtual Vascular Chapters in the ESVS Library on the ESVS website. It is only accessible for ESVS members, so if you are not a member yet subscribe now and don’t miss out on great educational content.]]></description>
      <link>https://rss.com/podcasts/esvs/975013</link>
      <enclosure url="https://content.rss.com/episodes/9552/975013/esvs/2023_05_31_15_31_27_dfde4fc3-c89b-48db-927f-70d57c72425c.mp3" length="33085325" type="audio/mpeg"/>
      <guid isPermaLink="false">ff3ffc19-0c34-455f-b6a8-e3b2accfc9d9</guid>
      <itunes:duration>2067</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 31 May 2023 16:09:04 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VV - Abdominal Aortic Aneurysms with Prof I. Van Herzeele and Dr A. Gratl]]></title>
      <itunes:title><![CDATA[VV - Abdominal Aortic Aneurysms with Prof I. Van Herzeele and Dr A. Gratl]]></itunes:title>
      <description><![CDATA[<p>New podcast episode on Virtual Vascular chapter of AAA is live! Tune in to hear experts dive into patient selection for open or endovascular repair, tough decision-making, and more! Don't miss out!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/957711</link>
      <enclosure url="https://content.rss.com/episodes/9552/957711/esvs/2023_05_19_10_06_46_3346427f-66ac-4676-bfd6-f5a02e0f1681.mp3" length="37010329" type="audio/mpeg"/>
      <guid isPermaLink="false">7b2c9e68-4a6b-43c3-a432-0d81036dc1f7</guid>
      <itunes:duration>2313</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Fri, 19 May 2023 10:14:57 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Unwrap the mystery behind Vascular Malformations]]></title>
      <itunes:title><![CDATA[Unwrap the mystery behind Vascular Malformations]]></itunes:title>
      <description><![CDATA[<p>This week, we decided to clarify the unclear on the topic of vascular malformations with one of the best in the field – Prof. Iris Baumgartner. This group of diseases is a rather neglected one in vascular medicine, but make no mistake after listening to this episode you will get clarifications on a topic and for your own comfort, we created some bullet points with shownotes below, so that you can start using it in your practice right away. Enjoy!<strong>Bullet points:</strong></p><ul><li><p>An inherited congenital vascular malformation is diagnosed in 0.5-1.5% of all people worldwide</p></li><li><p>A congenital vascular malformation is classified according to ISSVA (International Society for the Study of Vascular Anomalies) <a href="https://www.issva.org/classification">https://www.issva.org/classification</a></p></li><li><p>The most frequent congenital vascular malformation is venous malformation (up to 50-70% of all vascular malformations). The arterio-venous malformation is rather rare, with 10-15% at most.</p></li><li><p>Clinical symptoms depend on the vascular bed (venous, capillary, lymphatic, arterio-venous) involved and in combination with other anomalies (e.g., overgrowth)</p></li><li><p>Duplex ultrasound and magnetic resonance are basic imaging modalities to diagnose congenital vascular malformation.</p></li><li><p>Management of patients with congenital vascular malformations is a multidisciplinary approach.</p></li><li><p>The symptomatic arterio-venous malformation is progressive, and over time, most patients with large-sized arterio-venous malformation need therapy.</p></li><li><p>Most arterio-venous malformations are based on oncogenes activated in endothelial cells within the nidus.</p></li><li><p>For patients with extensive disease, molecularly targeted drug therapy might become lifesaving.</p></li><li><p>As targeted drug therapy comes along with side effects, it is necessary to collaborate with an experienced internist or oncologist.</p></li><li><p>Medial therapy still is experimental and needs acceptance for compassionate use.</p></li><li><p>Unexperienced colleagues should take some time and join large centres with experience to learn invasive and medical treatment under close supervision.</p></li></ul>]]></description>
      <link>https://rss.com/podcasts/esvs/935540</link>
      <enclosure url="https://content.rss.com/episodes/9552/935540/esvs/2023_05_03_16_54_48_b2a9256d-985c-4205-8e44-799d8b0c95d7.mp3" length="32577872" type="audio/mpeg"/>
      <guid isPermaLink="false">8047c8e9-b725-495d-8ef3-bb41941d226d</guid>
      <itunes:duration>2036</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 03 May 2023 16:55:47 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Virtual Vascual Chapter: Popliteal artery aneurysm with Dr. Anne Cervin, Dr. Igor Koncar, Prof. Dr Martin Björck]]></title>
      <itunes:title><![CDATA[Virtual Vascual Chapter: Popliteal artery aneurysm with Dr. Anne Cervin, Dr. Igor Koncar, Prof. Dr Martin Björck]]></itunes:title>
      <description><![CDATA[<p>In this week’s podcast, the three authors of the recently published Virtual Vascular Chapter about popliteal artery aneurysms. Dr. Anne Cervin, Dr. Igor Koncar, and Prof. Dr Martin Björck share their knowledge about this disease and the surgical treatment. You can find this chapter and all the other Virtual Vascular Chapters in the E-library on the ESVS website. It is only accessible to ESVS members, so if you are not a member yet subscribe now and don’t miss out on great educational content.<a href="https://esvs.org/e-library-home/">https://esvs.org/e-library-home/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/914605</link>
      <enclosure url="https://content.rss.com/episodes/9552/914605/esvs/2023_04_19_13_55_27_1cc703c1-4941-4f6d-b474-4583173d51b4.mp3" length="40612352" type="audio/mpeg"/>
      <guid isPermaLink="false">c7b2289d-e5dc-4015-8473-220e22a18cb6</guid>
      <itunes:duration>2538</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 19 Apr 2023 14:03:16 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Live from EVC: Prof. J. Schmidli and Prof. M. Jacobs on their careers & the future of vascular surgery (training) ]]></title>
      <itunes:title><![CDATA[Live from EVC: Prof. J. Schmidli and Prof. M. Jacobs on their careers & the future of vascular surgery (training) ]]></itunes:title>
      <description><![CDATA[<p>In this week’s podcast, two team members joined forces to interview two legendary vascular surgeons: Prof. Jürg Schmidli and Prof. Michael Jacobs. Both professors have left a significant imprint on the clinical and educational development of vascular surgery in Europe and beyond. Both are actively involved in educational work and throughout their career have been mentors and inspirations to a great number of colleagues, including Vaiva &amp; Suzanne. Take a listen and get to know their paths and their tips for your future as a vascular specialist. Shownotes:Greiner et al; Cyber medicine enables remote neuromonitoring during aortic surgery. J Vasc Surg. 2012 May;55(5):1227-32; discussion 1232-3. DOI: 10.1016/j.jvs.2011.11.121</p>]]></description>
      <link>https://rss.com/podcasts/esvs/897547</link>
      <enclosure url="https://content.rss.com/episodes/9552/897547/esvs/2023_04_06_10_46_09_272598d6-5e23-4d65-8437-4fa933eda5d1.mp3" length="42732866" type="audio/mpeg"/>
      <guid isPermaLink="false">d7f4ea5c-8171-45d1-981a-733a63c00d9c</guid>
      <itunes:duration>2670</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 06 Apr 2023 10:47:38 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Thoracic Outlet Syndrome with Dr. Rebecca Winterborn]]></title>
      <itunes:title><![CDATA[Thoracic Outlet Syndrome with Dr. Rebecca Winterborn]]></itunes:title>
      <description><![CDATA[<p>This is a Virtual Vascular podcast on the chapter of Thoracic Outlet Syndrome with dr. Rebecca Winterborn, where we hear tips and tricks on how to get good transaxillary exposure, the role of physical therapy, and much more!</p>]]></description>
      <link>https://rss.com/podcasts/esvs/881132</link>
      <enclosure url="https://content.rss.com/episodes/9552/881132/esvs/2023_03_25_21_37_44_014b101a-07ec-4733-83ba-e4facd8306ee.mp3" length="22314884" type="audio/mpeg"/>
      <guid isPermaLink="false">3c665c57-e0c6-43d0-9047-3c614443d02b</guid>
      <itunes:duration>1394</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Sat, 25 Mar 2023 21:38:18 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Physician modified stent-grafts: how, where, when and why? with Prof. V. Makaloski and Prof. N. Tsilimparis]]></title>
      <itunes:title><![CDATA[Physician modified stent-grafts: how, where, when and why? with Prof. V. Makaloski and Prof. N. Tsilimparis]]></itunes:title>
      <description><![CDATA[<p>In this podcast, we cover physician (or surgeon) modified stent-grafts with leading vascular experts in the field: Prof. Vladimir Makaloski, and Prof. Nikolaos Tsilimparis.</p><p>Designed for all colleagues from different backgrounds in vascular medicine, we go over the adequate preparation, execution and tips and tricks given by experienced colleagues. Take a listen!</p><p>Stay up to date with the European Society of Vascular Surgery as we offer more discussions like these in our webinars, our podcasts, our Masterclass and other events. We even offer hands-on and face-to-face practical experiences through our Academy workshops.</p><p>- Instagram: <a href="https://www.instagram.com/esvs_admin/">https://www.instagram.com/esvs_admin/</a></p><p>- Twitter: <a href="https://twitter.com/ESVSmembership">https://twitter.com/ESVSmembership</a></p><p>- Facebook: <a href="https://www.facebook.com/EuropeanSocietyforVascularSurgery">https://www.facebook.com/EuropeanSocietyforVascularSurgery</a></p><p>- LinkedIn: <a href="https://www.linkedin.com/company/european-society-for-vascular-surgery/">https://www.linkedin.com/company/european-society-for-vascular-surgery/</a></p><p><strong>Shownotes:</strong></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wanhainen+A&amp;cauthor_id=30528142">Wanhainen</a> et al. <em>Editor's Choice - European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms.</em> Eur J Vasc Endovasc Surg. 2019 Jan;57(1):8-93. DOI: <a href="https://doi.org/10.1016/j.ejvs.2018.09.020">10.1016/j.ejvs.2018.09.020</a></p><p>Gouveia e Melo et al. <em>Systematic Review and Meta-analysis of Physician Modified Endografts for Treatment of Thoraco-Abdominal and Complex Abdominal Aortic Aneurysms. </em>Eur J Vasc Endovasc Surg. 2022 Aug-Sep;64(2-3):188-199. DOI: <a href="https://doi.org/10.1016/j.ejvs.2022.04.015">10.1016/j.ejvs.2022.04.015</a></p><p>Coles-Back et al.<strong> </strong><em>A systematic review of three-dimensional printed template-assisted physician-modified stent grafts for fenestrated endovascular aneurysm repair</em>. J Vasc Surg. 2021 Jul;74(1):296-306.e1. DOI: <a href="https://doi.org/10.1016/j.jvs.2020.08.158">10.1016/j.jvs.2020.08.158</a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Canaud+L&amp;cauthor_id=35927926">Canaud</a> et al. <em>Total Arch Thoracic Endovascular Aortic Repair Using Double Fenestrated Physician-Modified Stent-Grafts: 100 Patients.</em> J Endovasc Ther. 2022 Aug 4;15266028221116747. DOI: <a href="https://doi.org/10.1177/15266028221116747">10.1177/15266028221116747</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/865919</link>
      <enclosure url="https://content.rss.com/episodes/9552/865919/esvs/2023_03_15_16_07_27_68b5ebf2-ff86-4c8e-8b5f-dbbf25ef2d34.mp3" length="39238470" type="audio/mpeg"/>
      <guid isPermaLink="false">d0f95148-e784-4ee8-9ae1-806752a3a244</guid>
      <itunes:duration>2452</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Tue, 14 Mar 2023 15:45:52 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Virtual Vascular - Asymptomatic Carotid Disease with HH. Eckstein and G. Menyhei. ]]></title>
      <itunes:title><![CDATA[Virtual Vascular - Asymptomatic Carotid Disease with HH. Eckstein and G. Menyhei. ]]></itunes:title>
      <description><![CDATA[<p>Can early carotid endarterectomy impact neurological impairment?</p><p>Our two experts, Hans-Henning Eckstein and Gabor Menyhei, discuss the latest evidence regarding the asymptomatic carotid disease. Listen and find out what they have to say!</p><p>Read more about what Hans-Henning Eckstein has to say about Asymptomatic Carotid Disease by becoming an ESVS member and accessing the Virtual Vascular chapter dedicated to the topic!</p><p><a href="https://esvs.org/blog/virtualvascular/asymptomatic-carotid-stenosis/">https://esvs.org/blog/virtualvascular/asymptomatic-carotid-stenosis/</a></p><p>Stay up to date with the European Society of Vascular Surgery as we offer more discussions like these in our webinars, our podcasts, our Masterclass and other events. We even offer hands-on and face-to-face practical experiences through our Academy workshops.</p><p>- Instagram: <a href="https://www.instagram.com/esvs_admin/">https://www.instagram.com/esvs_admin/</a></p><p>- Twitter: <a href="https://twitter.com/ESVSmembership">https://twitter.com/ESVSmembership</a></p><p>- Facebook: <a href="https://www.facebook.com/EuropeanSocietyforVascularSurgery">https://www.facebook.com/EuropeanSocietyforVascularSurgery</a></p><p>- LinkedIn: <a href="https://www.linkedin.com/company/european-society-for-vascular-surgery/">https://www.linkedin.com/company/european-society-for-vascular-surgery/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/857300</link>
      <enclosure url="https://content.rss.com/episodes/9552/857300/esvs/2023_03_08_15_02_08_75739aa9-99c8-4ea2-a592-9d56a4beba67.mp3" length="25559526" type="audio/mpeg"/>
      <guid isPermaLink="false">5df44103-90fd-4d33-bf98-c650a7c2aaf9</guid>
      <itunes:duration>1597</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 08 Mar 2023 15:03:03 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VFI on Mesenteric Ischaemia with Prof R.H. Geelkerken and F. Metz - Part 2/2]]></title>
      <itunes:title><![CDATA[VFI on Mesenteric Ischaemia with Prof R.H. Geelkerken and F. Metz - Part 2/2]]></itunes:title>
      <description><![CDATA[<p>This is the second part of the mesenteric ischemia interview with expert in the field professor Geelkerken. This podcast is solely focused on the median arcuate ligament syndrome (MALS) and whether it exists or not. We talk about aetiology, diagnostic tools &amp; treatment and will talk about the CARoSO study.</p><p><strong>Shownotes:</strong></p><p>Metz et al; Systematic Review of the Efficacy of Treatment for Median Arcuate Ligament Syndrome. Eur J Vasc Endovasc Surg. 2022 Dec;64(6):720-732</p><p>DOI: 10.1016/j.ejvs.2022.08.033</p><p>Blauw et al; Coeliac Artery Release or Sham Operation in Patients Suspected of Having Median Arcuate Ligament Syndrome: The CARoSO study. Eur J Vasc Endovasc Surg. 2022 Nov;64(5):573-574</p><p>DOI: 10.1016/j.ejvs.2022.07.043</p><p> Terlouw et al; The Incidence of Chronic Mesenteric Ischemia in the Well-Defined Region of a Dutch Mesenteric Ischemia Expert Center. Clin Transl Gastroenterol. 2020 Aug;11(8):e00200. </p><p>DOI: 10.14309/ctg.0000000000000200</p><p>Mensink et al; Gastric exercise tonometry: the key investigation in patients with suspected celiac artery compression syndrome. J Vasc Surg. 2006 Aug;44(2):277-81</p><p>DOI: 10.1016/j.jvs.2006.03.038</p><p>Van Petersen et al; Retroperitoneal endoscopic release in the management of celiac artery compression syndrome. J Vasc Surg. 2009 Jul;50(1):140-7</p><p>DOI: 10.1016/j.jvs.2008.12.077</p><p>ESVS 2017 guidelines Management of the Diseases of Mesenteric Arteries and Veins</p><p>DOI: <a href="https://doi.org/10.1016/j.ejvs.2017.01.010">https://doi.org/10.1016/j.ejvs.2017.01.010</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/847365</link>
      <enclosure url="https://content.rss.com/episodes/9552/847365/esvs/2023_03_01_15_24_58_9359b396-e68a-4973-a1c0-119deba02832.mp3" length="40019722" type="audio/mpeg"/>
      <guid isPermaLink="false">5e79f048-12d4-4526-a221-5a69708b506b</guid>
      <itunes:duration>2500</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 01 Mar 2023 15:27:26 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VFI on ESVS Academy with Ramon Vila and Igor Koncar]]></title>
      <itunes:title><![CDATA[VFI on ESVS Academy with Ramon Vila and Igor Koncar]]></itunes:title>
      <description><![CDATA[<p>The ESVS Academy offers a wide range of online and face-to-face workshops, covering various topics such as aortic, carotid, PAD, vascular access, venous, vascular ultrasound and more!</p><p>In this episode, Egle Kavaliunaite discusses with Ramon Vila and Igor Koncar, the people behind the ESVS Academy, its history, the challenges they overcame and how the Academy benefits not only young vascular trainees but also those who wish to improve their knowledge on certain techniques and skills.</p><p>Stay up to date with the European Society of Vascular Surgery as we offer more discussions like these in our webinars, our podcasts, our Masterclass and other events. We even offer hands-on and face-to-face practical experiences through our Academy workshops.</p><p>- Instagram: <a href="https://www.instagram.com/esvs_admin/">https://www.instagram.com/esvs_admin/</a></p><p>- Twitter: <a href="https://twitter.com/ESVSmembership">https://twitter.com/ESVSmembership</a></p><p>- Facebook: <a href="https://www.facebook.com/EuropeanSocietyforVascularSurgery">https://www.facebook.com/EuropeanSocietyforVascularSurgery</a></p><p>- LinkedIn: <a href="https://www.linkedin.com/company/european-society-for-vascular-surgery/">https://www.linkedin.com/company/european-society-for-vascular-surgery/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/838513</link>
      <enclosure url="https://content.rss.com/episodes/9552/838513/esvs/2023_02_23_13_37_12_29d93f20-e932-4ed6-8e14-e7041745f27a.mp3" length="23990483" type="audio/mpeg"/>
      <guid isPermaLink="false">419f4216-936d-4b82-bd34-a712ce2658e4</guid>
      <itunes:duration>1499</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 23 Feb 2023 13:38:40 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VFI on mesenteric ischaemia with Prof R.H. Geelkerken and F Metz - Part 1/2]]></title>
      <itunes:title><![CDATA[VFI on mesenteric ischaemia with Prof R.H. Geelkerken and F Metz - Part 1/2]]></itunes:title>
      <description><![CDATA[<p>The first of a 2-part interview on mesenteric ischaemia with expert in the field professor Bob Geelkerken.</p><p>In this episode we talk about the different forms of mesenteric ischemia (acute, chronic, venous) and clinical challenges in diagnosis and treatment. Great to refresh or deepen your knowledge on this topic.</p><p>Please also check the show notes for literature references if you are interested. Keep an eye out for the second part of the interview which is focussed completely on median arcuate ligament syndrome (MALS) - and if it exists or not..!</p><p></p><p><strong>Shownotes:</strong></p><p>Björk et al; Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS), European Journal of Vascular and Endovascular Surgery, Volume 53, Issue 4, 2017, Pages 460-510,</p><p>DOI: <a href="https://doi.org/10.1016/j.ejvs.2017.01.010">https://doi.org/10.1016/j.ejvs.2017.01.010</a></p><p></p><p>Terlouw et al; European guidelines on chronic mesenteric ischaemia. United European Gastroenterol J. 2020 May;8(4):371-395</p><p>DOI: 10.1177/2050640620916681</p><p></p><p>Huber et al; Chronic mesenteric ischemia: Clinical practice guidelines from the Society for Vascular Surgery. J Vasc Surg 2021 Jan;73(1S):87S-115S</p><p>DOI: 10.1016/j.jvs.2020.10.029</p><p></p><p>Bjork and Huber; Chronic Mesenteric Ischaemia, the Transatlantic Perspective. Eur J Vasc Endovasc Surg 2021 Feb;61(2):177-178</p><p>DOI: 10.1016/j.ejvs.2020.12.013</p><p></p><p>Van Dijk et al; Validation of a score chart to predict the risk of chronic mesenteric ischemia and development of an updated score chart. United European Gastroenterol J 2019 Nov;7(9):1261-1270</p><p>DOI 10.1177/2050640619856765</p><p></p><p>Vaassen et al; Intraoperative quantification of fluorescence angiography for assessment of intestinal perfusion: in vivo exploration of clinical value. BJS Open 2022 May 2;6(3):zrac058</p><p>DOI: <a href="https://emea01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fdoi.org%2F10.1093%2Fbjsopen%2Fzrac058&amp;data=05%7C01%7C%7C5d025c2e961e4793b4e808db0e9ba6cf%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C638119833916706807%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=2Esj8lRkeLWbr2X2h8AP%2B0nXX8G%2FRxFrys%2Bty315iec%3D&amp;reserved=0">10.1093/bjsopen/zrac058</a></p><p></p><p>Contact the mesenteric ischemia expert group in the Medisch Spectrum Twente trough: <a href="mailto:vaatchirurgie@mst.nl">vaatchirurgie@mst.nl</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/828778</link>
      <enclosure url="https://content.rss.com/episodes/9552/828778/esvs/2023_02_16_15_27_56_9500bc00-ba15-46d9-b2c6-13a808d0906c.mp3" length="37616495" type="audio/mpeg"/>
      <guid isPermaLink="false">423052c1-165f-4294-921e-6b826a7a92ba</guid>
      <itunes:duration>2350</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 16 Feb 2023 16:28:52 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Q&A 6 Dual pathway inhibition diabetes and CRF]]></title>
      <itunes:title><![CDATA[Q&A 6 Dual pathway inhibition diabetes and CRF]]></itunes:title>
      <description><![CDATA[<p>This is the 6th and final episode in our series on Dual Pathway strategy for the treatment of PAD patients, with our guests Sebastian Debus and Rupert Bauersachs.</p><p>Listen to them discuss with Melina Vega de Ceniga about the indications, risks and net clinical benefits of the Dual pathway in diabetic vs. non-diabetic patients.</p><p>Stay up to date with the European Society of Vascular Surgery as we offer more discussions like these in our webinars, our podcasts, our Masterclass and other events. We even offer hands-on and face-to-face practical experiences through our Academy workshops.</p><p>- Instagram: <a href="https://www.instagram.com/esvs_admin/">https://www.instagram.com/esvs_admin/</a></p><p>- Twitter: <a href="https://twitter.com/ESVSmembership">https://twitter.com/ESVSmembership</a></p><p>- Facebook: <a href="https://www.facebook.com/EuropeanSocietyforVascularSurgery">https://www.facebook.com/EuropeanSocietyforVascularSurgery</a></p><p>- LinkedIn: <a href="https://www.linkedin.com/company/european-society-for-vascular-surgery/">https://www.linkedin.com/company/european-society-for-vascular-surgery/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/816521</link>
      <enclosure url="https://content.rss.com/episodes/9552/816521/esvs/2023_02_08_10_32_51_cb2ca5a4-32aa-439d-88e7-28580146213e.mp3" length="6648632" type="audio/mpeg"/>
      <guid isPermaLink="false">86045b32-3e27-4e53-ba9a-619c4d034123</guid>
      <itunes:duration>415</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 08 Feb 2023 10:33:18 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Q&A 5 Dual pathway inhibition and open surgical revascularisation]]></title>
      <itunes:title><![CDATA[Q&A 5 Dual pathway inhibition and open surgical revascularisation]]></itunes:title>
      <description><![CDATA[<p>This is the 5th episode of our series on Dual Pathway strategy for the treatment of PAD patients.</p><p>Today, Melina Vega de Ceniga, Sebastian Debus, and Rupert Bauersachs discuss the results from studies conducted on patients with PAD, who had undergone lower extermity revascularisation. </p><p>are back this week for the 4th episode of this series about dual pathway inhibition.</p><p>Stay up to date with the European Society of Vascular Surgery as we offer more discussions like these in our webinars, our podcasts, our Masterclass and other events. We even offer hands-on and face-to-face practical experiences through our Academy workshops.</p><p>- Instagram: <a href="https://www.instagram.com/esvs_admin/">https://www.instagram.com/esvs_admin/</a></p><p>- Twitter: <a href="https://twitter.com/ESVSmembership">https://twitter.com/ESVSmembership</a></p><p>- Facebook: <a href="https://www.facebook.com/EuropeanSocietyforVascularSurgery">https://www.facebook.com/EuropeanSocietyforVascularSurgery</a></p><p>- LinkedIn: <a href="https://www.linkedin.com/company/european-society-for-vascular-surgery/">https://www.linkedin.com/company/european-society-for-vascular-surgery/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/807482</link>
      <enclosure url="https://content.rss.com/episodes/9552/807482/esvs/2023_02_02_14_32_25_0b593175-6e84-4c4e-8052-dcf6ea2bcec9.mp3" length="5400207" type="audio/mpeg"/>
      <guid isPermaLink="false">7819fbb4-dcfd-48dc-806b-101de8c93829</guid>
      <itunes:duration>337</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 02 Feb 2023 15:41:35 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Q&A 4 Dual pathway inhibition and endovascular treatment]]></title>
      <itunes:title><![CDATA[Q&A 4 Dual pathway inhibition and endovascular treatment]]></itunes:title>
      <description><![CDATA[<p>Sebastian Debus and Rupert Bauersachs are back this week for the 4th episode of this series about dual pathway inhibition.</p><p>Join the discussion as Melina Vega de Ceniga asks them some of the most reoccuring questions about how to best implement dual pathway after an endovascular therapy. </p><p>Stay up to date with the European Society of Vascular Surgery as we offer more discussions like these in our webinars, our podcasts, our Masterclass and other events. We even offer hands-on and face-to-face practical experiences through our Academy workshops.</p><p>- Instagram: <a href="https://www.instagram.com/esvs_admin/">https://www.instagram.com/esvs_admin/</a></p><p>- Twitter: <a href="https://twitter.com/ESVSmembership">https://twitter.com/ESVSmembership</a></p><p>- Facebook: <a href="https://www.facebook.com/EuropeanSocietyforVascularSurgery">https://www.facebook.com/EuropeanSocietyforVascularSurgery</a></p><p>- LinkedIn: <a href="https://www.linkedin.com/company/european-society-for-vascular-surgery/">https://www.linkedin.com/company/european-society-for-vascular-surgery/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/798349</link>
      <enclosure url="https://content.rss.com/episodes/9552/798349/esvs/2023_01_27_13_30_17_61b06d2c-effe-4efd-886a-31b4ea03b7ea.mp3" length="4725194" type="audio/mpeg"/>
      <guid isPermaLink="false">8ce0dd7b-96bd-4b9a-852a-ee939fa355f1</guid>
      <itunes:duration>295</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Fri, 27 Jan 2023 13:30:24 GMT</pubDate>
      <itunes:image href="https://media.rss.com/esvs/ep_cover_20230127_010113_ced82ffe51b2863dde14bb102e2f02d9.jpg"/>
    </item>
    <item>
      <title><![CDATA[Q&A 3 Dual pathway inhibition and gender]]></title>
      <itunes:title><![CDATA[Q&A 3 Dual pathway inhibition and gender]]></itunes:title>
      <description><![CDATA[<p>Join Melina Vega de Ceniga and our two experts in dual pathway. Sebastian Debus and Rupert Bauersachs as they discuss the factor of gender in the treatment of patients with peripheral artery disease.</p><p>Stay up to date with the European Society of Vascular Surgery as we offer more discussions like these in our webinars, our podcasts, our Masterclass and other events. We even offer hands-on and face-to-face practical experiences through our Academy workshops.</p><ul><li><p><a href="http://esvs.org">esvs.org</a> </p></li><li><p><a href="https://www.instagram.com/esvs_admin/">Instagram</a></p></li><li><p><a href="https://twitter.com/ESVSmembership">Twitter</a></p></li><li><p><a href="https://www.facebook.com/EuropeanSocietyforVascularSurgery">Facebook</a></p></li><li><p><a href="https://www.linkedin.com/company/european-society-for-vascular-surgery/">LinkedIn</a></p></li></ul>]]></description>
      <link>https://rss.com/podcasts/esvs/788310</link>
      <enclosure url="https://content.rss.com/episodes/9552/788310/esvs/2023_01_20_09_39_38_deec137b-6221-491b-9beb-a9bf7290cae5.mp3" length="4740643" type="audio/mpeg"/>
      <guid isPermaLink="false">2f51fe29-5353-4dd5-8ceb-78baf6063c70</guid>
      <itunes:duration>296</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Fri, 20 Jan 2023 09:41:09 GMT</pubDate>
      <podcast:soundbite startTime="115" duration="18"/>
    </item>
    <item>
      <title><![CDATA[Q&A 2 Age and dual pathway inhibition]]></title>
      <itunes:title><![CDATA[Q&A 2 Age and dual pathway inhibition]]></itunes:title>
      <description><![CDATA[<p>Join Melina Vega de Ceniga and our two experts in dual pathway. Sebastian Debus and Rupert Bauersachs as they discuss the factor of age in the treatment of patients with peripheral artery disease.</p><p>Stay up to date with the European Society of Vascular Surgery as we offer more discussions like these in our webinars, our podcasts, our Masterclass and other events. We even offer hands-on and face-to-face practical experiences through our Academy workshops.</p><p>- Instagram: <a href="https://www.instagram.com/esvs_admin/">https://www.instagram.com/esvs_admin/</a></p><p>- Twitter: <a href="https://twitter.com/ESVSmembership">https://twitter.com/ESVSmembership</a></p><p>- Facebook: <a href="https://www.facebook.com/EuropeanSocietyforVascularSurgery">https://www.facebook.com/EuropeanSocietyforVascularSurgery</a></p><p>- LinkedIn: <a href="https://www.linkedin.com/company/european-society-for-vascular-surgery/">https://www.linkedin.com/company/european-society-for-vascular-surgery/</a></p>]]></description>
      <link>https://rss.com/podcasts/esvs/777977</link>
      <enclosure url="https://content.rss.com/episodes/9552/777977/esvs/2023_01_13_09_18_23_4f5058e9-605a-4608-934a-7795dd0ed118.mp3" length="4759866" type="audio/mpeg"/>
      <guid isPermaLink="false">11e53427-230b-49f6-ba57-6b71284fa76a</guid>
      <itunes:duration>297</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Fri, 13 Jan 2023 09:18:29 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VFI on the BEST CLI trial with A Farber M Menard and M Venermo]]></title>
      <itunes:title><![CDATA[VFI on the BEST CLI trial with A Farber M Menard and M Venermo]]></itunes:title>
      <description><![CDATA[<p>VFI on the BEST CLI trial </p>]]></description>
      <link>https://rss.com/podcasts/esvs/769049</link>
      <enclosure url="https://content.rss.com/episodes/9552/769049/esvs/2023_01_06_11_41_33_c5efa0b8-5ad0-404e-b178-5643d6eaa96d.mp3" length="36286129" type="audio/mpeg"/>
      <guid isPermaLink="false">73fc648a-9717-49fc-8935-7d690963cd5a</guid>
      <itunes:duration>2267</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Fri, 06 Jan 2023 11:43:00 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Q&A on dual pathway - bleeding]]></title>
      <itunes:title><![CDATA[Q&A on dual pathway - bleeding]]></itunes:title>
      <description><![CDATA[<p>Q&amp;A</p>]]></description>
      <link>https://rss.com/podcasts/esvs/769036</link>
      <enclosure url="https://content.rss.com/episodes/9552/769036/esvs/2023_01_06_11_18_24_5086ce7a-bd58-4a03-a161-435fe47727eb.mp3" length="6755644" type="audio/mpeg"/>
      <guid isPermaLink="false">22ebd38e-2272-41e1-bb51-4fb6a4cd68c9</guid>
      <itunes:duration>422</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Fri, 06 Jan 2023 11:18:34 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VFI VV carotid chapter with R Naylor and S Debus]]></title>
      <itunes:title><![CDATA[VFI VV carotid chapter with R Naylor and S Debus]]></itunes:title>
      <description><![CDATA[<p>VFI</p>]]></description>
      <link>https://rss.com/podcasts/esvs/699200</link>
      <enclosure url="https://content.rss.com/episodes/9552/699200/esvs/2022_11_17_10_12_03_68d07caf-e656-49e2-a38b-ad50daadacc8.mp3" length="25544347" type="audio/mpeg"/>
      <guid isPermaLink="false">2372b54a-3677-4f5b-b449-9a6d3e8e4db8</guid>
      <itunes:duration>1674</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 17 Nov 2022 10:12:11 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Vascular Forum Interview on endoanchors with JP. de Vries and M. Gargiulo]]></title>
      <itunes:title><![CDATA[Vascular Forum Interview on endoanchors with JP. de Vries and M. Gargiulo]]></itunes:title>
      <description><![CDATA[<p>Vascular Forum Interview</p>]]></description>
      <link>https://rss.com/podcasts/esvs/604981</link>
      <enclosure url="https://content.rss.com/episodes/9552/604981/esvs/20220903_080947_e26b44b79b766497738469e31b5fac23.mp3" length="32068536" type="audio/mpeg"/>
      <guid isPermaLink="false">7f656f83-f830-4fff-9aca-1955b1e441d9</guid>
      <itunes:duration>2033</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Sat, 03 Sep 2022 08:57:55 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Simulation and vascular training with I Van Herzeele and C Bicknell Part1]]></title>
      <itunes:title><![CDATA[Simulation and vascular training with I Van Herzeele and C Bicknell Part1]]></itunes:title>
      <description><![CDATA[<p>Simulation and vascular training with I Van Herzeele and C Bicknell Part1</p>]]></description>
      <link>https://rss.com/podcasts/esvs/532162</link>
      <enclosure url="https://content.rss.com/episodes/9552/532162/esvs/20220627_060644_72027291d1da0adcdf63839f2b20ba7c.mp3" length="22731259" type="audio/mpeg"/>
      <guid isPermaLink="false">4d48a67a-a359-4337-b313-2024eddb8d64</guid>
      <itunes:duration>1458</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 27 Jun 2022 06:51:47 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Clinical scenario 4 postoperative treatment after hybrid revascularization]]></title>
      <itunes:title><![CDATA[Clinical scenario 4 postoperative treatment after hybrid revascularization]]></itunes:title>
      <description><![CDATA[<p>Clinical scenario 4 postoperative treatment after hybrid revascularization</p>]]></description>
      <link>https://rss.com/podcasts/esvs/528653</link>
      <enclosure url="https://content.rss.com/episodes/9552/528653/esvs/20220623_070635_809c380b44c3f5271cf66a369c5b3eb3.mp3" length="14385990" type="audio/mpeg"/>
      <guid isPermaLink="false">d94d9c01-18b0-432e-aed6-cc4cd71ee061</guid>
      <itunes:duration>695</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 23 Jun 2022 07:41:37 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Systematic reviews of the literature are not always either useful or the best way to add to science]]></title>
      <itunes:title><![CDATA[Systematic reviews of the literature are not always either useful or the best way to add to science]]></itunes:title>
      <description><![CDATA[<p>#Edutorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/459992</link>
      <enclosure url="https://content.rss.com/episodes/9552/459992/esvs/20220419_060418_7d4b5b5d14e6f601e39c86a61e62b26b.mp3" length="15763494" type="audio/mpeg"/>
      <guid isPermaLink="false">16142a4c-5525-4bb5-bf4c-771fc552469e</guid>
      <itunes:duration>793</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Tue, 19 Apr 2022 06:22:16 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Clinical scenario 3- baseline treatment for CLTI]]></title>
      <itunes:title><![CDATA[Clinical scenario 3- baseline treatment for CLTI]]></itunes:title>
      <description><![CDATA[<p>sponsored</p>]]></description>
      <link>https://rss.com/podcasts/esvs/428638</link>
      <enclosure url="https://content.rss.com/episodes/9552/428638/esvs/20220322_070353_32701e56442fd858b5564b988d015961.mp3" length="16373586" type="audio/mpeg"/>
      <guid isPermaLink="false">6c770824-375b-44c4-8e5a-879a008491aa</guid>
      <itunes:duration>928</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Tue, 22 Mar 2022 07:30:35 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VFI with K Donas and M Lachat on ChEVAR]]></title>
      <itunes:title><![CDATA[VFI with K Donas and M Lachat on ChEVAR]]></itunes:title>
      <description><![CDATA[<p>sponsored</p>]]></description>
      <link>https://rss.com/podcasts/esvs/386348</link>
      <enclosure url="https://content.rss.com/episodes/9552/386348/esvs/20220208_100251_35f1f0da5e66c081a9bd22f6b435b901.mp3" length="27204782" type="audio/mpeg"/>
      <guid isPermaLink="false">51e6c36f-d73a-46df-8d18-fa007543e28e</guid>
      <itunes:duration>1798</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Tue, 08 Feb 2022 22:18:14 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VF Interview with Rebecca Hultgren]]></title>
      <itunes:title><![CDATA[VF Interview with Rebecca Hultgren]]></itunes:title>
      <description><![CDATA[<p>sponsored</p>]]></description>
      <link>https://rss.com/podcasts/esvs/377005</link>
      <enclosure url="https://content.rss.com/episodes/9552/377005/esvs/20220131_050155_00df1d842f2b1f8254d00ac001cd076b.mp3" length="10719000" type="audio/mpeg"/>
      <guid isPermaLink="false">d36bf92c-758a-4e89-a373-b88de4d34b67</guid>
      <itunes:duration>831</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 31 Jan 2022 05:54:08 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VFI on sac regression with Hence Verhagen]]></title>
      <itunes:title><![CDATA[VFI on sac regression with Hence Verhagen]]></itunes:title>
      <description><![CDATA[<p>sponsored</p>]]></description>
      <link>https://rss.com/podcasts/esvs/345987</link>
      <enclosure url="https://content.rss.com/episodes/9552/345987/esvs/20211221_121222_726bec970852f7084108dac1ae4eabb2.mp3" length="31591203" type="audio/mpeg"/>
      <guid isPermaLink="false">6388aec0-b522-4195-9ffb-95e3776461ca</guid>
      <itunes:duration>1977</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Tue, 21 Dec 2021 12:55:02 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Clinical scenario 2: intermittent claudication]]></title>
      <itunes:title><![CDATA[Clinical scenario 2: intermittent claudication]]></itunes:title>
      <description><![CDATA[<p>sponsored</p>]]></description>
      <link>https://rss.com/podcasts/esvs/340935</link>
      <enclosure url="https://content.rss.com/episodes/9552/340935/esvs/20211214_031235_96d947f946d40e05d96cd6a47d563f77.mp3" length="14480975" type="audio/mpeg"/>
      <guid isPermaLink="false">a04ab75e-878d-460b-a47d-b5d7cbcbe2c3</guid>
      <itunes:duration>694</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Tue, 14 Dec 2021 15:24:25 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Clinical scenario 1 iliac stent]]></title>
      <itunes:title><![CDATA[Clinical scenario 1 iliac stent]]></itunes:title>
      <description><![CDATA[<p>Clinical Scenarios</p>]]></description>
      <link>https://rss.com/podcasts/esvs/295434</link>
      <enclosure url="https://content.rss.com/episodes/9552/295434/esvs/20211013_083246_ec37394f58f140fed7451042b8e05084.mp3" length="10047177" type="audio/mpeg"/>
      <guid isPermaLink="false">c56528e1-db1e-dce8-8aff-58ae12081a18</guid>
      <itunes:duration>695</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 13 Oct 2021 08:32:52 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VFI with K. Mani and C. Behrendt on Registry Data]]></title>
      <itunes:title><![CDATA[VFI with K. Mani and C. Behrendt on Registry Data]]></itunes:title>
      <description><![CDATA[<p>VFI</p>]]></description>
      <link>https://rss.com/podcasts/esvs/271779</link>
      <enclosure url="https://content.rss.com/episodes/9552/271779/esvs/20210909_202018_d1d8ec78cc234456158418881bf16bf4.mp3" length="28117572" type="audio/mpeg"/>
      <guid isPermaLink="false">dd0f117a-30a8-ecc7-8535-c7476c275a49</guid>
      <itunes:duration>1790</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 09 Sep 2021 20:20:22 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Understanding the basis of radiation protection for EV procedures]]></title>
      <itunes:title><![CDATA[Understanding the basis of radiation protection for EV procedures]]></itunes:title>
      <description><![CDATA[<p>VF</p>]]></description>
      <link>https://rss.com/podcasts/esvs/262511</link>
      <enclosure url="https://content.rss.com/episodes/9552/262511/esvs/20210826_093020_821bd4fabafae003ccb265e2485bdec5.mp3" length="12882042" type="audio/mpeg"/>
      <guid isPermaLink="false">5621a84a-2eed-5381-4e9f-fb8fa6366c26</guid>
      <itunes:duration>639</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 26 Aug 2021 09:30:39 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VFI on iBEVAR]]></title>
      <itunes:title><![CDATA[VFI on iBEVAR]]></itunes:title>
      <description><![CDATA[<p>Vascular Forum Interview with Sebastien Deglise</p>]]></description>
      <link>https://rss.com/podcasts/esvs/239909</link>
      <enclosure url="https://content.rss.com/episodes/9552/239909/esvs/20210719_071200_e0062cb0c547331296757534f93a7af2.mp3" length="11718115" type="audio/mpeg"/>
      <guid isPermaLink="false">08838baf-3e76-d4e4-0e8c-98cfdb9c2703</guid>
      <itunes:duration>1351</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 19 Jul 2021 07:12:03 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[International variations and sex dispatities in the treatment of PAOD a report from VASCUNET and the ICVR]]></title>
      <itunes:title><![CDATA[International variations and sex dispatities in the treatment of PAOD a report from VASCUNET and the ICVR]]></itunes:title>
      <description><![CDATA[<p>Editor's choice</p>]]></description>
      <link>https://rss.com/podcasts/esvs/209641</link>
      <enclosure url="https://content.rss.com/episodes/9552/209641/esvs/20210531_094033_5daa54a52ef4c3b6fd55073d3d0864c4.mp3" length="13387916" type="audio/mpeg"/>
      <guid isPermaLink="false">01262400-4276-2c35-9245-bb3dcf2976bd</guid>
      <itunes:duration>922</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 31 May 2021 09:40:36 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Trends in lower extremity amputation incidence in 1990-2017]]></title>
      <itunes:title><![CDATA[Trends in lower extremity amputation incidence in 1990-2017]]></itunes:title>
      <description><![CDATA[<p>Editor's Choice</p>]]></description>
      <link>https://rss.com/podcasts/esvs/190882</link>
      <enclosure url="https://content.rss.com/episodes/9552/190882/esvs/20210503_074816_e64435cb42d34a2ed4c646eb81c85db3.mp3" length="12325815" type="audio/mpeg"/>
      <guid isPermaLink="false">4c0f4c82-b955-c843-7cc7-29574acec62e</guid>
      <itunes:duration>820</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 03 May 2021 07:48:34 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VFI with Pirkka Vikatmaa on noninvasive foot perfusion assessment]]></title>
      <itunes:title><![CDATA[VFI with Pirkka Vikatmaa on noninvasive foot perfusion assessment]]></itunes:title>
      <description><![CDATA[<p>Vascular Forum Interview</p>]]></description>
      <link>https://rss.com/podcasts/esvs/182465</link>
      <enclosure url="https://content.rss.com/episodes/9552/182465/esvs/20210421_130326_ebcd8263202fc82094a3ced7b99c78ac.mp3" length="19126876" type="audio/mpeg"/>
      <guid isPermaLink="false">eb195879-cb0b-150f-1043-7ef6ea96b2c6</guid>
      <itunes:duration>1196</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 21 Apr 2021 13:03:30 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VFI with Sebasian Debus on the VOYAGER Trial]]></title>
      <itunes:title><![CDATA[VFI with Sebasian Debus on the VOYAGER Trial]]></itunes:title>
      <description><![CDATA[<p>Vascular Forum Interview</p>]]></description>
      <link>https://rss.com/podcasts/esvs/158198</link>
      <enclosure url="https://content.rss.com/episodes/9552/158198/esvs/20210317_105434_01f22d21a7b8f96049d7cd45bab0611c.mp3" length="19159695" type="audio/mpeg"/>
      <guid isPermaLink="false">2bc09021-c906-80c2-200a-635ce6366611</guid>
      <itunes:duration>1231</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 17 Mar 2021 10:54:37 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Acute Deep Vein Thrombosis and Pulmonary Embolism Chapter - Authors Interview]]></title>
      <itunes:title><![CDATA[Acute Deep Vein Thrombosis and Pulmonary Embolism Chapter - Authors Interview]]></itunes:title>
      <description><![CDATA[<p>Interview of the authors of the Virtual Vascular chapter "Acute Deep Vein Thrombosis and Pulmonary Embolism"</p>]]></description>
      <link>https://rss.com/podcasts/esvs/157536</link>
      <enclosure url="https://content.rss.com/episodes/9552/157536/esvs/20210316_134800_0955a6bb6ba8be2d178d4dd6041a8821.mp3" length="15717096" type="audio/mpeg"/>
      <guid isPermaLink="false">ff3dfa1e-d2e8-4e86-4147-64f9c7490ed9</guid>
      <itunes:duration>1024</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Tue, 16 Mar 2021 13:48:04 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Effect of statins on total mortality in AAA repair: a systematic review and meta-analysis]]></title>
      <itunes:title><![CDATA[Effect of statins on total mortality in AAA repair: a systematic review and meta-analysis]]></itunes:title>
      <description><![CDATA[<p>Editor's Choice</p>]]></description>
      <link>https://rss.com/podcasts/esvs/152027</link>
      <enclosure url="https://content.rss.com/episodes/9552/152027/esvs/20210308_085122_5e804e098d7a2f3faa0332fef9d936c2.mp3" length="6359289" type="audio/mpeg"/>
      <guid isPermaLink="false">a7ea7128-a6a1-f5fb-06a0-9321fa6aedb1</guid>
      <itunes:duration>395</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 08 Mar 2021 08:51:27 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VFI with the Virtual Vascular Editors]]></title>
      <itunes:title><![CDATA[VFI with the Virtual Vascular Editors]]></itunes:title>
      <description><![CDATA[<p>Vascular Forum Interview</p>]]></description>
      <link>https://rss.com/podcasts/esvs/142202</link>
      <enclosure url="https://content.rss.com/episodes/9552/142202/esvs/20210222_083227_171e8f19d6779339870ac8d7b989613d.mp3" length="16002045" type="audio/mpeg"/>
      <guid isPermaLink="false">fbace33a-727e-eb2e-4e17-f3a9ca6ac9fd</guid>
      <itunes:duration>1027</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 22 Feb 2021 08:32:32 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[VFI with S. Kakkos and M. Gohel on the ESVS DVT guidelines]]></title>
      <itunes:title><![CDATA[VFI with S. Kakkos and M. Gohel on the ESVS DVT guidelines]]></itunes:title>
      <description><![CDATA[<p>Vascular Forum Interview</p>]]></description>
      <link>https://rss.com/podcasts/esvs/137391</link>
      <enclosure url="https://content.rss.com/episodes/9552/137391/esvs/20210215_085857_ef9d8e7198510d818d807d5638057c97.mp3" length="13418286" type="audio/mpeg"/>
      <guid isPermaLink="false">cd6cf0f2-3ea5-86df-5c93-ab75637b311d</guid>
      <itunes:duration>895</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 15 Feb 2021 08:59:15 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Volume-outcome relationship in elective AAA surgery: analysis of the UK hospital episodes statistics database for the GIRFT programme]]></title>
      <itunes:title><![CDATA[Volume-outcome relationship in elective AAA surgery: analysis of the UK hospital episodes statistics database for the GIRFT programme]]></itunes:title>
      <description><![CDATA[<p>Editor's Choice</p>]]></description>
      <link>https://rss.com/podcasts/esvs/120766</link>
      <enclosure url="https://content.rss.com/episodes/9552/120766/esvs/20210118_154024_83ec3d11316e187233549d07dec61855.mp3" length="10575012" type="audio/mpeg"/>
      <guid isPermaLink="false">3b2f4a71-cf38-f86a-48a3-b494cf16d011</guid>
      <itunes:duration>576</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 18 Jan 2021 15:40:27 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Protamine reduces serious bleeding complications associated with CEA in asymptomatic patients without increasing the risk of stroke, MI or death in a large national analysis]]></title>
      <itunes:title><![CDATA[Protamine reduces serious bleeding complications associated with CEA in asymptomatic patients without increasing the risk of stroke, MI or death in a large national analysis]]></itunes:title>
      <description><![CDATA[<p>EC</p>]]></description>
      <link>https://rss.com/podcasts/esvs/113263</link>
      <enclosure url="https://content.rss.com/episodes/9552/113263/esvs/20210104_093058_3860a2fa49a8d53eaa203325a19588e1.mp3" length="8946756" type="audio/mpeg"/>
      <guid isPermaLink="false">3fedda8a-19b7-b6c7-4cf2-fb4d9f74931b</guid>
      <itunes:duration>539</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 04 Jan 2021 09:31:01 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[COMPREHENSIVE LITERATURE REVIEW OF RADIATION LEVELS DURING EVAR IN CATHLABS AND OPERATING THEATRES]]></title>
      <itunes:title><![CDATA[COMPREHENSIVE LITERATURE REVIEW OF RADIATION LEVELS DURING EVAR IN CATHLABS AND OPERATING THEATRES]]></itunes:title>
      <description><![CDATA[<p>EC</p>]]></description>
      <link>https://rss.com/podcasts/esvs/113262</link>
      <enclosure url="https://content.rss.com/episodes/9552/113262/esvs/20210104_093708_bddec5468d4ff4b6876c0fbd43e40971.mp3" length="11054416" type="audio/mpeg"/>
      <guid isPermaLink="false">81b2b4ac-12b8-ef2d-00ca-9f31e17d6ead</guid>
      <itunes:duration>766</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 04 Jan 2021 09:29:19 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Relationship betwwen GLASS and clinical outcomes following revasculrisation for CLTI in the BASIL-1]]></title>
      <itunes:title><![CDATA[Relationship betwwen GLASS and clinical outcomes following revasculrisation for CLTI in the BASIL-1]]></itunes:title>
      <description><![CDATA[<p>EC</p>]]></description>
      <link>https://rss.com/podcasts/esvs/113261</link>
      <enclosure url="https://content.rss.com/episodes/9552/113261/esvs/20210104_092819_15e28adf20cf49fe24721f1bc8881089.mp3" length="11458095" type="audio/mpeg"/>
      <guid isPermaLink="false">f11e573a-878a-067d-9968-81eeb282e88e</guid>
      <itunes:duration>696</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 04 Jan 2021 09:28:23 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[EJVES VF_December Headlines 2020]]></title>
      <itunes:title><![CDATA[EJVES VF_December Headlines 2020]]></itunes:title>
      <description><![CDATA[<p>EJVES VF_December Headlines 2020</p>]]></description>
      <link>https://rss.com/podcasts/esvs/100963</link>
      <enclosure url="https://content.rss.com/episodes/9552/100963/esvs/20201204_125152_6696fe1b47c55009ffd384e4e99c5ef1.mp3" length="3910714" type="audio/mpeg"/>
      <guid isPermaLink="false">6e94add8-26bf-c0e5-2014-3ab06694320f</guid>
      <itunes:duration>211</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Fri, 04 Dec 2020 12:52:03 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[EJVES VF November Headlines 2020]]></title>
      <itunes:title><![CDATA[EJVES VF November Headlines 2020]]></itunes:title>
      <description><![CDATA[<p>EJVES VF November Headlines 2020</p>]]></description>
      <link>https://rss.com/podcasts/esvs/91101</link>
      <enclosure url="https://content.rss.com/episodes/9552/91101/esvs/20201105_075007_3895de079cf3004a6261473c263542da.mp3" length="2642631" type="audio/mpeg"/>
      <guid isPermaLink="false">db5b5bb9-3e84-acbe-5292-ae957f23b084</guid>
      <itunes:duration>147</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 05 Nov 2020 07:50:12 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Detection of late complications after EVA and implications for follow-up]]></title>
      <itunes:title><![CDATA[Detection of late complications after EVA and implications for follow-up]]></itunes:title>
      <description><![CDATA[<p>Editor's Choice</p>]]></description>
      <link>https://rss.com/podcasts/esvs/90793</link>
      <enclosure url="https://content.rss.com/episodes/9552/90793/esvs/20201104_084721_22537808a8e769db87f269a8a8b85e42.mp3" length="14632307" type="audio/mpeg"/>
      <guid isPermaLink="false">4592f93a-cd86-367a-c05e-0919a3449a4c</guid>
      <itunes:duration>846</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 04 Nov 2020 08:48:13 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[Which mouse model of AAA deserves triple A status?]]></title>
      <itunes:title><![CDATA[Which mouse model of AAA deserves triple A status?]]></itunes:title>
      <description><![CDATA[<p>Edutorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/81594</link>
      <enclosure url="https://content.rss.com/episodes/9552/81594/esvs/20201006_123420_813cb7e7325d59c740d8743763e2cfa0.mp3" length="7650469" type="audio/mpeg"/>
      <guid isPermaLink="false">c4bea882-6aac-e6ce-efc1-f4625dea9540</guid>
      <itunes:duration>476</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Tue, 06 Oct 2020 12:34:19 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[EJVES VF October Headlines 2020]]></title>
      <itunes:title><![CDATA[EJVES VF October Headlines 2020]]></itunes:title>
      <description><![CDATA[<p>EJVES VF October Headlines 2020</p>]]></description>
      <link>https://rss.com/podcasts/esvs/79680</link>
      <enclosure url="https://content.rss.com/episodes/9552/79680/esvs/20200930_075846_25591335c85563ba5044990412c60ca4.mp3" length="2863205" type="audio/mpeg"/>
      <guid isPermaLink="false">4e4bc463-da17-ee4d-fc08-e6e5f26ba270</guid>
      <itunes:duration>143</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 30 Sep 2020 07:58:45 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[OPTIMAL PHARMACOLOGICAL TREATMENT OF SYMPTOMATIC PAD AND EVIDENCE OF FEMALE PATIENT DISADVANTAGE]]></title>
      <itunes:title><![CDATA[OPTIMAL PHARMACOLOGICAL TREATMENT OF SYMPTOMATIC PAD AND EVIDENCE OF FEMALE PATIENT DISADVANTAGE]]></itunes:title>
      <description><![CDATA[<p>Editor's Choice</p>]]></description>
      <link>https://rss.com/podcasts/esvs/79027</link>
      <enclosure url="https://content.rss.com/episodes/9552/79027/esvs/20200928_092829_7ff77259144bb963e10c26a6690bd23a.mp3" length="10708078" type="audio/mpeg"/>
      <guid isPermaLink="false">48d3b3a9-13db-eb65-4d1a-53e7891a7e51</guid>
      <itunes:duration>588</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 28 Sep 2020 09:28:28 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[CURRENT MANAGEMENT OF AORTIC ENFOGRAFT INFECTION]]></title>
      <itunes:title><![CDATA[CURRENT MANAGEMENT OF AORTIC ENFOGRAFT INFECTION]]></itunes:title>
      <description><![CDATA[<p>Edutorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/72118</link>
      <enclosure url="https://content.rss.com/episodes/9552/72118/esvs/20200907_152305_8c27027a08fbfbad65aa290d09692a95.mp3" length="11331712" type="audio/mpeg"/>
      <guid isPermaLink="false">88dde1c0-872d-a6e7-72e7-9b670a08efad</guid>
      <itunes:duration>579</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 07 Sep 2020 15:23:04 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[EJVES VF September Headlines 2020]]></title>
      <itunes:title><![CDATA[EJVES VF September Headlines 2020]]></itunes:title>
      <description><![CDATA[<p>EJVES VF September Headlines 2020</p>]]></description>
      <link>https://rss.com/podcasts/esvs/71537</link>
      <enclosure url="https://content.rss.com/episodes/9552/71537/esvs/20200905_112858_c0c49a9d4090600994d8ba8787aae76d.mp3" length="2126716" type="audio/mpeg"/>
      <guid isPermaLink="false">278cafdd-70cd-c777-cdbe-9a810190fcdd</guid>
      <itunes:duration>118</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Sat, 05 Sep 2020 11:28:57 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[MORTALITY AND MAJOR AMPUTATION AFTER REVASCULARISATION IN OCTOGENARIANS VERSUS NON-OCTOGENARIANS WITH CLTI: A SYSTEMATIC REVIEW AND META-ANALYSIS]]></title>
      <itunes:title><![CDATA[MORTALITY AND MAJOR AMPUTATION AFTER REVASCULARISATION IN OCTOGENARIANS VERSUS NON-OCTOGENARIANS WITH CLTI: A SYSTEMATIC REVIEW AND META-ANALYSIS]]></itunes:title>
      <description><![CDATA[<p>Editor's Choice</p>]]></description>
      <link>https://rss.com/podcasts/esvs/70108</link>
      <enclosure url="https://content.rss.com/episodes/9552/70108/esvs/20200831_092333_22d9aba1f8f29597da20cd00875bb02f.mp3" length="9586700" type="audio/mpeg"/>
      <guid isPermaLink="false">70482e81-0926-c236-da82-71dd08dd15f2</guid>
      <itunes:duration>535</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 31 Aug 2020 09:23:33 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ROLE OF COMPRESSION AFTER RFA OF VARICOSE VEINS A RCT]]></title>
      <itunes:title><![CDATA[ROLE OF COMPRESSION AFTER RFA OF VARICOSE VEINS A RCT]]></itunes:title>
      <description><![CDATA[<p>Editor's Choice</p>]]></description>
      <link>https://rss.com/podcasts/esvs/68183</link>
      <enclosure url="https://content.rss.com/episodes/9552/68183/esvs/20200824_100836_2ddb21700a10a14271484094ad82c831.mp3" length="9075714" type="audio/mpeg"/>
      <guid isPermaLink="false">6904ce23-0985-87ac-1c9b-518fe59b9001</guid>
      <itunes:duration>600</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 24 Aug 2020 10:08:35 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[FOCUSED SEARCH OF THE LITERATURE]]></title>
      <itunes:title><![CDATA[FOCUSED SEARCH OF THE LITERATURE]]></itunes:title>
      <description><![CDATA[<p>Edutorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/66222</link>
      <enclosure url="https://content.rss.com/episodes/9552/66222/esvs/20200817_085244_4a8926972aca6cb269b065b57dca5393.mp3" length="9276715" type="audio/mpeg"/>
      <guid isPermaLink="false">59591851-1e51-dc30-d9e2-befac136a5b4</guid>
      <itunes:duration>561</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 17 Aug 2020 08:52:44 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[NICE and ESVS AAA guidelines: Interviews with J. Powell and J. Boyle]]></title>
      <itunes:title><![CDATA[NICE and ESVS AAA guidelines: Interviews with J. Powell and J. Boyle]]></itunes:title>
      <description><![CDATA[<p>VF Interview</p>]]></description>
      <link>https://rss.com/podcasts/esvs/64403</link>
      <enclosure url="https://content.rss.com/episodes/9552/64403/esvs/20200810_071439_2768fefc14a123361fd18db148d480ce.mp3" length="23968456" type="audio/mpeg"/>
      <guid isPermaLink="false">0a30f651-9b14-493e-39fc-e9927ee0c4d8</guid>
      <itunes:duration>1526</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 10 Aug 2020 07:14:39 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[EJVES VF August headlines 2020]]></title>
      <itunes:title><![CDATA[EJVES VF August headlines 2020]]></itunes:title>
      <description><![CDATA[<p>Journal highlights August 2020</p>]]></description>
      <link>https://rss.com/podcasts/esvs/63568</link>
      <enclosure url="https://content.rss.com/episodes/9552/63568/esvs/20200806_094727_427805c8dddab9d4de9ab7dc42910aab.mp3" length="2819008" type="audio/mpeg"/>
      <guid isPermaLink="false">e28e3f07-7fd8-41d5-f45a-7963e0c64804</guid>
      <itunes:duration>108</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 06 Aug 2020 09:47:27 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[NATIONWIDE ANALYSIS OF PATIENTS UNDERGOING ILIAC ARTERY ANEURYSM REPAIR IN THE NETHERLANDS]]></title>
      <itunes:title><![CDATA[NATIONWIDE ANALYSIS OF PATIENTS UNDERGOING ILIAC ARTERY ANEURYSM REPAIR IN THE NETHERLANDS]]></itunes:title>
      <description><![CDATA[<p>Editor's Choice</p>]]></description>
      <link>https://rss.com/podcasts/esvs/62712</link>
      <enclosure url="https://content.rss.com/episodes/9552/62712/esvs/20200803_083254_9872301842507f27b76dff3bfeccd68e.mp3" length="13734571" type="audio/mpeg"/>
      <guid isPermaLink="false">8a2da0cc-5c74-179e-334b-e1def696427f</guid>
      <itunes:duration>551</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 03 Aug 2020 08:32:54 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[AKI IN AORTIC INTERVENTION FINDINGS FROM THE MARI COHORT STUDY]]></title>
      <itunes:title><![CDATA[AKI IN AORTIC INTERVENTION FINDINGS FROM THE MARI COHORT STUDY]]></itunes:title>
      <description><![CDATA[<p>Editor's Choice</p>]]></description>
      <link>https://rss.com/podcasts/esvs/60792</link>
      <enclosure url="https://content.rss.com/episodes/9552/60792/esvs/20200727_083912_3d28fb155126fba77da8ce32968e2e8c.mp3" length="19595064" type="audio/mpeg"/>
      <guid isPermaLink="false">360e4138-47be-1478-bcd9-b3dbf54b5ec5</guid>
      <itunes:duration>797</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 27 Jul 2020 08:39:12 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ASSESSMENT OF CORRELATION BETWEEN MEAN SIZE OF INFRARENAL AAA AT TIME OF INTACT REPAIR AGAINST REPAIR AND RUPTURE RATE IN 9 COUNTRIES]]></title>
      <itunes:title><![CDATA[ASSESSMENT OF CORRELATION BETWEEN MEAN SIZE OF INFRARENAL AAA AT TIME OF INTACT REPAIR AGAINST REPAIR AND RUPTURE RATE IN 9 COUNTRIES]]></itunes:title>
      <description><![CDATA[<p>Editor's Choice</p>]]></description>
      <link>https://rss.com/podcasts/esvs/60791</link>
      <enclosure url="https://content.rss.com/episodes/9552/60791/esvs/20200727_083814_cca3e7947195d79ec52afb1249e3fd9f.mp3" length="12372049" type="audio/mpeg"/>
      <guid isPermaLink="false">a5d7606c-029c-e3d6-d746-6639e7f790c0</guid>
      <itunes:duration>444</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 27 Jul 2020 08:38:14 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[PROSPECTIVE COHORT STUDIES]]></title>
      <itunes:title><![CDATA[PROSPECTIVE COHORT STUDIES]]></itunes:title>
      <description><![CDATA[<p>Edutorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/58116</link>
      <enclosure url="https://content.rss.com/episodes/9552/58116/esvs/20200715_112931_a561b36a75e19af42df22608850175eb.mp3" length="11764823" type="audio/mpeg"/>
      <guid isPermaLink="false">2fc0611f-676a-211b-bd1a-b99e555af947</guid>
      <itunes:duration>477</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 15 Jul 2020 11:29:31 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[A SYSTEMATIC REVIEW OF THE USE OF ENDOANCHORS IN ENDOVASCULAR AORTIC ANEURYSM REPAIR]]></title>
      <itunes:title><![CDATA[A SYSTEMATIC REVIEW OF THE USE OF ENDOANCHORS IN ENDOVASCULAR AORTIC ANEURYSM REPAIR]]></itunes:title>
      <description><![CDATA[<p>Editor's Choice</p>]]></description>
      <link>https://rss.com/podcasts/esvs/56374</link>
      <enclosure url="https://content.rss.com/episodes/9552/56374/esvs/20200708_134448_ecf5934805f8f7ce55fcd56645bcf9f8.mp3" length="21939049" type="audio/mpeg"/>
      <guid isPermaLink="false">40fb9b02-6d30-3edd-4406-330cd612a4f3</guid>
      <itunes:duration>861</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Wed, 08 Jul 2020 13:44:48 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[TRANSLATING EVIDENCE INTO PRACTICE SURVEILLANCE AFTER CAROTID INTERVENTIONS]]></title>
      <itunes:title><![CDATA[TRANSLATING EVIDENCE INTO PRACTICE SURVEILLANCE AFTER CAROTID INTERVENTIONS]]></itunes:title>
      <description><![CDATA[<p>Editorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/55772</link>
      <enclosure url="https://content.rss.com/episodes/9552/55772/esvs/20200706_095721_0028c11fea5bcb75dc58a953eef0a52b.mp3" length="14067530" type="audio/mpeg"/>
      <guid isPermaLink="false">6c241288-7381-01aa-f37c-56739c8d86ba</guid>
      <itunes:duration>522</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 06 Jul 2020 09:57:20 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[RETROSPECTIVE STUDIES]]></title>
      <itunes:title><![CDATA[RETROSPECTIVE STUDIES]]></itunes:title>
      <description><![CDATA[<p>Editorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/55770</link>
      <enclosure url="https://content.rss.com/episodes/9552/55770/esvs/20200706_095637_9cf19daca31c3e9e9e44e7e85fc9a451.mp3" length="10204802" type="audio/mpeg"/>
      <guid isPermaLink="false">721a0f40-adba-9be4-b0ee-79d0970c7acd</guid>
      <itunes:duration>401</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Mon, 06 Jul 2020 09:56:37 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[EJVES VASCULAR FORUM]]></title>
      <itunes:title><![CDATA[EJVES VASCULAR FORUM]]></itunes:title>
      <description><![CDATA[<p>Introduction to EJVES Vascular Forum</p>]]></description>
      <link>https://rss.com/podcasts/esvs/49140</link>
      <enclosure url="https://content.rss.com/episodes/9552/49140/esvs/20200611_151024_a810a904b80df4ccec927fab79819348.mp3" length="7575499" type="audio/mpeg"/>
      <guid isPermaLink="false">679e6fe6-7307-d141-6c85-49aee23683c4</guid>
      <itunes:duration>259</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 15:10:24 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[SHORT TERM AND LONG TERM OUTCOMES AFTER ENDOVASCULAR OR OPEN REPAIR FOR RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSMS IN THE VQI]]></title>
      <itunes:title><![CDATA[SHORT TERM AND LONG TERM OUTCOMES AFTER ENDOVASCULAR OR OPEN REPAIR FOR RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSMS IN THE VQI]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49137</link>
      <enclosure url="https://content.rss.com/episodes/9552/49137/esvs/20200611_150716_324833a6def2be768a6439a8b4685e54.mp3" length="14949568" type="audio/mpeg"/>
      <guid isPermaLink="false">6dc9396f-80cd-e899-3287-2eca1a1e357d</guid>
      <itunes:duration>585</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 15:07:15 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[THE ECONOMIC EVALUATION OF SURGICAL INTERVENTIONS]]></title>
      <itunes:title><![CDATA[THE ECONOMIC EVALUATION OF SURGICAL INTERVENTIONS]]></itunes:title>
      <description><![CDATA[<p>Editorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/49135</link>
      <enclosure url="https://content.rss.com/episodes/9552/49135/esvs/20200611_150520_c52118d40fa1d74add8eb35dd8962e01.mp3" length="9352591" type="audio/mpeg"/>
      <guid isPermaLink="false">b3f020c0-f014-e058-c99b-3176b8b3f95e</guid>
      <itunes:duration>361</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 15:05:20 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[LONG TERM SURVIVAL AFTER FEMOROPOPLITEAL ARTERY REVASCULARISATION WITH PACLITAXEL COATED DEVICES: A PROPENSITY SCORE MATCHED COHORT ANALYSIS]]></title>
      <itunes:title><![CDATA[LONG TERM SURVIVAL AFTER FEMOROPOPLITEAL ARTERY REVASCULARISATION WITH PACLITAXEL COATED DEVICES: A PROPENSITY SCORE MATCHED COHORT ANALYSIS]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49134</link>
      <enclosure url="https://content.rss.com/episodes/9552/49134/esvs/20200611_150411_234385cb1a1f6fa993649965bfa95546.mp3" length="17285793" type="audio/mpeg"/>
      <guid isPermaLink="false">fb04f9cc-3b47-1a1b-9ae4-f1837885cfde</guid>
      <itunes:duration>665</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 15:04:10 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[PROGNOSTIC ROLE OF PREOPERATIVE SYMPTOMA STATUS IN CEA A SYSTEMATIC REVIEW AND METANAYLSIS]]></title>
      <itunes:title><![CDATA[PROGNOSTIC ROLE OF PREOPERATIVE SYMPTOMA STATUS IN CEA A SYSTEMATIC REVIEW AND METANAYLSIS]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49132</link>
      <enclosure url="https://content.rss.com/episodes/9552/49132/esvs/20200611_150218_fd0a9b70a639cc80c28304867a7195e5.mp3" length="13519955" type="audio/mpeg"/>
      <guid isPermaLink="false">5de93b1a-9cb2-85b2-09a7-4ea5d754816d</guid>
      <itunes:duration>508</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 15:02:18 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[SIGNIFICANCE AND LIMITATIONS OF THE P VALUE]]></title>
      <itunes:title><![CDATA[SIGNIFICANCE AND LIMITATIONS OF THE P VALUE]]></itunes:title>
      <description><![CDATA[<p>Editorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/49131</link>
      <enclosure url="https://content.rss.com/episodes/9552/49131/esvs/20200611_150048_702114620e2abb3c601c4ed03d19948b.mp3" length="11985566" type="audio/mpeg"/>
      <guid isPermaLink="false">18a9b867-7bcf-c784-e7d0-1991e2d0c81f</guid>
      <itunes:duration>488</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 15:00:48 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[EVAR VERSUS OPEN REPAIR FOR AAA: SYSTEMATIC REVIEW AND METANALYSIS OF UPDATED PERIOPERATIVE AND LONG TERM DATA OF RANDOMIZED CONTROLLED TRIALS]]></title>
      <itunes:title><![CDATA[EVAR VERSUS OPEN REPAIR FOR AAA: SYSTEMATIC REVIEW AND METANALYSIS OF UPDATED PERIOPERATIVE AND LONG TERM DATA OF RANDOMIZED CONTROLLED TRIALS]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49129</link>
      <enclosure url="https://content.rss.com/episodes/9552/49129/esvs/20200611_145952_57ddbe8aa901d97e29a9d4b7b0a7a0d6.mp3" length="18646930" type="audio/mpeg"/>
      <guid isPermaLink="false">1da77354-f0ba-c5b6-8b91-aea98c85dff7</guid>
      <itunes:duration>678</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:59:52 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[HOW TO AVOID LYMPHATIC WOUND COMPLICATIONS AFTER VASCULAR GROIN SURGERY]]></title>
      <itunes:title><![CDATA[HOW TO AVOID LYMPHATIC WOUND COMPLICATIONS AFTER VASCULAR GROIN SURGERY]]></itunes:title>
      <description><![CDATA[<p>Editorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/49128</link>
      <enclosure url="https://content.rss.com/episodes/9552/49128/esvs/20200611_145909_19388b215f428b11f9fcd67f3952aeaf.mp3" length="9973896" type="audio/mpeg"/>
      <guid isPermaLink="false">7b0dfff6-1437-92cb-aabe-42703da6c194</guid>
      <itunes:duration>364</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:59:09 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[QUICK GUIDE TO SYSTEMATIC REVIEWS AND METANALYSIS]]></title>
      <itunes:title><![CDATA[QUICK GUIDE TO SYSTEMATIC REVIEWS AND METANALYSIS]]></itunes:title>
      <description><![CDATA[<p>Editorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/49127</link>
      <enclosure url="https://content.rss.com/episodes/9552/49127/esvs/20200611_145811_e977093cd7c9c86898816455dea4d5ee.mp3" length="10196848" type="audio/mpeg"/>
      <guid isPermaLink="false">6bca5a45-980e-ab7d-7cfe-73c338c3462a</guid>
      <itunes:duration>391</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:58:10 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[DRUG COATED BALLOON ANGIOPLASTY VS. STANDARD PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN BELOW THE KNEE PERIPHERAL ARTERIAL DISEASE]]></title>
      <itunes:title><![CDATA[DRUG COATED BALLOON ANGIOPLASTY VS. STANDARD PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN BELOW THE KNEE PERIPHERAL ARTERIAL DISEASE]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49126</link>
      <enclosure url="https://content.rss.com/episodes/9552/49126/esvs/20200611_145730_476c27f01868e406286a99ed8249ee58.mp3" length="11432003" type="audio/mpeg"/>
      <guid isPermaLink="false">fbb41b11-b647-6a0b-3e18-8d9915f489b0</guid>
      <itunes:duration>468</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:57:30 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[QUESTIONNAIRES FOR SURGICAL RESEARCH: NOT ALWAYS A SIMPLE OPTION]]></title>
      <itunes:title><![CDATA[QUESTIONNAIRES FOR SURGICAL RESEARCH: NOT ALWAYS A SIMPLE OPTION]]></itunes:title>
      <description><![CDATA[<p>Editorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/49125</link>
      <enclosure url="https://content.rss.com/episodes/9552/49125/esvs/20200611_145653_bb81b0be302b547fe2c5cbbafcdf5532.mp3" length="9929748" type="audio/mpeg"/>
      <guid isPermaLink="false">f1a8066b-40fc-a808-4055-3e871ce9fe63</guid>
      <itunes:duration>386</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:56:52 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[SHARED DECISION MAKING IN VASCULAR SURGERY.WHY WOULD YOU?]]></title>
      <itunes:title><![CDATA[SHARED DECISION MAKING IN VASCULAR SURGERY.WHY WOULD YOU?]]></itunes:title>
      <description><![CDATA[<p>Editorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/49124</link>
      <enclosure url="https://content.rss.com/episodes/9552/49124/esvs/20200611_145517_1258671f64de9fce220bd82161ddef90.mp3" length="10749462" type="audio/mpeg"/>
      <guid isPermaLink="false">0b3eeb8f-521d-0d3d-12b2-999a0e6be149</guid>
      <itunes:duration>408</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:55:17 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[SEX SPECIFIC DIFFERENCES IN THE MANAGEMENT OF DESCENDING THORACIC AORTIC ANEURYSMS]]></title>
      <itunes:title><![CDATA[SEX SPECIFIC DIFFERENCES IN THE MANAGEMENT OF DESCENDING THORACIC AORTIC ANEURYSMS]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49123</link>
      <enclosure url="https://content.rss.com/episodes/9552/49123/esvs/20200611_145434_5583846932ba5f11702cf6f7cdbaa632.mp3" length="7434059" type="audio/mpeg"/>
      <guid isPermaLink="false">65219653-2f14-c7b4-3027-f4626c586e9f</guid>
      <itunes:duration>282</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:54:34 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[DURABILITY OF OR OF JAAA A MULTICENTER RETROSPECTIVE STUDY IN 5 FRENCH ACADEMIC CENTERS]]></title>
      <itunes:title><![CDATA[DURABILITY OF OR OF JAAA A MULTICENTER RETROSPECTIVE STUDY IN 5 FRENCH ACADEMIC CENTERS]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49121</link>
      <enclosure url="https://content.rss.com/episodes/9552/49121/esvs/20200611_144601_1e5be03507072374ddd6a76d319769fa.mp3" length="14372938" type="audio/mpeg"/>
      <guid isPermaLink="false">0e9f02cb-2a86-2883-b758-80729c9d2056</guid>
      <itunes:duration>30</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:45:00 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[MEDICAL MALPRACTICE IN VASCULAR SURGERY]]></title>
      <itunes:title><![CDATA[MEDICAL MALPRACTICE IN VASCULAR SURGERY]]></itunes:title>
      <description><![CDATA[<p>Ask Away</p>]]></description>
      <link>https://rss.com/podcasts/esvs/49116</link>
      <enclosure url="https://content.rss.com/episodes/9552/49116/esvs/20200611_143004_7b58ac905bb9a86d2872c4feebd96e60.mp3" length="25331797" type="audio/mpeg"/>
      <guid isPermaLink="false">02174d08-c14b-f61a-9608-0829bc321f29</guid>
      <itunes:duration>1020</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:30:04 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[INFORMED CONSENT]]></title>
      <itunes:title><![CDATA[INFORMED CONSENT]]></itunes:title>
      <description><![CDATA[<p>Ask Away</p>]]></description>
      <link>https://rss.com/podcasts/esvs/49115</link>
      <enclosure url="https://content.rss.com/episodes/9552/49115/esvs/20200611_142921_bf9daba393dc9ae99698f893bd23751d.mp3" length="13450452" type="audio/mpeg"/>
      <guid isPermaLink="false">358dc5c9-0541-8938-a0b0-69d417e6ceca</guid>
      <itunes:duration>542</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:29:20 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[IMPACT OF ENDOVASCULAR PEDAL ARTERY REVASCULARISATION ON WOUND HEALING IN PATIENTS WITH CLI]]></title>
      <itunes:title><![CDATA[IMPACT OF ENDOVASCULAR PEDAL ARTERY REVASCULARISATION ON WOUND HEALING IN PATIENTS WITH CLI]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49113</link>
      <enclosure url="https://content.rss.com/episodes/9552/49113/esvs/20200611_142828_31426151200a1463feb5cf8eacc7cade.mp3" length="15765161" type="audio/mpeg"/>
      <guid isPermaLink="false">590410ac-e0d2-479b-be1a-312b839cd8ac</guid>
      <itunes:duration>562</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:28:28 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[FOLLOW-UP OF PATIENTS AFTER REVASCULARISATION FOR PAD A CONSENSUS DOCUMENT FROM THE ESC AND THE ESVS]]></title>
      <itunes:title><![CDATA[FOLLOW-UP OF PATIENTS AFTER REVASCULARISATION FOR PAD A CONSENSUS DOCUMENT FROM THE ESC AND THE ESVS]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49112</link>
      <enclosure url="https://content.rss.com/episodes/9552/49112/esvs/20200611_142705_30f37c65ed4bc5930b890ee79ccd4d9f.mp3" length="16761561" type="audio/mpeg"/>
      <guid isPermaLink="false">b1f5759e-33c7-8fc0-9470-26afc575b362</guid>
      <itunes:duration>589</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:27:05 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[PUBLICATION OF VASCULAR SURGICAL REGISTRY DATA]]></title>
      <itunes:title><![CDATA[PUBLICATION OF VASCULAR SURGICAL REGISTRY DATA]]></itunes:title>
      <description><![CDATA[<p><strong>Editorials</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49111</link>
      <enclosure url="https://content.rss.com/episodes/9552/49111/esvs/20200611_142557_b98c14454c49c2005a83c02dd817f562.mp3" length="10764750" type="audio/mpeg"/>
      <guid isPermaLink="false">6348cca9-3fe8-baae-94d6-547a6c66da74</guid>
      <itunes:duration>390</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:25:56 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[MAJOR SOURCES OF BIAS]]></title>
      <itunes:title><![CDATA[MAJOR SOURCES OF BIAS]]></itunes:title>
      <description><![CDATA[<p>Editorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/49109</link>
      <enclosure url="https://content.rss.com/episodes/9552/49109/esvs/20200611_142155_6ef12d039c62cb58158d7143189e03f4.mp3" length="7560662" type="audio/mpeg"/>
      <guid isPermaLink="false">692976b9-f97d-0f48-ec11-463369235a66</guid>
      <itunes:duration>432</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:21:55 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[UNDERSTANDING CONFOUNDING IN OBSERVATIONAL STUDIES]]></title>
      <itunes:title><![CDATA[UNDERSTANDING CONFOUNDING IN OBSERVATIONAL STUDIES]]></itunes:title>
      <description><![CDATA[<p>Editorial</p>]]></description>
      <link>https://rss.com/podcasts/esvs/49108</link>
      <enclosure url="https://content.rss.com/episodes/9552/49108/esvs/20200611_142003_b15876a71ad021f9afd1a52cb39702f6.mp3" length="7291001" type="audio/mpeg"/>
      <guid isPermaLink="false">96d89eac-f62d-9981-f736-52ad7066d16e</guid>
      <itunes:duration>421</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:20:01 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[NEW CONSULTANT IN VASCULAR SURGERY]]></title>
      <itunes:title><![CDATA[NEW CONSULTANT IN VASCULAR SURGERY]]></itunes:title>
      <description><![CDATA[<p><strong>Editorials</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49106</link>
      <enclosure url="https://content.rss.com/episodes/9552/49106/esvs/20200611_141910_f7860b549690ab56b91da97afdb63a15.mp3" length="13048213" type="audio/mpeg"/>
      <guid isPermaLink="false">02029769-904d-a00a-81ee-b09785fb22b1</guid>
      <itunes:duration>486</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:19:10 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[HOW TO WRITE A RESEARCH PROPOSAL IN VASCULAR SURGERY THE BASICS AND DETAILS NOT TO FORGET]]></title>
      <itunes:title><![CDATA[HOW TO WRITE A RESEARCH PROPOSAL IN VASCULAR SURGERY THE BASICS AND DETAILS NOT TO FORGET]]></itunes:title>
      <description><![CDATA[<p><strong>Editorials</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49105</link>
      <enclosure url="https://content.rss.com/episodes/9552/49105/esvs/20200611_141717_91e6b746ba846dd043ffcc69b8eb0148.mp3" length="7953118" type="audio/mpeg"/>
      <guid isPermaLink="false">080dc9a2-b97c-aee2-5cf5-472996715d63</guid>
      <itunes:duration>454</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:17:17 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[BULLYING, UNDERMINING, AND HARASSMENT IN VASCULAR SURGICAL TRAINING IN THE UK HOW CAN IT BE CONFRONTED]]></title>
      <itunes:title><![CDATA[BULLYING, UNDERMINING, AND HARASSMENT IN VASCULAR SURGICAL TRAINING IN THE UK HOW CAN IT BE CONFRONTED]]></itunes:title>
      <description><![CDATA[<p><strong>Editorials</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49104</link>
      <enclosure url="https://content.rss.com/episodes/9552/49104/esvs/20200611_141547_c860d1f8ac050b1a936514ae2d93288a.mp3" length="14913297" type="audio/mpeg"/>
      <guid isPermaLink="false">f9a53b49-e079-bfe3-2a78-dcc5661f2ca2</guid>
      <itunes:duration>586</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:15:47 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[PREDICTORS OF NEW ISCHAEMIC BRAIN LESIONS ON DIFFUSION IMAGING AFTER CAS AND CEA A SYSTEMATIC REVIEW]]></title>
      <itunes:title><![CDATA[PREDICTORS OF NEW ISCHAEMIC BRAIN LESIONS ON DIFFUSION IMAGING AFTER CAS AND CEA A SYSTEMATIC REVIEW]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49101</link>
      <enclosure url="https://content.rss.com/episodes/9552/49101/esvs/20200611_141155_ff5f591509a4f42731352531aa6ba4db.mp3" length="5493560" type="audio/mpeg"/>
      <guid isPermaLink="false">581caff2-2ba8-60b0-416e-399a1c776447</guid>
      <itunes:duration>353</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 14:11:55 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[FIVE YEAR OUTCOMES OF THE ENDURANT STENT GRAFT FOR EVAR IN THE ENGAGE REGISTRY]]></title>
      <itunes:title><![CDATA[FIVE YEAR OUTCOMES OF THE ENDURANT STENT GRAFT FOR EVAR IN THE ENGAGE REGISTRY]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49097</link>
      <enclosure url="https://content.rss.com/episodes/9552/49097/esvs/20200611_135725_39ccc86317138176feeda9ead19a7589.mp3" length="6501203" type="audio/mpeg"/>
      <guid isPermaLink="false">abdb26aa-46aa-de74-06ba-4fb779f1c1b2</guid>
      <itunes:duration>354</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 13:57:24 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[THE PROGNOSTIC VALUE OF THE WIFI CLASSIFICATION IN PATIENTS WITH CHRONIC LIMB THREATENING ISCHAEMIA A SYSTEMATIC REVIEW AND META-ANALYSIS]]></title>
      <itunes:title><![CDATA[THE PROGNOSTIC VALUE OF THE WIFI CLASSIFICATION IN PATIENTS WITH CHRONIC LIMB THREATENING ISCHAEMIA A SYSTEMATIC REVIEW AND META-ANALYSIS]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49093</link>
      <enclosure url="https://content.rss.com/episodes/9552/49093/esvs/20200611_134721_331c4db6edc1a0db4d5d507bdd5ec9ec.mp3" length="11489966" type="audio/mpeg"/>
      <guid isPermaLink="false">befb3e1c-b928-a915-02ec-408965f43576</guid>
      <itunes:duration>437</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 13:47:21 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[THE IMPACT OF EVAR ON LONG TERM RENAL FUNCTION BASED ON HARD RENAL OUTCOMES]]></title>
      <itunes:title><![CDATA[THE IMPACT OF EVAR ON LONG TERM RENAL FUNCTION BASED ON HARD RENAL OUTCOMES]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49086</link>
      <enclosure url="https://content.rss.com/episodes/9552/49086/esvs/20200611_131815_133e7212c2ecdb189ad530dbce5af85a.mp3" length="5938101" type="audio/mpeg"/>
      <guid isPermaLink="false">0dd0a65c-b46c-64e1-34da-e4d4c1f2394a</guid>
      <itunes:duration>342</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 13:18:14 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[OVERVIEW OF PRIMARY AND SECONDARY ANALYSES FROM 20 RANDOMISED CONTROLLED TRIALS COMPARING CAS WITH CEA]]></title>
      <itunes:title><![CDATA[OVERVIEW OF PRIMARY AND SECONDARY ANALYSES FROM 20 RANDOMISED CONTROLLED TRIALS COMPARING CAS WITH CEA]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49085</link>
      <enclosure url="https://content.rss.com/episodes/9552/49085/esvs/20200611_131536_03abc8049fa2ab024695c29317d5673a.mp3" length="13329028" type="audio/mpeg"/>
      <guid isPermaLink="false">fba27d30-961d-4601-0f2d-cc7650857aa1</guid>
      <itunes:duration>512</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 13:15:36 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[THE PROBLEM OF MULTIPLE HYPOTHESIS TESTING AND THE ASSUMPTION OF CAUSALITY]]></title>
      <itunes:title><![CDATA[THE PROBLEM OF MULTIPLE HYPOTHESIS TESTING AND THE ASSUMPTION OF CAUSALITY]]></itunes:title>
      <description><![CDATA[<p><strong>Editorials</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49084</link>
      <enclosure url="https://content.rss.com/episodes/9552/49084/esvs/20200611_130554_4a2d694be408015e79d32e3820273005.mp3" length="6907557" type="audio/mpeg"/>
      <guid isPermaLink="false">01f17f08-0e41-71ae-1de3-d4b31ba41d63</guid>
      <itunes:duration>400</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 13:05:54 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ALTERNATIVES TO RCTS FOR THE POOR, THE IMPATIENT AND WHEN EVALUATING EMERGING TECHNOLOGIES]]></title>
      <itunes:title><![CDATA[ALTERNATIVES TO RCTS FOR THE POOR, THE IMPATIENT AND WHEN EVALUATING EMERGING TECHNOLOGIES]]></itunes:title>
      <description><![CDATA[<p><strong>Edutorials</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49083</link>
      <enclosure url="https://content.rss.com/episodes/9552/49083/esvs/20200611_130342_09f225bda593dbb1c18c9054be8b9eff.mp3" length="6623144" type="audio/mpeg"/>
      <guid isPermaLink="false">8d347c21-e5c7-6109-f564-7f367f38f74e</guid>
      <itunes:duration>382</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 13:03:42 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[ABDOMINAL COMPARTMENT SYNDROME AFTER SURGERY FOR AAA]]></title>
      <itunes:title><![CDATA[ABDOMINAL COMPARTMENT SYNDROME AFTER SURGERY FOR AAA]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49082</link>
      <enclosure url="https://content.rss.com/episodes/9552/49082/esvs/20200611_125948_09fb2ab7c1cdeb8037d46ed22523ed0c.mp3" length="10491145" type="audio/mpeg"/>
      <guid isPermaLink="false">26b71e58-2710-1654-c935-ab41d5a657ae</guid>
      <itunes:duration>395</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 12:59:48 GMT</pubDate>
    </item>
    <item>
      <title><![CDATA[SEX RELATED DIFFERENCES IN PERIOPERATIVE MORTALITY AFTER ELECTIVE REPAIR OF AN ASYMPTOMATIC AAA IN THE NETHERLANDS]]></title>
      <itunes:title><![CDATA[SEX RELATED DIFFERENCES IN PERIOPERATIVE MORTALITY AFTER ELECTIVE REPAIR OF AN ASYMPTOMATIC AAA IN THE NETHERLANDS]]></itunes:title>
      <description><![CDATA[<p><strong><em>EJVES</em> Editor’s Choice</strong></p>]]></description>
      <link>https://rss.com/podcasts/esvs/49079</link>
      <enclosure url="https://content.rss.com/episodes/9552/49079/esvs/20200611_125535_8bc558d925085850c9eb327494901ddf.mp3" length="15782293" type="audio/mpeg"/>
      <guid isPermaLink="false">abf00632-d271-f8e0-bdce-dbed3093bb3b</guid>
      <itunes:duration>536</itunes:duration>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:explicit>false</itunes:explicit>
      <pubDate>Thu, 11 Jun 2020 12:55:34 GMT</pubDate>
    </item>
  </channel>
</rss>